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The study of traits involved with behavior disorders and immune system can be complex and 
challenging. Gene expression and network analysis can help to elucidate the main molecules and 
pathways that influence complex traits. The goal of these studies is to understand factors that affect 
gene co-regulation patterns related to attention-deficit/hyperactivity disorder (ADHD), drug 
addiction, depression-like behavior, and immune challenge. ADHD is a common neuropsychiatric 
disorder that affects people of different ages. People with ADHD also have a predisposition to 
high levels of physical activity, and some drugs like amphetamine, are used to treat these type of 
disorders. The molecular mechanisms that contribute to the effectiveness of amphetamine therapy 
to ameliorate the symptoms of attention-deficit hyperactivity disorder (ADHD) are partially 
understood. The first experiment aimed to understand the molecular profiles supporting the 
ameliorating effect of amphetamine in a mouse hyperactivity line that exhibits ADHD-like 
behavior using mice striatum transcriptome. The findings support the development of therapies to 
ameliorate ADHD-like behaviors that target gene sub-networks while minimizing the disruption 
in other pathways triggered by amphetamine-based treatments. The second experiment implicated 
in understand the association between inflammation mechanism of action and behavioral disorders 
such as depression-like behavior. The tryptophan (Trp) metabolic route has been linked with 
chronic inflammatory diseases and psychiatric disorders, being tryptophan-degrading enzyme 
Indoleamine 2,3-dioxygenase (IDO1) activated during the inflammatory process. The goal of this 
study was to understand pathways associated with depression-like symptoms after recovery from 
immune challenge and deficiency of a gene associated with depression-like symptoms. The results 
confirmed that the genes identified can be used as potential candidates to understand the 
mechanisms involved in the infection leading to inflammation and depression-like behavior. The 
third study is a continuation of the first experiment, where a systems biology approach was used 
to elucidate mechanisms that regulate functional processes and pathways that are shared between 
genes found in the differential expression analyses. Differential co-expression analysis was also 
used to compare the structure of two co-expression networks between the conditions. Both 
weighted gene co-expression network analysis (WGCNA) and differential co-expression analysis 
were powerful alternatives to find more answers about complex systems. Differences in gene 
expression correlation across treatments and lines helped to understand changes in connectivity 
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CHAPTER 1. INTRODUCTION AND LITERATURE REVIEW 
 
Introduction  
Many complex traits such as behavioral disorders, immune challenge, gene knockout, and 
use of drugs in immune response are influenced by the level of RNA transcribed from the 
genes.  Studies of gene expression are offering insights into the pathways that influence these traits. 
The aim of the study in Chapter 2 was to advance the understanding of the molecular profiles 
supporting the ameliorating effect of amphetamine in a mouse hyperactivity line that exhibits 
ADHD-like behavior using mice striatum transcriptome. Gene network analysis of the molecular 
pathways disrupted by amphetamine treatment in hyperactivity and control lines relative to saline 
treatment uncovered interactions between amphetamine treatment and ADHD-like hyperactivity 
line. In Chapter 3, gene differential expression and networks of peripheral macrophage after 
sickness recovery from BCG challenge relative to saline control in IDO1-KO relative to WT mice 
were explored. After the gene expression analysis studied in Chapter 2, Chapter 4 reported a 
systems biology approach to understanding the molecular basis of the simultaneous effects of 
hyperactivity line and amphetamine treatment. A review of approaches to measure and analyze 
gene expression and systems biology, and a review of traits that are influenced by gene expression 
variation follows. 
 
Gene expression measurements using RNA-seq platform 
RNA is a small molecule similar to DNA, but with few chemical modifications that change 
its properties relative to DNA, as the presence of ribonucleic acid. There are many classes of RNA: 
mRNA, tRNA, rRNA, and others. They are involved in the evolution of life and also play 
functional and regulatory roles in extant organisms  (Brosius and Raabe, 2016). 
Transcription is the process of copying DNA and creating mRNA. In eukaryotes, the 
mRNA, an intermediary molecule which carries the genetic information from the cell nucleus to 
the cytoplasm is converted to a protein sequence by the rRNA in a process called translation. Many 
proteins can be translated from a single mRNA molecule  (Brosius and Raabe, 2016). 
Transcriptome analysis with microarrays was widely used a few years ago. This 
methodology is still used, but it presents some limitations. The mRNA is converted into a stable 





with fluorochrome dyes Cy3 (green) and Cy5 (red) (Govindarajan et al., 2012). Complementary 
sequences are fixed in the chip, and they react with the cDNA targets resulting in a signal from the 
hybridization. The presence of artifacts from hybridization, poor dye-based detection, low 
detection of RNA splice patterns, and no discovery of new genes are some disadvantages of using 
microarray (Govindarajan et al., 2012). 
A new way to measure transcriptome composition and to discover new exons or genes is 
by next generation high-throughput sequencing of cDNA (Mortazavi et al., 2008). This technique 
is called RNA-sequencing (RNA-seq), and it results in sequence reads that will be individually 
mapped to the source genome and counted to obtain the number and density of reads corresponding 
to RNA from each new candidate gene, known exon, or splice event. If samples have enough reads, 
for example above 40 million, it is possible to detect and quantify RNAs (Mortazavi et al., 2008). 
There is a variety of different pipelines available for the analysis of RNA-seq, the choice 
will depend on research goals and organisms to be studied (Conesa et al., 2016). Also, there are 
some aspects that should be evaluated before RNA-seq analysis, like the design of the experiment, 
library type, depth of sequencing, and number of biological replicates. The analysis starts with the 
selection of the mRNA using 3’ polyadenylated (poly (A)) from the total RNA. Then the mRNA 
is fragmented and processed in double-stranded cDNA, adapters are fixed at one end (single-end) 
or both ends (paired-end), this step is called cDNA library preparation (Wang et al., 2009). After 
sequencing, data is acquired containing raw reads that will pass for a quality filtering due to 
possible biases that could be introduced during PCR amplification or other steps of the library 
preparation. FastQC, FASTX-Toolkit, and Trimmomatic are popular software used to quality 
control, the first one generate graphics to visualize the quality, and the others are used for filtering 
low-quality reads or bases and remove adaptor sequences (Conesa et al., 2016). 
RNA-seq technique improves genome annotation, allow discoveries of biological 
functions, and detection of alternative splices and new splices, resulting in more information of 
complex regulatory mechanisms of RNA (Martin and Wang, 2011). The depth coverage of RNA-
seq decreases the cost of the detection of gene expression, which facilitates proteomic studies and 
comparisons of peptides found by mass spectrometry with their respective gene sequence. RNA-
Seq has also been used as an efficient method to identify SNPs in transcribed regions from different 





knowledge and resources that are necessary to the analyses and the interpretation of huge volume 
of data. 
 
Bioinformatics analysis of gene expression studies 
Once the data passed the quality control, next step is to align reads against a reference 
genome or assemble them when there is no reference genome available. A frequent issue for the 
alignment step is that reads may map in multiple sequences of the genome due to repetitive 
sequences or common domains of paralogous genes (Conesa et al., 2016). The use of paired-end, 
in which both ends of the fragment are sequenced, is a more precise technique that facilitates 
reducing the number of alignment errors (Wang et al., 2009). 
Among various software available for mapping, TopHat2 is one of the most popular. This 
method identifies splice sites by first locating non-junction reads (those contained within exons) 
using Bowtie (http://bowtie-bio.sourceforge.net), and then splitting the unmapped reads and 
aligning them independently to identify exon junctions (Langmead et al., 2009). Bowtie is a 
mapping program that indexes the reference genome using the Burrows-Wheeler method which 
scan reads against a genome (Burrows and Wheeler, 1994). There are sequenced parts with 
incorrect base calls due to sequencing errors in low coverage regions. The reference genome is 
used by TopHat2 to call bases and captures missing sequences at the end of exons. TopHat2 also 
controls the gaps presented in exons using a parameter that merges different single exons when 
necessary (Trapnell et al., 2009). Pseudogenes are present in the reference genome and have high 
similarity with some functional genes that contain introns. Reads can be aligned in the pseudogene 
version of these genes by mistake, also may fail to align to structural variations of the genome. 
TopHat2 was implemented with a new algorithm that allows the right alignment of reads in indels 
(insertions and deletions), inversions and translocations (Kim et al., 2013). 
After the alignment, it is necessary to generate an assembly for each condition if one is 
using a similar method to TopHat2. There is a genome-guided method that takes advantage of 
longer read lengths; it is called Cufflinks2 (Trapnell et al., 2012). Cufflinks2 identify splice 
variants of genes and reports only the sets of isoforms that are compatible with read data, 
maximizing the precision of finding the most accurate combination of paths for assembling 
(Garber et al., 2011). Cufflinks2 quantify the expression level based on a statistical model, for 





transcript fragments that are necessary to explain the splicing events. The normalization of the 
count is based on the length of each transcript, computed as FPKMs (fragments per kilo base of 
exon per million fragments mapped). Cufflinks2 algorithm also excludes less abundant transcripts 
that can be artifacts, and quantify abundances using a reference annotation (Trapnell et al., 2012). 
All the assemblies are merged using Cuffmerge, which generates a file that is used as the basis for 
calculating gene expression of each condition. Many of the concepts and algorithms used for 
Cuffmerge are the same that was used in Cufflinks assembles of individual reads. It is also possible 
to integrate Cuffmerge merged assemble with a reference genome annotation (Trapnell et al., 
2012). 
The merged assembly file is used for differentially expression analysis. Cuffdiff2 algorithm 
accurately identifies gene and isoform expression and consider the variability present across 
biological replicates (Trapnell et al., 2012). The consequences of not controlling for variability are 
the over-prediction of differentially expressed genes or transcripts and high false-positive rates. 
Errors can also be introduced due uncertainty in the presence of alternative splicing or repetitive 
regions. Cuffdiff2 addresses these problems by modeling variability of fragments abundance. It 
implements a Poisson model where the estimated variability is the mean count across replicates. 
The P-value is calculated for any observed change in the count of fragments. It identifies 
differential expression at transcriptional or post-transcriptional level (Trapnell et al., 2012). 
A different approach to analyze RNA-Seq data is using Kallisto (Bray et al., 2016). 
Aligning to a reference genome, and estimating the transcript abundances can be time-consuming 
in the analysis of RNA-seq. Kallisto is a two order methodology that is based on a pseudoaligment 
of reads to a reference genome, it combines information from k-mers within reads, and avoids to 
align individual bases, instead, it produces a list of transcripts that are compatible with each read. 
This program makes alignment using transcriptome de Bruijn graph constructed from k-mers 
(Compeau et al., 2011). For quantification, the method includes a model for bias and the 
expectation-maximization algorithm (Patro et al., 2014). The advantages of this software are the 
speed, the accuracy, and the simplicity. 
For analysis of similar methods to Kallisto, it is possible to integrate transcript-level 
abundance estimates into count-based statistical inference using an R package called tximport 
(Soneson et al., 2015). In this software, evidence showed that the use of gene-level is more 





advantage of transcript-level abundance estimates to improve differentially expression results. The 
package tximport imports transcript length and abundance estimates from Kallisto, for example, 
and export count matrices (Soneson et al., 2015). There is also an option to average transcript 
length correction terms and apply them to common statistical R packages that use counts as input 
to analyze differential expressions like edgeR (Robinson et al., 2010) and DESeq2 (Love et al., 
2014). 
 Both edgeR and DESeq2 are software packages available in R, the input data is a table of 
counts, where columns correspond to samples and rows to genes or transcripts (Love et al., 2014; 
Robinson et al., 2010). These packages determine if there are significant differences between 
counts across experimental conditions. To account for biological and technical variability edgeR 
uses an overdispersed Poisson model and empirical Bayes to improve the reliability of inference 
(Robinson et al., 2010). In DESeq2, each gene is described with a generalized linear model (GLM) 
of the negative binomial distribution, but it also uses empirical Bayes shrinkage for dispersion 
estimation (Love et al., 2014). The difference between DESeq2 and edgeR is that the first one 
estimates the width of the prior distribution from the data and controls the amount of shrinkage 
based on the observed properties of the data. The second one requires the prior degrees of freedom 
to weight the contribution of each gene and for the dispersion fit (Love et al., 2014). The advantage 
of using DESeq2 and edgeR is that they both provide the flexibility to analyze more complex 
designs, and present high sensitivity of the algorithms to controlled type-I error (Love et al., 2014). 
Figure 1 shows a brief workflow of bioinformatics tools used to perform the analysis in the 






Figure 1. Workflow of bioinformatics tools used in the analysis of each Chapter. 
 
The Kallisto methodology 
Kallisto is considerate an ultra-fast alignment-free method, where alignments are not 
necessary to find the origins of reads (Bray et al., 2016). Kallisto does pseudo-alignments of reads 
by using hashing of k-mers (hash function is used for rapid data lookup, mapping data of any size 
to data with fixed size). Then, Kallisto combines the hashing k-mers with de Bruijn graph to 
perform the pseud-alignment, called transcriptome de Bruijn graph (T-DBG), which will be used 
to make the comparison of the reads to the transcripts (Bray et al., 2016). After the T-DBG is built, 
Kallisto maps each k-mer to the contig by using a hash table (a hash map that associate keys to 
values) and create the Kallisto index (Bray et al., 2016). The association of each k-mer in the T-
DBG with transcripts will belong to a determined class called k-compatibility class. The 
intersection of all k-compatibility classes that reads are associated will give the transcript that the 
read is compatible (Bray et al., 2016). Kallisto takes advantage of the redundant information along 
the path of the graph and does not consider k-mers that have same equivalent class because the k-
mers are redundant and provide no new information. Then, the intersection of the k-compatibility 





In comparison with Kallisto, Cufflinks has an alignment-dependent algorithms and is the 
most popular tool that makes novel transcript and isoforms discovery and quantification (Zhang et 
al., 2017). Although alignment-free methods like Kallisto are fastest for requiring less 
computational time, both methods showed strong concordance for highly expressed transcripts 
(Zhang et al., 2017). Cufflinks showed inferior accuracy performance than Kallisto, and also, 
FPKMs from Cufflinks produces largest variations in the estimation of quantification and 
underestimates the expression of absent transcript (Zhang et al., 2017). In general, Kallisto present 
more advantages related to speed and accuracy compared to Cufflinks to perform RNA-Seq 
analysis. 
 
Interpretation of gene expression analyses through Annotation, Enrichment, and Networks 
The use of technology like high-throughput next generation sequencing to ‘omics’ studies, 
usually result in large output files of genes. Understanding the biological meaning of large volume 
of data may be challenging. The software DAVID (the Database for Annotation, Visualization, 
and Integrated Discovery) allows analyzing many types of gene lists, coming from diverse 
platforms (Huang et al., 2009). It is a computational procedure that explores the biological meaning 
of the data. It provides annotation, enrichments, and have integrated data-mining environment. 
One can submit a list of genes for different purposes as genes that contain the same characteristics, 
genes for expression studies with fold changes >|2| or p-values <0.05, genes up or down regulated 
or lists of genes with an important statistical threshold to search for biological processes. Larger 
gene lists result in higher statistical power, higher sensitivity, consequently having more 
significant P-values and more enriched terms (Huang et al., 2009). One disadvantage of using 
DAVID is that it gets very limited if the gene list is small. The principle of the enrichment in 
DAVID analysis is that higher potential genes (enriched) are selected based on the background list 
and type of species that is provided. The enrichment is quantified by more than one method: 
Fisher’s exact test, Binomial probability, and Hypergeometric distribution. Enriched Gene 
Ontology (GO) terms, for example, are the most statistically over-represented terms of the list, 
which increases the likelihood to identify important biological processes (Huang et al., 2009). 
According to Huang et al. (2008), the enrichment score for groups is “the geometric mean 
of all the enrichment p-values (Expression Analysis Systematic Explorer - EASE scores) for each 





on Fisher exact test (Gonzalez-Pena et al., 2016a). To be a relative score, the P-values suffer minus 
log transformation. Higher group score results in more enriched terms for gene members of that 
group. To control for false discovery rate, DAVID provides three types of multiple testing 
corrections for the enriched P-values: Bonferroni, Benjamini, and FDR (Huang et al., 2008). For 
the Functional Annotation Chart, the significance of enriched clusters is evaluated with a modified 
Fisher’s exact test (EASE score) (Huang et al., 2008). 
The Gene Set Enrichment Analysis (GSEA) is another analytical method to interpret gene 
expression data. As DAVID, it also focuses on a set of genes that share the same biological 
functions or patterns. The difference between them is that instead of just use genes that show 
largest differences to determine the biological meanings, GSEA uses all genes that are expressed 
on the list. In GSEA, it is considerate a gene set S (originated from prior studies and biological 
knowledge) and a list of genes L. The aim is to analyze if genes of the sets tend to go toward to 
the top or to the bottom of the list, showing if it is correlated with phenotype and its distribution 
(Subramanian et al., 2005). 
GSEA method has three principles: first, is the calculation of an enrichment score (ES), 
which means the level in where the sets S is overrepresented at the thorough list. The score 
increases when genes are part of the set, and it decreases when genes are not present in the set 
along the whole list. The ES is the maximum deviation from zero found on the list and is equivalent 
to a weighted Kolmogorov–Smirnov-like statistic (Hollander and Wolfe, 1999). Second, there is 
the estimation of the significance level of ES, where the nominal p-value of ES is calculated using 
an empirical phenotype-based permutation test method that maintains the correlation structure of 
data, generating a null distribution for the ES (Subramanian et al., 2005). Finally, the adjustment 
for multiple hypothesis testing is when the whole list of genes is evaluated, first it is normalized 
to account for the size of the set (normalized enrichment score - NES), then false positives are 
controlled by FDR (Subramanian et al., 2005). Also, significance levels are estimated for both 
positive and negative scoring gene sets. 
Networks have been used for data visualization and to find biological-meaningful answers 
for the data (Martin et al., 2010). Networks are used as a graph representation of molecules 
interaction in a known relationship, where nodes and edges are used to represent functional 
relations and type of entity, respectively. Estimated values associated with P-values resulted from 





differential expression P-value and colors represent over- or under-expression between treatments 
(Martin et al., 2010; Shannon et al., 2003). There are several tools for construction and 
visualization of networks as VisANT (Hu et al., 2005), Osprey (Breitkreutz et al., 2003), and 
BisoGenet (Martin et al., 2010). VisANT provides a visual interface, annotation, integrates 
different types of biological information based on association and connectivity data. Osprey is a 
similar application and uses a wide range of platforms; it can incorporate new interactions into 
existing networks, and also uses connectivity levels to filter networks. However, these 
methodologies present some limitations, for example, Osprey is not efficient for large-scale 
network analysis and VisANT’s visual integration tools do not take any combination of operations 
in any order (Pavlopoulos et al., 2008). Bisogenet is a new tool for analyzing networks; it is 
different from the others because it can represent coding relations, for example, finding multiple 
isoforms of a gene as a result of alternative splicing (Martin et al., 2010). This program provides 
information of disease-related and tissue-specific, more regulatory information as transcription 
factors, and microRNA silencing relations, and consequently a more complete systems biology 
tool (Martin et al., 2010). BisoGenet is used as a Cytoscape plugin, and the information of 
annotation and pathways come from SysBiomics, a database that integrates many public data 
sources (Martin et al., 2010; Shannon et al., 2003). The statistical is based on cluster coefficient, 
and degree of the node depends on neighbor’s relationship and distance of paths (Martin et al., 
2010).  
The use of gene expression analysis, with the study of different statistical methods and 
bioinformatics tools and finally network analysis are provided to understand how biological 
information underlies complex traits such the molecular architecture of behavioral disorders and 
drug addiction.  
 
Weighted Gene Co-expression Network Analysis and differential co-expression analysis 
Studies of systems biology can be applied to transcriptome data to elucidate more complex 
mechanisms of regulation (Langfelder and Horvath, 2007). The use of systems biology has been 
widely applied to diseases (Sengupta et al., 2009). Methods of correlation network analysis 
contribute to finding patterns among genes across the samples. Gene co-expression networks have 





processes and pathways. A methodology that uses gene co-expression is the Weighted Gene Co-
expression Network Analysis (WGCNA) (Langfelder and Horvath, 2007). 
The concept for fundamental networks varies in three types: 1) networks not related to 
modules, 2) network properties of a module (intramodular), and 3) relationship between modules 
(intermodular) (Zhang and Horvath, 2005). Gene co-expression networks only identify 
correlations, indicating what genes act simultaneously in the same processes. Networks can 
explain the relationship between n nodes, which can be any biomolecule like genes or proteins. 
Networks are specified by an nxn dimensional adjacency matrix A = (Aij), being Aij the 
connection strength from node i to j (Zhang and Horvath, 2005). The gene-gene similarity matrix 
describes the similarity between expression patterns across samples. Measures of correlation are 
applied to construct the networks (van Dam et al., 2017). 
The resulted co-expression associations are used to construct modules. Modules are groups 
of co-expressed genes, identified using clustering methodologies as hierarchal clustering (van Dam 
et al., 2017). This clustering method divides each cluster into sub-clusters, resulting in a tree with 
branches where the branches are modules. An eigengene is a vector that best describes the patterns 
of all genes inside each module. As co-expressed genes are functionally related, functional 
enrichment analysis can be used to interpret the list of genes in each module. Final results will 
depend on the heterogeneity of samples, co-expression analysis decrease the statistical power to 
detect modules when limited to specific conditions to identify common co-expression patterns (van 
Dam et al., 2017). 
Differential co-expression analysis detects modules that cannot be detected in the regular 
co-expression or differential expression methods. Co-expression networks identify correlations, 
and genes active in the same biological process, while the differential co-expression analysis 
identifies co-expressed genes under different conditions, such as treatments, identifying modules 
unique to the specific type of treatment (van Dam et al., 2017). Therefore, genes identified in this 
analysis are more likely to explain the differences between phenotypes. Figure 2 shows the 






Figure 2. Workflow of WGCNA, including each step of the analysis. 
 
Complex behavior and immune traits 
Attention deficit/hyperactivity disorder and Drugs of Abuse 
Attention deficit/hyperactivity disorder (ADHD) is a common mental disorder that occurs 
during the childhood and may continue into adulthood. It has a substantial impact on someone’s 
life and despite it is characterized by high level of inattention, increased impulsivity and 
hyperactivity the diagnosis may not be so easy (Castellanos and Proal, 2012). The genetic 
predisposition for hyperactivity was already related to ADHD; the estimated heritability is 
approximately 76% in humans (Faraone et al., 2005). ADHD prevalence rate in the world is 
estimated at 5.9–7.1% for children and adolescents (Willcutt, 2012).  
People with ADHD also have a predisposition to high levels of physical activity 
(hyperactivity). These levels of physical activity are influenced by complex genetic factors that 
are associated with behavioral diseases, which require further elucidations of neurobiological 
mechanisms. A mouse line selected for increased home cage activity (Hyperactivity line) is an 
effective model to understand genetic factors involved in neurobiological processes influencing 
behavioral disorders (Majdak et al., 2014). This line emerged from a selective breeding method to 





was made in a population over many generations to understand how genes related to 
neurobiological circuits increase levels of physical activity and consequently the features of 
ADHD (Zombeck et al., 2011). 
For the breeding selection, increased physical activity was measured by voluntary wheel 
running, open field behavior and forced treadmill running in mice. These traits are involved with 
neural circuits and act in different regions of the brain. The selection for increased home cage 
activity started from two populations: Hsd:ICR and Collaborative Cross G2:F1 (CC) mice (Chesler 
et al., 2008). Hsd:ICR was used because it was already explored for a selective breeding 
experiment for increased voluntary wheel running behavior (Swallow et al., 1998). The 
Collaborative Cross mice were used because it increases the genetic diversity due to the eight 
inbred strains that derived it: A/J, C57BL/6J, 129S1/SvImJ, NOD/LtJ, NZO/H1LtJ, CAST/EiJ, 
PWK/PhJ, and WSB/EiJ (Beck, et al. 2000; Zombeck et al., 2011). Based on these populations 
emerged two lines, High-Active and Control (Zombeck et al., 2011). 
After generations, the High-Active mice still demonstrated increased hyperactivity, being 
used as a model to study ADHD (Majdak et al., 2014). This study however also had another goal 
which was to demonstrate that the use of different doses of d-amphetamine can be therapeutic and 
ameliorate the behavioral symptoms of ADHD. Rhodes et al. (2004) (Rhodes et al., 2004) showed 
that exposure to methylphenidate made mice selectively bred to diminish running levels, while 
control lines that also received the same treatment increased wheel running. Majdak et al. (2014) 
(Majdak et al., 2014) had as a result that High-Active mouse line can be used to study 
neurobiological mechanisms related to hyperactivity suggesting that there is a response to 
amphetamine administration to it. 
The administration of different drugs had already shown addiction effects using striatum 
tissue. Drug administration affects dopamine and serotonin, neurotransmitters that can be 
responsible for developing the addiction. Studies showed the increase in total serotonin 
concentration in brain tissues including striatum after drug (cocaine) administration in rats (Kirby 
et al., 2011; Krzascik et al., 2015). In a study of meta-analysis using in vivo imaging of 
amphetamine and methamphetamine to understand the dopamine system and dependence process 
in humans, the amphetamine decreased striatal dopamine transporter availability (Ashok et al., 





Some genes already showed an important role in ADHD, a study of genotyping in Chinese 
children and adolescent suggested that SLC6A1 gene variants may have a significant effect on the 
ADHD risk (Yuan et al., 2017). Another study with mice also showed that SLC6A1 gene knock-
out (−/−) had hyperactivity and impaired sustained attention as phenotype (Chen et al., 2015). 
Growth factor receptor-bound protein isoform 10 (GRB10) is highly expressed in many brain 
regions rich in dopaminergic and serotonergic neurons, which are associated with ADHD (Franke 
et al., 2009). The gene cadherin 13 (CDH13) was associated with addiction vulnerability to 
substances like methamphetamine; it is expressed in regions of the brain that are related to ADHD 
and addiction behavior (Uhl et al., 2008). 
 
Understanding immune response 
The immune system is composed of dynamic and functional networks of specialized cell 
types and tissues that provide complex molecular and cellular events during an immune response. 
Gene expression analysis has been applied to all cell types of immune system, like cytokines and 
chemokines, to find the interaction between immune system components at the molecular level 
(Furman and Davis, 2015). 
Gene expression and bioinformatics tools have also been used to addiction-related traits to 
help to elucidate mechanisms of the immune system and how they are influenced by multiple 
genetic and environmental factors. Differentially expressed genes identify genes in regions 
depending on the magnitude of the behavioral trait complexity. These analyses are important to 
find genetic markers that influence amphetamine-related responses and identify genes and their 
precise function in a given behavior, however, they are also challenging due to the complexity of 
drug-related traits. Using genomic approaches, it was possible to link the action of amphetamine 
in the dopaminergic system and find dopamine-related genes to drug-response (Phillips et al., 
2008).  
Another method is the use of gene knockout on behavioral responses to drugs and immune 
system. Addiction studies found answers related to signaling and cell support molecules involved 
in complex drug reward-related traits (Phillips et al., 2008). Gene expression analyses take 
advantage of this technology allowing to understand the difference between transgenic animals 





Advances in technology also allowed researchers to make detailed studies of the 
immunoglobulin (Ig) and T-cell receptor (TCR) repertoires responding to vaccines. The 
development of computational tools to integrate models to analyze human immune response 
accelerates the understanding of how the immune system works and consequently accelerates 
vaccine and other medical treatments (Furman and Davis, 2015).  
The use of high-throughput sequencing approaches can be applied to the immune system 
to gives insights and identify immune biomarkers (Furman and Davis, 2015). The goal of these 
studies is to use information from gene expression analysis to understand the molecular basis of 
two complex traits: the simultaneous effect of amphetamine and ADHD, and immune response of 
macrophages. 
 
Inflammation in depression and ADHD 
Studies have been shown the relationship between inflammation and other conditions such 
as psychiatric disorders (Mitchell et al., 2017). Children and adolescents present high prevalence 
of conditions related to inflammation, like obesity, asthma, and allergy (Mitchell et al., 2017). 
Inflammation is a complex trait that can have a broad variety of reactions, including systemic 
reactions, migration and activation of leukocytes, and vascular responses (Mitchell et al., 2017). 
The key modulators of inflammation are the cytokines, which are also mediators between the 
immune system and the central nervous system (Mitchell et al., 2017). Studies show the link 
between inflammation, pro-inflammatory cytokines, and depression in adult humans (Dowlati et 
al., 2010). Interferon (IFN)-a therapy can induce depression in patients treated for hepatitis C 
(Lotrich et al., 2009). People with depression present higher concentration of interleukin 6 (Il-6) 
and TNF-a relative to no depressed people (Mitchell et al., 2017). Inflammation was also 
associated with bipolar disorder, schizophrenia, and ADHD (Mitchell et al., 2017). Low levels of 
Il-10 are associated with ADHD and schizophrenia (Mittleman et al., 1997). Increased Il-16 and 
Il-13 were related to ADHD symptoms of hyperactivity and inattention in humans, respectively 
(Oades et al., 2010).  
ADHD and depression might be sharing common causative pathways. One example is the 
kynurenine metabolites that can modulate neurotransmission and have neuroprotective or 





indoleamine 2,3-dioxygenase (IDO) (Christmas et al., 2011). The increase of IDO1 activity may 
increase neurotoxic metabolites of the kynurenine pathways and cause tryptophan depletion, 
causing depression (Christmas et al., 2011). Metabolites of tryptophan/kynurenine pathway and 
cytokines activities were also related to children with ADHD symptoms in a medicated group 
(Oades et al., 2010).  
ADHD in children might be related to maternal care during pregnancy, affecting the 
kynurenine levels. Maternal smoking during pregnancy is related to decreasing levels of 
kynurenine, and increased levels of 3-hydroxy-kynurenine (3HK) in children with ADHD (Oades, 
2011). Medications and supplementations taken during pregnancy are also related to children that 
had ADHD compared to mothers of healthy children. Increasing levels of kynurenic acid in 
children with ADHD was associated with stressful events that occurred during pregnancy (Oades, 
2011). Tryptophan levels tend to decrease in children with ADHD that consume seafood and spend 
time with parents (Oades, 2011). Also, increased child care in these cases also decreases 
tryptophan levels and cytokines Il-2, IFN-y, and S100 calcium Protein B (S100B). Diet with fish 
might be beneficial to a kid with ADHD and increase pro-inflammatory IL-2 and IFN-y (Oades, 
2011). The tryptophan metabolism and cytokines may be influencing the occurrence of both 
ADHD and depression symptoms. 
 
The overarching goal of this thesis is to understand factors that affect gene co-regulation 
patterns. Complementary methodology was applied to two RNA-seq data sets. One experiment 
aimed at understanding the pathways associated with high voluntary activity genotype and the 
central nervous system stimulant amphetamine. The other experiment aimed at understanding the 
pathways associated with depression-like symptoms after recovery from immune challenge and 
deficiency of a gene associated with depression-like symptoms. The first experiment profiled the 











CHAPTER 2 - GENE NETWORK EVIDENCE OF INTERACTION BETWEEN 
AMPHETAMINE TREATMENT AND HYPERACTIVITY IN A MOUSE MODEL OF 
ATTENTION-DEFICIT HYPERACTIVITY DISORDER 
 
Abstract 
The psychostimulant amphetamine is frequently used in treatments to ameliorate the symptoms of 
attention-deficit hyperactivity disorder (ADHD). The molecular mechanisms that contribute to the 
effectiveness of this therapy are partially understood. To address this, the striatum of mice from a 
line (H) selected for hyperactivity that models ADHD and a contemporary control line (C) 
receiving either amphetamine treatment (A) or saline (S) treatments were studied using RNA-Seq. 
Among the 1,498 genes that exhibited significant (FDR adjusted P-value < 0.05) treatment-by-line 
interaction effect. These genes included a high number of neuropeptide coding genes and genes 
associated with neurogenesis, memory and neuroplasticity, cell adhesion, angiogenesis, and 
synaptic signaling. Lesser frequent genes are exhibiting interaction effects associated with energy 
and redox processes that exhibited opposite differential expression between A and S treatments 
across H and C lines genes. Network analysis uncovers a unique association between the synaptic 
signaling genes Nrgn and Rims1 that could explain the therapeutic effect of amphetamine on 
ADHD symptoms. Our study of gene co-regulatory network uncovered one mode of action by 
which amphetamine ameliorates the antagonistic disruption of Arc and Shank in the hyperactive 
line that exhibits ADHD-like behaviors. The network module including Shank1, Arc, Rims1, 
Dlgap1, Rapgef4, and Dlgap1, Rapgef4 suggests that treatment A decreases the differential 
expression of genes between the H and C lines by targeting whole subnetworks of connected genes, 
rather than isolated genes. Our findings support the development of therapies to ameliorate 
ADHD-like behaviors that target gene sub-networks while minimizing the disruption in other 












Amphetamine is a synthetic psychological and metabolic stimulant that enhances 
concentration and awareness. Individuals exposed to amphetamine exhibit over-activity levels 
disrupted sleep patterns, and reduced appetite (Weyandt et al., 2014). The effects of this stimulant 
have been harnessed in treatments to ameliorate the symptoms of behavioral disorders including 
attention-deficit hyperactivity disorder (ADHD) and in weight loss programs (Berman et al., 
2009). Amphetamine usage has an increased risk for development of tolerance, abuse, dependence, 
and addiction (Weyandt et al., 2014). Both ADHD status and amphetamine effects involve 
dysregulation of neurological and molecular mechanisms in the striatum (Burns et al., 1993; 
Castellanos and Proal, 2012), a brain region that controls locomotor activities, voluntary behavior, 
spatial memory, and response and addiction to psychostimulants (Gruber and McDonald, 2012; 
Mizumori et al., 2009; Yager et al., 2015).  
Given the therapeutic effect of amphetamine treatment on ADHD, mice “knocked out” for 
individual genes in the amphetamine addiction pathway have been used to understand the 
molecular mechanisms underlying ADHD. For example, heterozygous knockout mice for 
dopamine transporter hypofunctional (DAT+/-) exhibited hyperactivity, attentional and 
impulsivity deficits and molecular disruptions and these deficits were ameliorated with a low-dose 
chronic amphetamine treatment (Ashok et al., 2017; Mereu et al., 2017). Brain-derived 
neurotrophic factor (Bdnf) serves as a neurotransmitter and plays a role in the etiology of ADHD. 
Likewise, a conditional knockout of Bdnf ADHD exhibited high locomotor hyperactivity and 
ADHD behavioral characteristics (Sagvolden et al., 2005; Tsai, 2016). Another model 
encompasses mice null for adhesion G protein-coupled receptor L3 (Adgrl3), a gene associated 
with ADHD and susceptibility to addiction. Mice from this line took more time to become 
immobile and were immobile for shorter periods in a forced swimming test than wild-type mice 
and 11 genes associated with neuron structure and function were differentially expressed between 
these groups (Orsini et al., 2016). 
Selective breeding strategies that address the polygenic nature of ADHD offer effective 
models of this disorder (Majdak et al., 2016; Yen et al., 2013). One ADHD model consists of a 
mouse line selected for hyperactivity not only run and traveled more in the cage but also 
underperformed in the open field behavior and Morris water maze relative to the control line 





motor impulsivity and the activation of neurons in the prefrontal cortex and cerebellum in the 
selected line (Majdak et al., 2016). This treatment had the opposite effect on the activation of 
neurons in the control line suggesting a potential interaction between amphetamine treatment and 
activity line. Another ADHD model involves a mouse line selected for low trait anxiety-related 
behavior that displays hyperactivity in home cages (Yen et al., 2015). In this model, acute low-
dose amphetamine treatment was associated with a reduction of locomotor activity and inhibition 
of the activity of glycogen synthase kinase 3beta (Gsk3b) in the medial prefrontal cortex. A 
microarray study identified 75 genes differentially expressed in the spontaneously hypertensive rat 
line when exposed to amphetamine (dela Peña et al., 2015). These 75 genes were associated with 
angiogenesis, cell adhesion, apoptosis, and neural development. 
The objective of this study is to advance the understanding of the molecular profiles 
supporting the ameliorating effect of amphetamine in a mouse hyperactivity line that exhibits 
ADHD-like behavior. A comprehensive study of the molecular patterns disrupted by amphetamine 
treatment in the striatum of a mouse model of ADHD provides a complete understanding of the 
mode of action of amphetamine therapy. This model provides insights into the dysregulation of 
molecular mechanisms associated with amphetamine (independent of hyperactivity line) and into 
dysregulation associated with hyperactivity line (independent of amphetamine treatment). 
Moreover, our comparative gene network analysis of the molecular pathways disrupted by 
amphetamine treatment in hyperactivity and control lines relative to saline treatment uncover 
interactions between amphetamine treatment and ADHD-like hyperactivity line.  
 
Material and methods 
Animal experiments 
Generation 17 mice from a hyperactivity line selected for increased home cage activity 
(line H) and from a contemporary control line (line C) were studied (Majdak et al., 2014; Majdak 
et al., 2016; Zombeck et al., 2011). This selective breeding line constitutes a model for ADHD-
like behaviors. Home cage activity is individually measured using video recording at 
approximately two months of age as the average distance traveled during two days (Zombeck et 
al., 2011). By generation 16, male H mice exhibited significantly higher activity (distance traveled, 





mice. Moreover, H mice exhibited significant lower motor coordination and learning skills 
measured using the accelerating rotarod task (Majdak et al., 2016). 
Male mice were group-housed after weaning, and cages were placed in rooms monitored 
for temperature (21 ± 1 °C) and photo-period (12:12 Light:Dark; lights off at 8:00 AM). Food 
(Harlan Teklad, 7012) and water were provided ad libitum. At approximately five months of age, 
drug-naive mice were acclimated to their home cage for four days. The average activity traveled 
during days 2 and 3 of individual mice were used as a baseline measurement to confirm that the 
mice studied were representative of the H and C lines. On day 4, 1.5 hours into the Dark cycle 
(active phase for mice), one intraperitoneal injection of either 0.25 mg/kg of d-amphetamine 
(treatment A) or equal amount of saline (treatment S) was given to each mouse in the home cage 
over 3 days (Majdak et al., 2016). Two hours after injection, mice were decapitated followed by 
immediate removal of the brain. In total, 20 mice were analyzed across the 2 activity lines and the 
two amphetamine treatments. The Illinois Institutional Animal Care and Use Committee approved 
all animal procedures, and these procedures were in accordance with the National Institutes of 
Health Guide for the Care and Use of Laboratory Animals. 
 
RNA-Seq analysis 
Striatum was extracted and dissected on a chilled aluminum block, snap frozen on dry ice, 
and stored in a centrifuge tube at -80oC following our published protocols (Caetano-Anollés et al., 
2016; Saul et al., 2017). The RNase-free disposable pellet pestle (Fisher Scientific, Pittsburgh, PA, 
USA) was used for tissue homogenization, and RNeasy1 Lipid Tissue Mini Kit (Qiagen, Valencia, 
CA, USA) was used for RNA extraction. The isolated RNA was purified with DNase I (Qiagen, 
Valencia, CA, USA). Total RNA yield measured using Qubit1 2.0 (Life Technologies, Carlsbad, 
CA, USA) was > 14 ug per sample. The RNA Integrity Number (RIN) measured using Fragment 
Analyzer (Advanced Analytical Technologies Inc., Ankeny, IA, USA) was > 8 for all samples. 
Libraries from individual mouse striatum samples were prepared using Illumina's TruSeq Stranded 
RNAseq Sample Prep kit (Illumina Inc., San Diego, CA, USA) and 100nt-long paired-end reads 
from each animal separately were obtained. The libraries were sequenced using Illumina HiSeq 
2500, and a TruSeq SBS sequencing kit version 4 (Illumina, San Diego, CA, USA) and the FASTQ 
files containing paired-end reads of length 100nt were generated and demultiplexed with the 





The average Phred quality score of the reads was assessed using the software program 
FastQC (Andrews, 2010). The nucleotide quality score was > 30 across all read positions and was 
not trimmed (Nixon et al., 2015). The software program TopHat2 v2.1.1 was used to map the reads 
to the mouse genome assembly Genome Reference Consortium GRCm38 (Pruitt et al., 2006; 
Trapnell et al., 2009). Transcripts were assembled and abundance estimated using the software 
program Cufflinks (Trapnell et al., 2012) with default specifications: bias correction; weight reads 
mapping to multiple locations in the genome; upper quartile normalization of the number of 
fragments mapping to individual loci; use of reference genome annotation to provide additional 
information for assembly (Trapnell et al., 2012). Cuffdiff was used to test the changes in gene 
expression between groups (Trapnell et al., 2012).  
Comparison among line-treatment combination groups offers insights into the interaction 
between line and treatment (Caetano-Anollés et al., 2015). Mouse groups are identified with a 2-
letter acronym: the first letter denotes the line and the second letter denotes the treatment: H line 
and S treatment (HS group); H line and A treatment (HA group); C line and S treatment (CS 
group); and C line and A treatment (CA group). These four line-treatment groups enable the 
evaluation of six pairwise contrasts. The contrasts HA-HS and CA-CS offer information on gene 
dysregulation associated with amphetamine treatment within the H and C lines, respectively; HS-
CS and HA-CA offer information on gene dysregulation associated with hyperactivity within the 
A and S treatments, respectively; and HS-CA and HA-CS offer information on gene dysregulation 
associated with simultaneous effects of hyperactivity line and amphetamine treatment. Among the 
six possible contrasts between hyperactivity line-amphetamine treatment groups, the three 
orthogonal contrasts that will be interpreted are CA-CS, HA-HS, HS-CS. Comparison between 
lines (irrespective of treatment) and between treatments (irrespective of the line) offer insights into 
the main effects of line and treatment. All genes with 5 or more reads per line-treatment group 
were analyzed to ensure adequate representation across groups. The Benjamini-Hochberg false 
discovery rate (FDR) was used to adjust the differential expression P-value for multiple testing 
(Benjamini and Hochberg, 1995).  
 
Functional and network analysis 
Functional analysis was used to aggregate information on the level and pattern of gene 





complementary analyses were undertaken. The enrichment of functional categories among the 
differentially expressed genes was evaluated using a hypergeometric test within the web-service 
Database for Annotation, Visualization and Integrated Discovery (DAVID; Version 6.8) (Huang 
et al., 2009). The enrichment of functional categories was also evaluated using a Kolmogorov test 
on the standardized expression profile of all genes available in the Gene Set Enrichment Analysis 
(GSEA) software (Subramanian et al., 2005). The functional categories assessed included Gene 
Ontology (GO) biological processes (BP), molecular functions (MF), and the Kyoto Encyclopedia 
of Genes and Genomes (KEGG) pathways. The Functional Annotation Tool (FAT) categories 
corresponding to the GO terms available in DAVID were used to minimize redundancies across 
the GO hierarchy (Caetano-Anollés et al., 2016). Categories were clustered in DAVID, and the 
geometric mean of the enrichment P-values (Enrichment Score, ES) was used as evidence 
supporting the category clusters. The mouse genome was used as background for testing and FDR 
was used to adjust the enrichment P-values for multiple testing (Pruitt et al., 2006). 
Gene networks were reconstructed to uncover gene dysregulation on a system-level basis, 
using Bisogenet package within the Cytoscape environment (Delfino et al., 2011; Killcoyne et al., 
2009; Martin et al., 2010; Serao et al., 2013). These networks depict gene relationships based on 
protein-protein interactions annotated in BIOGRID, HPRD, DIP, BIND, INTACT, and MINT 
databases (Keshava Prasad et al., 2008; Mathivanan et al., 2006). Networks encompassing 75 
genes exhibiting significant differential expression in at least one of the 3 orthogonal contrasts 
between hyperactivity line-amphetamine treatment groups (CA-CS, HA-HS, HS-CS) were 
reconstructed to facilitate the comparison of disrupted networks across contrasts and interpretation 
(Caetano-Anollés et al., 2016; Gonzalez-Pena et al., 2016a; Gonzalez-Pena et al., 2016b). All 
genes in the final networks were associated with functional categories enriched among the genes 
exhibiting a significant interaction effect. The comparison and study of the expression profiles 
within networks reveal shared and distinct co-regulation patterns and complement the information 
from functional analysis. 
 
Results and discussion 
The sequencing of the striatum libraries produced a total of over 2.1 billion paired-end 
reads of length 100nt and on average 109 million reads per sample. Approximately 49 million 





89.54% of concordant read pairs aligned. Approximately 19,450 genes were tested for gene 
expression analysis across the six contrasts between hyperactivity line-amphetamine treatment 
groups.  
 
Amphetamine treatment-by-hyperactivity line interaction effects on the transcriptome 
Our study of differential gene expression between hyperactivity line- amphetamine 
treatment groups, offered insights into transcriptome disruptions that are line- and amphetamine-
dependent. Overall, 1,498 genes exhibited significant (FDR adjusted P-value < 0.05) treatment-
by-line interaction effect. Table 1 highlights the top differentially expressed genes exhibiting 
significant interaction effect (FDR-adjusted P-value < 1.xE-7). Within pairwise contrast, the 
numbers of significantly differentially expressed (FDR adjusted P-value < 0.05) genes were: 494 
genes (HS-CS), 186 genes (HA-HS), 319 genes (HA-CA), 93 genes (CA-CS); 208 genes (HA-
CS), and 1,084 genes (HS-CA). 
 
Table 1. Most significant genes exhibiting amphetamine treatment-by-hyperactivity line 
interaction effect and log2(fold change) between combinations of treatment (A=amphetamine, 
S=saline) and line (H=hyperactivity, C=control) groups. 
  Log2(Fold Change)a Overall 




LOC100861610 4.20 1.26 -1.73 3.73 2.47 -0.47 7.8E-13 7.0E-10 
Neurod6 0.79 1.62 -1.99 0.41 -1.20 -0.38 7.8E-13 7.0E-10 
3110035E14Rik 0.77 1.10 -1.45 0.41 -0.68 -0.36 7.8E-13 7.0E-10 
C1ql3 0.65 1.01 -1.26 0.40 -0.61 -0.25 7.8E-13 7.0E-10 
Prss12 0.65 1.09 -1.52 0.22 -0.88 -0.43 7.8E-13 7.0E-10 
Nr4a2 0.57 1.26 -1.55 0.29 -0.98 -0.29 7.8E-13 7.0E-10 
Ctgf 0.63 0.85 -1.42 0.06 -0.79 -0.57 7.8E-13 7.0E-10 
Cck 0.42 1.22 -1.39 0.25 -0.97 -0.18 7.8E-13 7.0E-10 
Nov 0.50 1.28 -1.64 0.14 -1.14 -0.36 7.8E-13 7.0E-10 
Slc17a7 0.45 1.58 -1.87 0.16 -1.42 -0.29 7.8E-13 7.0E-10 
Nptx1 0.40 0.80 -1.09 0.11 -0.69 -0.30 7.8E-13 7.0E-10 
Hap1 -0.34 -0.42 0.79 0.02 0.45 0.36 7.8E-13 7.0E-10 






Table 1 (cont.)         
 Log2(Fold Change)a Overall 




Peg10 -0.52 -0.62 1.14 -0.01 0.62 0.51 7.8E-13 7.0E-10 
Irs4 -0.87 -0.59 1.68 0.23 0.81 1.09 7.8E-13 7.0E-10 
Gm9800 -1.54 1.46 0.25 0.17 -1.29 1.70 7.8E-13 7.0E-10 
Avp -1.70 -1.51 3.14 -0.07 1.44 1.63 7.8E-13 7.0E-10 
Gm5506 -0.51 0.83 -1.86 -1.54 -2.37 -1.04 7.8E-13 7.0E-10  
Oxt -2.41 -1.65 3.66 -0.40 1.26 2.01 7.8E-13 7.0E-10 
Cplx3 0.65 1.08 -1.46 0.26 -0.81 -0.39 1.6E-12 1.2E-09 
Tbr1 0.45 1.25 -1.53 0.17 -1.08 -0.28 1.6E-12 1.2E-09 
Sv2b 0.30 0.70 -0.95 0.05 -0.65 -0.26 1.6E-12 1.2E-09 
Adcy1 0.31 0.76 -1.02 0.04 -0.72 -0.26 2.3E-12 1.5E-09 
AW551984 -0.66 -0.48 1.33 0.19 0.67 0.84 2.3E-12 1.5E-09 
Arhgap36 -0.80 -0.74 1.74 0.19 0.93 0.99 2.3E-12 1.5E-09 
Gm11549 0.59 1.44 -1.78 0.25 -1.19 -0.34 3.1E-12 1.9E-09 
Scube1 0.43 1.33 -1.53 0.23 -1.10 -0.20 6.8E-12 4.2E-09 
Il1f9 -0.50 -1.05 1.13 -0.42 0.63 0.08 1.1E-11 6.2E-09 
Lingo1 0.30 0.59 -0.80 0.08 -0.51 -0.21 1.1E-11 6.4E-09 
Neurod2 0.43 1.54 -1.89 0.08 -1.46 -0.35 1.6E-11 8.6E-09 
Satb2 0.47 1.43 -1.68 0.21 -1.22 -0.25 1.9E-11 9.6E-09 
Galnt9 0.35 0.67 -0.86 0.16 -0.51 -0.19 1.9E-11 9.6E-09 
Trh -1.17 -0.57 2.20 0.47 1.03 1.64 1.9E-11 9.6E-09 
Ttr -1.63 -0.63 2.31 0.05 0.68 1.68 2.4E-11 1.2E-08 
Nrn1 0.31 1.22 -1.26 0.26 -0.96 -0.05 3.5E-11 1.6E-08 
Mical2 0.28 0.73 -0.81 0.19 -0.53 -0.09 3.6E-11 1.6E-08 
Calb2 -0.70 -0.38 1.64 0.56 0.94 1.25 4.3E-11 1.9E-08 
Pde1a 0.36 0.52 -0.66 0.23 -0.30 -0.14 4.9E-11 2.1E-08 
Igsf1 -0.67 -0.65 1.30 -0.02 0.63 0.65 5.4E-11 2.3E-08 
Mpped1 0.26 0.55 -0.68 0.12 -0.42 -0.13 5.9E-11 2.4E-08 
Rtn4rl2 0.42 1.65 -2.03 0.04 -1.61 -0.38 9.9E-11 4.0E-08 
Magel2 -0.50 -0.89 1.43 0.05 0.93 0.55 1.2E-10 4.6E-08 
Resp18 -0.46 -0.30 0.91 0.14 0.45 0.60 1.3E-10 4.8E-08 
Nts -0.37 -0.67 1.09 0.05 0.72 0.42 1.5E-10 5.6E-08 
Ecel1 -0.29 -0.49 0.77 -0.01 0.48 0.28 1.6E-10 5.7E-08 
Baiap3 -0.68 -0.46 1.14 0.00 0.46 0.67 1.7E-10 6.0E-08 
Mef2c 0.21 0.57 -0.73 0.05 -0.52 -0.16 1.7E-10 6.0E-08 
Fam70a -0.32 -0.42 0.85 0.11 0.52 0.43 1.7E-10 6.0E-08 






Table 1 (cont.)         
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Serpini1 0.21 0.56 -0.66 0.12 -0.44 -0.09 1.8E-10 6.0E-08 
Robo3 0.33 0.88 -1.10 0.11 -0.77 -0.23 1.9E-10 6.3E-08 
3110047P20Rik 0.31 0.79 -1.12 -0.03 -0.82 -0.33 2.2E-10 6.9E-08 
Prlr -0.54 -0.57 1.30 0.19 0.76 0.73 2.3E-10 7.2E-08 
Hba-a2 -1.42 -0.60 3.66 1.64 2.24 3.07 2.4E-10 7.2E-08 
aLog2(fold change) between different pairs of treatment-line groups: H=hyperactivity line; 
C=control line; A=amphetamine treatment; and S=saline treatment. 
bFalse Discovery rate adjusted P-value for the overall line-by-treatment interaction. 
 
The Venn diagram in Figure 3 depicts the overlap of differentially expressed genes (FDR-
adjusted P-value < 0.05) within each of four informative contrasts (CA-HA, CS-HS, CA-CS, and 
HA-HS). This diagram highlights the majority of the genes in the contrasts with the highest 
numbers of differentially expressed genes were unique to that contrast: 248 genes in CS-HS 
amounting to 33.4% of all differentially expressed genes, and 144 genes in CA-HA amounting to 
19.4% of all differentially expressed genes. In addition, a large number of differentially expressed 
genes (107 genes amounting to 14.4% of all differentially expressed genes overlapped between 
both contrasts suggesting a prevalent gene dysregulation that is associated with differences 






Figure 3. Venn diagram summarizing the number of differentially expressed genes (FDR-adjusted 
P-value < 0.05) within each of four informative contrasts between combinations of treatment 
(A=amphetamine, S=saline) and line (H=hyperactive, C=control) groups analyzed separately and 
the overlap. CAHA=CA-HA, CSHS=CS-HS, CACS=CA-CS, HAHS=HA-HS)  
 
The lowest number of differentially expressed genes were detected in the CS-CA contrast, 
and 13 of these genes (1.8% of all differentially expressed genes) did not overlap with another 
contrast. This suggests that the A treatment used elicits modest disruption in the transcriptome 
compared to the S treatment in the C line. Most of the differentially expressed genes in the CA-
CS contrast (52 genes amounting to 7% of the differentially expressed genes) overlapped with the 
CS-HS contrast. Both of these contrasts share the CS mouse group, and thus the response of these 
genes to CA and HS relative to CS support the effectiveness of the hyperactivity line model of 
ADHD to understand the responsive to amphetamine treatment.   
As expected, the lower number of differentially expressed genes in HA-HS (186 genes) 





CS mice. The Venn diagram highlights the large percentage of the differentially expressed genes 
in HA-HS that overlap with CS-HS (115 genes amounting to 15.5% of the differentially expressed 
genes). Overall, the overlap of differentially expressed genes between HA-HS and CS-HS 
indicates that the A treatment reverted some of the gene dysregulation associated with the 
hyperactivity ADHD-like line. This conclusion is also supported by the number of differentially 
expressed genes (319 genes) in HA-CA that is intermediate between HA-HS and HS-CS. The 
previous results are consistent with the therapeutic effects of low-dose amphetamine on ADHD-
like symptoms and the interaction between the same amphetamine treatments and lines at earlier 
generation assessed at behavioral and protein levels. In early generations of the H line studied, 
amphetamine treatment lowered the locomotor activity in the line and increased the activity in the 
C line (Majdak et al., 2014). In later generations, a significant interaction between treatment and 
line on impulsivity was reported (Majdak et al., 2016). A significant interaction between anxiety 
behavior and amphetamine treatment on the activity of glycogen synthase kinase 3 beta (GSK3B) 
was also reported in another ADHD model that used a line selected for low trait anxiety behavior 
and amphetamine treatment (Yen et al., 2015). 
The Venn diagram identifies 14 genes that were differentially expressed in the four 
contrasts (Figure 3). These genes are: Rho GTPase activating protein 36 (Arhgap36), arginine 
vasopressin (Avp), expressed sequence AW551984 (AW551984), BAI1 associated protein 3 
(Baiap3), connective tissue growth factor (Ctgf), delta like non-canonical Notch ligand 1 (Dlk1), 
enolase 1B, retrotransposed (Gm5506), predicted gene 9800 (Gm9800), Huntingtin associated 
protein 1 (Hap1), immunoglobulin superfamily member 1 (Igsf1), insulin receptor substrate 4 
(Irs4), neuronal pentraxin 1 (Nptx1), oxytocin/neurophysin (Oxt), and paternally expressed 10 
(Peg10). From these 14 genes, 10 are among top 20 genes with lowest FDR P-value: Ctgf, Nptx1, 
Hap1, Dlk1, Peg10, Irs4, Gm9800, Avp, Gm5506, and Oxt. Also, most of the genes (Hap1, Dlk1, 
Peg10, Irs4, Avp, AW551984, Arhgap36, Igsf1, and Baiap3) present the same interaction profile 
“- - +”. Ctgf and Nptx1 present the opposite profile “+ + -”, while Gm9800 and Gm5506 present 
“- + -” profile. These interaction profiles, and especially the genes Avp, and Oxp are discussed in 









The sign of the log2(fold change) corresponding to the three orthogonal contrasts enabled 
the precise characterization of the interaction profiles. The “+” or “-” sign of each denotes over-
expression or under-expression respectively in the first mice group relative to the second mouse 
group specified in the contrast. Profiles are expressed regarding the signs of the three contrasts in 
the following order: CA-CS, HA-HS, and HS-CS. For example, the profile “+ + -” corresponds to 
gene positive CA-CS (i.e., over-expression in CA relative to CS), positive HA-CS (i.e., over-
expression in HA relative to HS), and negative HS-CS (i.e., under-expression in HS relative to CS 
mice). Alternatively, this profile can also be summarized as positive A-S treatment contrast across 
both lines and negative HS-CS. Likewise, the profile “- - +” corresponds to negative CA-CS, 
negative HA-HS, and positive HS-CS log2(fold change) respectively. 
Profile “+ + -” was the most common profile (470 genes) among the 1,498 genes exhibiting 
significant treatment-by-line interaction effect. The “+ + -” profile includes positive CA-CS, 
positive HA-HS, and negative HS-CS. The frequencies of the remaining ordered profiles were 378 
genes “- - +” (negative CA-CS, negative HA-HS, and positive HS-CS); 256 genes “+ - +” (positive 
CA-CS, negative HA-HS, and positive HS-CS); 167 genes “- + -” (negative CA-CS, positive HA-
HS, and negative HS-CS); 97 genes “- - -” (negative CA-CS, negative HA-HS, and negative HS-
CS); 80 genes “+ + +” (positive CA-CS, positive HA-HS, and positive HS-CS); 32 genes “- + +” 
(negative CA-CS, positive HA-HS, and positive HS-CS); and 17 genes “+ - -” (positive CA-CS, 
negative HA-HS, and negative HS-CS). 
The predominance of the 2 opposite profiles “+ + -” and “- - +” across the 3 orthogonal 
contrasts CA-CS, HA-HS, and CS-HS highlights the impact of the differential gene expression 
between A and S treatments across both lines and the correspondence between A and S treatments 
with C and H lines receiving the S treatment. These profiles may trigger molecular mechanisms 
elucidating reports that low doses of amphetamine can decrease wheel running in mouse lines 
exhibiting standard activity levels (Williams and White, 1984) in addition to decreasing activity 







Amphetamine treatment-by-hyperactivity line interaction effects on individual gene 
expression profiles 
The fundamental study of individual gene profiles thrust our understanding of the 
molecular mechanisms that exhibited amphetamine treatment and ADHD model line-specific 
profiles. An unexpected finding was the high number of genes coding for neuropeptides and 
hormone, and associated receptors exhibited either one of the two most common yet opposite 
profiles (“+ + -” and “- - +”) across the three orthogonal contrasts CA-CS, HA-HS, and CS-HS 
(Table 1). Genes positive for the A-S treatment contrast in both lines and negative for HS-CS (“+ 
+ -” profile) included: cholecystokinin (Cck), neurogranin (Nrgn), vasoactive intestinal 
polypeptide (Vip), somatostatin receptor 3 (Sstr3), and cholecystokinin B receptor (Cckbr). Genes 
negative for the A-S contrast in both lines and positive for HS-CS ( “- - +” profile) included: Avp 
and Oxt (both common between the four contrasts in the Venn diagram presented in Figure 3), 
thyrotropin-releasing hormone (Trh), neurotensin (Nts), angiotensinogen (Agt), galanin (Gal), 
prolactin receptor (Prlr), and calcitonin receptor (Calcr). Our novel identification of a large number 
of hormone and neuropeptide genes exhibiting amphetamine treatment-by-hyperactivity line 
interaction is confirmed across numerous reports of dysregulation of neuropeptide genes, in 
particular, ADHD-related or amphetamine scenarios. Neuropeptides and hormones modulate the 
dopaminergic neurotransmitter systems and influence the effects of amphetamine. Nts blocks the 
hyperactivity induced by amphetamine treatment in rats (Boules et al., 2001). The observed over-
expression of Nrgn in the amphetamine-treated mice relative to saline is consistent with increased 
levels of Nrgn in the frontal cortex of amphetamine-treated rats (Szabo et al., 2009). Cck 
diminishes the locomotor stimulatory effects of low amphetamine doses in rats (Weiss et al., 1988). 
Cck diminishes the locomotor stimulatory effects of low amphetamine doses in rats. Amphetamine 
exposure alters Oxt, and dopamine neurotransmission in prairie voles (Young et al., 2014) and Oxt 
lowers the locomotor activity in cocaine- and methamphetamine-exposed mice (Carson et al., 
2013; Leong et al., 2016; Qi et al., 2008; Sarnyai and Kovács, 1994). Avp also reduces locomotor 
stimulation by amphetamine in mice (Chiu et al., 1998).  
Two thyroid-related genes exhibited the “- - +” profile characterized by negative A-S 
treatment contrast in both lines: Trh and transthyretin (Ttr). Trh plays a role in stimulating the 





hormones influence behavior and cognitive function and individuals that have lower levels of this 
hormone exhibit behaviors similar to ADHD (Builee and Hatherill, 2004). The under-expression 
of Trh in the A relative to the S group is consistent with lower levels of Trh in the striatum of rats 
2 hours after amphetamine administration (Jaworska-Feil et al., 1995). Our findings demonstrate 
the potential impact of neuropeptide-driven therapies to ameliorate hyperactivity ADHD-like 
behaviors while minimizing the disruption in other pathways triggered by amphetamine-based 
treatments. 
In addition to neuropeptide- and thyroid-related genes, other genes exhibiting interaction 
effect have been associated with amphetamine or other psychostimulants, and to ADHD or related 
comorbidities (Table 1). Genes participating in synaptic signaling that exhibited the “+ + -” profile 
characterized by positive CA-CS and HA-HS and negative HS-CS included: Bdnf, 5-
hydroxytryptamine (serotonin) receptor (Htr5a), adenosine A1 receptor (Adora1), synapsin I 
(Syn1), syntaxin 1A (Stx1a), and synaptotagmin I, XIII and XVII (Syt1, Syt13, and Syt17). The 
profile of Bdnf is consistent with the well-established positive association between Bdnf levels 
and amphetamine administration (Meredith et al., 2002) and with higher striatal levels of Bdnf in 
wild-type mice relative to heterozygous Bdnf knockout mice after acute amphetamine injection 
(Saylor and McGinty, 2008). Consistent with the profile uncovered in this study, mutations and 
other disruptions in serotonin receptors including Htr5a have been linked to ADHD (Romanos et 
al., 2008). Also, Htr5a is over-expressed in the nucleus accumbens of mice exposed to the 
psychostimulant cocaine (Eipper‐Mains et al., 2013). Likewise, in agreement with the pattern 
detected in this study, mutations in Adora1 have been associated with anxiety (Johansson et al., 
2001) and the psychostimulant caffeine affects the level of Adora1 (Muñiz et al., 2016). Adora1 
has also been associated with regulation of blood pressure and blood vessel diameter, hormone 
secretion, synaptic depression, and cognition (Yang et al., 2010). Ours is the first study to 
simultaneously link hyperactivity and amphetamine exposure to Hrt5a and Adora1. 
Many genes associated with neuronal development presented the “+ + -” profile 
characterized by positive A-S treatment contrast across both lines and negative HS-CS (Table 1). 
These genes include transcription factor nuclear receptor subfamily 4, group A, member 2 (Nr4a2), 
and genes in the neuronal differentiation (Neurod) family (Neurod6, Neurod2, and Neurod1). 
Additional genes associated with neuronal development that exhibited positive CA-CS and 





members of the nuclear receptor (Nr) subfamily (Nr4a3, and Nr4a1). Egr2, Nr4a1, and Nr4a3 were 
also differentially expressed in a study of amphetamine-treated rats from the spontaneously 
hypertensive model of ADHD (dela Peña et al., 2015). The transcriptome study of the homozygous 
Lphn3 knockout model of ADHD uncovered disruption on genes that play a role in neuron 
structure and function (Orsini et al., 2016). Other transcription factors including SRY-box 1 (Sox1) 
and Forkhead box J1 (Foxj1) exhibited the reverse pattern, characterized by under-expression in 
A relative to S in both lines and were over-expressed in HS-CS (Table 1). Sox1 is associated with 
forebrain neuron development, and Foxj1 has been linked to brain development (Christie et al., 
2013). 
Genes participating in memory and learning processes that exhibited a significant 
interaction effect and a “+ + -” profile included Bdnf, neurogenic differentiation 2 (Neurod2), and 
Nrgn (Table 1). The positive A-S treatment contrast across lines exhibited by neurotrypsin 
(Prss12) is consistent with the higher focus observed in individuals exposed to amphetamine while 
Prss12 knockout mice exhibit impaired long-term memory formation and cognitive deficits and 
behavioral disorders in humans and mice (Schachtschneider et al., 2016). Our study confirms that 
ADHD and psychostimulant use are involved in disruption of neuronal development and cognition 
processes (Webb et al., 2009) and furthers the understanding that this effect expands across 
hyperactivity genotypes associated with ADHD.  
In addition to genes associated with neurogenesis and cognitive processes, several ion 
transport genes associated with neuroplasticity presented the “+ + -” profile (Table 1). These genes 
include various ATPase Ca++ transporters (e.g., Atp2b1), potassium channel family members 
(e.g., Kcnk2), and solute carrier family members (e.g., Slc17a7). The solute carrier family 17 
(sodium-dependent inorganic phosphate cotransporter), member 7 (Slc17a7, also known as 
vesicular glutamate transporter or VGluT1) plays a role in behavioral flexibility and adaptation 
(Granseth et al., 2015) that is typically associated with neuroplasticity in response to 
psychostimulants and ADHD-related disorders. 
Several genes that participate in cell adhesion processes exhibited significant amphetamine 
treatment-by-hyperactivity line interaction effect including connective tissue growth factor (Ctgf), 
adhesion G protein-coupled receptor L3 (Adgrl3 or Lphn3), and various members of the collagen 
(Col) family: Col9a3, Col24a1, Col6a5, Col11a1, Col5a2, Col6a2, Col19a1, Col6a3, Col8a2, 





characterized by positive A-S treatment contrast across both lines is consistent with the profile 
observed in amphetamine-treated rats from the spontaneously hypertensive model of ADHD (dela 
Peña et al., 2015). Adgrl3 or Lphn3 also exhibited the “+ + -” profile. This gene is also involved 
in cell-cell adhesion and has been associated with susceptibility to ADHD, addiction processes 
(Liu et al., 2006) and a homozygous Lphn3 knockout mouse line are used as ADHD model (Orsini 
et al., 2016). Nephroblastoma overexpressed gene (Nov), together with plexin domain containing 
1 (Plxdc1) and R-spondin 3 (Rspo3) have the same profile as collagen genes Col4a2 and Col8a2, 
and all these genes are associated with angiogenesis processes. Consistent with our findings, genes 
involved in cell adhesion angiogenesis were differentially expressed in amphetamine-treated rats 
from the spontaneously hypertensive model of ADHD (dela Peña et al., 2015). Our findings ratify 
the proposition that physical activity stimulated by A treatment supports brain vasculature and 
blood flow and increases angiogenesis, and neurogenesis (Gapin et al., 2011). 
Dopamine receptor 3 (Drd3) is among the genes exhibiting the second most frequent profile 
(“- - +” profile) that is characterized by negative A-S treatment contrast in both lines and positive 
HS-CS (Table 1). Drd3 is associated with regulation of blood pressure, behavioral response to the 
psychostimulant cocaine, and locomotor behavior similar to genes exhibiting the reverse 
trajectory. Our Drd3 finding is in agreement with the reported striatal over-expression of Drd3 in 
the spontaneously hypertensive rat model of ADHD relative to control rats (Li et al., 2007).  
Among the third most common profile (“- + -” profile), ribosomal protein L29 (Rpl29) and 
Enolase 1B, retrotransposed (GM5506 or Eno1b) presented negative CA-CS, positive HS-CS, and 
negative HS-CS. The under-expression in H relative to C lines under S treatment is consistent with 
reports under-expression of Rpl29 in the Lphn3 null model of ADHD relative to wild-type mice 
(Orsini et al., 2016). Eno1b has been associated with neuronal diseases and is part of the glycolytic 
pathway that plays a role in ATP production in the brain (Sultana et al., 2006). The profile of 
Eno1b observed in the present study is consistent with the role of enolases in ATP production in 
the brain, where low energy availability in the brain may lead to cellular dysfunction (Sultana et 
al., 2006). LOC100042025 predicted as glyceraldehyde-3-phosphate dehydrogenase-like, 
transcript variant 2, also plays a role in glycolysis and follows a similar profile of positive HA-HS 
and negative HS-CS albeit no substantial expression differential in CA-CS.  
Glyceraldehyde 3-phosphate dehydrogenase (Gapdh) exhibited less significant interaction 





Kadmiri et al., 2014) and mice exposed to methamphetamine treatment exhibit higher GAPDH 
protein levels and had more oxidative stress in the brain (Mark et al., 2007; Nakajima et al., 2009). 
Amphetamine exposure is also associated with increased oxidative stress in rodent striatum (Frey 
et al., 2006; Wan et al., 2000). Also, in vitro studies detected that Gapdh increases cellular toxicity 
and enhances pathogenicity of intercellular transmission of Huntington disease (Mikhaylova et al., 
2016). The energy required by neuronal processes to sustain high activity in H mice or in response 
to treatment A may trigger the dysregulation of the previously reviewed genes involved in energy 
pathways.  
S-adenosylmethionine decarboxylase 2 (Amd2) and Glutathione S-transferase Pi 2 (Gstp2) 
were positive CA-CS, negative HA-HS, and positive HS-CS. The profile of these genes in related 
experiments is consistent with our findings. Amd2 is part of the polyamine system, and polyamine 
treatment has been associated with modulation of limbic dopamine function that is involved 
climbing and wheel running behavior in rodents (Hirsch et al., 1987). Gstp2 plays an important 
role in detoxification, protect cells from injury by toxic chemicals and from products of oxidative 
stress (Hayes et al., 2005). Forms of Gstp2 ameliorate the oxidative milieu especially prevalent in 
dopaminergic neurons (Beiswanger et al., 1994). Drd3 exhibited the same negative HA-HS and 
positive HS-CS profile as Gstp2 confirming the impact of H line and A treatment in the dopamine 
system.  
Three related transcription factors, FBJ osteosarcoma oncogene (Fos), FBJ osteosarcoma 
oncogene B (Fosb), and fos-like antigen 2 (Fosl2) exhibited the most frequent profile characterized 
by positive CA-CS, negative HA-HS, and positive HS-CS. Our result agrees with reports of 
elevated Fosb expression in the striatum of rats after exposure to the psychostimulant 
Methylphenidate (Ritalin) that is commonly used to treat ADHD and with findings of Fos 
induction associated with amphetamine exposure in young mice (Chase et al., 2005; Labandeira-
Garcia et al., 1994).  
Our study of treatment-by-line interaction effects on gene expression enabled us to detect 
transcript profiles that are simultaneously amphetamine-treatment and hyperactivity line-
dependent. This information will aid in the identification of molecular targets that can effectively 
ameliorate ADHD symptoms in consideration of psychostimulant treatments or alleviate the 






Amphetamine treatment-by-hyperactivity line interaction effects on molecular mechanisms 
The investigation of molecular mechanisms encompassing multiple genes exhibiting 
significant interaction effects augmented our understanding of the pathways and processes that are 
affected by an amphetamine treatment and hyperactivity line-dependent manner. Highly enriched 
and informative clusters and descriptive GO and KEGG terms among the 1,498 genes exhibiting 
a significant amphetamine treatment-by-hyperactivity line interaction effect are listed in Table 2. 
Enriched categories include the GO BP terms forebrain development, synaptic transmission, 
neurogenesis and neuronal development, ion transport, peptide hormone secretion, memory and 
learning, response to stimuli including hormones, and regulation of sensory perception.  
 
Table 2. Informative clusters (Enrichment Score ≥ 4) of descriptive DAVID FAT categories 
including Gene Ontology (GO) biological processes (BP) and molecular functions (MF) enriched 
among genes exhibiting significant (FDR adjusted P-value < 0.05) amphetamine treatment-by-
hyperactivity line interaction effects. 




Cluster 1 Enrichment Score: 14.81 
   
BP  GO:0007399~nervous system development 268 8.45E-28 1.67E-24 
BP  GO:0030900~forebrain development 63 6.70E-11 1.33E-07 
Cluster 2 Enrichment Score: 13.98 
   
BP  GO:0007267~cell-cell signaling 176 3.52E-24 6.96E-21 
BP  GO:0099536~synaptic signaling 101 6.05E-22 1.20E-18 
Cluster 3 Enrichment Score: 12.36 
   
BP  GO:0007399~nervous system development 268 8.45E-28 1.67E-24 
BP  GO:0022008~neurogenesis 203 6.27E-23 1.24E-19 
BP  GO:0030182~neuron differentiation 172 1.29E-19 2.56E-16 
Cluster 4 Enrichment Score: 12.32 
   
BP  GO:0043269~regulation of ion transport 94 1.04E-17 2.06E-14 
MF  GO:0022843~voltage-gated cation channel activity 38 1.68E-14 2.78E-11 
Cluster 6 Enrichment Score: 7.73 
   
BP  GO:0007610~behavior 105 1.59E-17 3.15E-14 
BP  GO:0050890~cognition 51 1.19E-10 2.36E-07 
BP GO:0007611~learning or memory 45 3.59E-09 7.09E-06 
Cluster 10 Enrichment Score: 6.25 
   
BP GO:0009719~response to endogenous stimulus 165 4.85E-11 9.59E-08 






Table 2 (cont.)     




Cluster 19 Enrichment Score: 4.98 
   
BP  GO:0051049~regulation of transport 205 4.34E-18 8.58E-15 
BP  GO:0030072~peptide hormone secretion 44 1.70E-08 3.37E-05 
aNumber of genes in the enriched category. 
bFalse Discovery rate adjusted P-value. 
 
Many of the functional categories exhibiting significant treatment-by-line interaction 
effects in this study have been previously associated with amphetamine exposure, hyperactivity, 
and ADHD (Gruber and McDonald, 2012). Neuronal development was enriched among the genes 
differentially expressed in the striatum of spontaneously hypertensive rats, an ADHD model, 
treated with amphetamine (dela Peña et al., 2015). The enrichment of genes associated with 
synaptic transmission was expected since ADHD treatment using amphetamine acts through 
disruption of this signaling system (Mazei-Robison and Blakely, 2006). The enrichment of the 
memory and learning term is consistent with the impaired working memory observed in congenic 
wiggling rats that are hyperactive, exhibit impulsive behaviors and are a model to study ADHD 
(Masuo et al., 2007). These functional analysis results advance the understanding of the etiology 
of ADHD that is characterized by poor performance in executive functions including attention, 
correct response time and working memory (Loos et al., 2010).  
Several enriched categories among the genes exhibiting significant treatment-by-line 
interaction effects are consistent with categories indirectly associated with ADHD and 
amphetamine effects. These categories are consistent with previous functional studies of behaviors 
and phenotypes typically associated with amphetamine treatment or ADHD. For example, high 
levels of physical activity have been associated with anatomical and physiological alterations in 
the brain, like size, volume, and spatial memory (Phillips et al., 2014).  
Many enriched clusters and categories shared genes that exhibited significant treatment-
by-line interaction effects. This finding supports both the understanding that multiple processes 
are associated with the effects of ADHD and amphetamine and that these processes are highly 
interconnected by genes. For example, Oxt participates in the enrichment of many categories 
ranging from cellular homeostasis to behavior, such as social behavior, and can have a therapeutic 





various functional categories previously discussed including the Oxt signaling pathway, cellular 
response to parathyroid hormone stimulus, and transcription factor activity. Mef2c presented a 
profile of positive CA-CS, positive HA-HS, and negative HS-CS. In agreement with this profile, 
conditional deletion of Mef2c was associated with the disrupted balance between excitatory and 
inhibitory synapses in the developing brain, neurodevelopmental disorders, behavioral changes 
including hyperactivity and repetitive movements (Harrington et al., 2016). Over-expression of 
Mef2c in mice prefrontal cortex neurons improves cognition, behavior, and working memory 
(Mitchell et al., 2017). 
In addition to the enrichment of categories among genes exhibiting significant treatment-
by-line interaction effects, the enrichment of categories within the most frequent profiles across 
the three orthogonal contrasts was studied. Highly enriched and informative clusters of descriptive 
categories identified by DAVID for the profiles with an Enrichment Score ≥ 4 are presented in 
Table 3. The most enriched categories among all genes exhibiting a significant interaction effect 
are also enriched in the two most frequent profiles: positive CA-CS, positive HA-HS, and negative 
HS-CS (“+ + -” profile) and negative CA-CS, negative HA-HS, and positive HS-CS (“- - +” 
profile). The remaining profiles included less than 170 genes, and no category reached an 
Enrichment Score > 2. 
 
Table 3. Highly enriched and informative clusters of DAVID FAT categories including Gene 
Ontology (GO) biological process (BP) and molecular function (MF) among genes exhibiting 
significant interaction effect and the 3 most common profiles across the 3 orthogonal contrast ((“+ 
+ -“, “- - +”, and “+ - +”)). 





  Positive CA-CS, positive HA-HS, and negative HS-
CS (“+ + -“ contrast) 
      
Cluster 1 Enrichment Score: 11.13       
BP GO:0099536~synaptic signaling 49 2.0E-16 4.8E-13 
BP GO:0006836~neurotransmitter transport 19 3.5E-08 4.9E-06 
Cluster 2 Enrichment Score: 6.83       
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  Positive CA-CS, positive HA-HS, and negative HS-
CS (“+ + -“ contrast) 
      
BP GO:0006811~ion transport 58 4.4E-07 3.8E-05 
Cluster 3 Enrichment Score: 6.49       
BP GO:0030900~forebrain development 30 1.8E-08 3.3E-06 
Cluster 4 Enrichment Score: 5.9       
BP GO:0022008~Neurogenesis 79 5.4E-12 3.9E-09 
BP GO:0048666~neuron development 61 8.5E-12 4.6E-09 
Cluster 5 Enrichment Score: 5.56       
BP GO:0007610~Behavior 43 1.1E-09 3.3E-07 
BP GO:0007611~learning or memory 22 3.4E-07 3.1E-05 
Cluster 16 Enrichment Score: 2.64       
BP GO:0015833~peptide transport 19 8.3E-05 3.8E-03 
BP GO:0046879~hormone secretion 20 1.7E-04 7.2E-03 
Category Negative CA-CS, negative HA-HS, and positive HS-






Cluster 1 Enrichment Score: 4.94       
BP GO:0099536~synaptic signaling 26 6.0E-06 1.6E-03 
Cluster 2 Enrichment Score: 4.84       
MF GO:0005184~neuropeptide hormone activity 9 1.3E-08 1.0E-05 
MF GO:0005179~hormone activity 12 5.3E-06 1.0E-03 
Cluster 3 Enrichment Score: 3.78       
BP GO:0050801~ion homeostasis 30 5.9E-06 1.7E-03 
BP GO:0008015~blood circulation 20 1.2E-04 1.0E-02 
BP GO:0003013~circulatory system process 20 1.3E-04 1.1E-02 
Cluster 4 Enrichment Score: 3.39       
BP GO:0030900~forebrain development 19 1.3E-04 1.0E-02 
BP GO:0040011~Locomotion 43 4.3E-04 2.0E-02 
Cluster 10 Enrichment Score: 2.57       
BP GO:0046879~hormone secretion 16 5.4E-04 2.3E-02 
BP GO:0002790~peptide secretion 14 7.5E-04 2.9E-02 
Cluster 21 Enrichment Score: 2.19       
BP GO:1901698~response to nitrogen compound 33 1.8E-04 1.2E-02 
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Category Positive CA-CS, negative HA-HS, and positive HS-






Cluster 1 Enrichment Score: 2.74       
BP GO:0003341~cilium movement 9 9.7E-08 3.2E-04 
BP GO:0007018~microtubule-based movement 12 1.1E-05 1.8E-02 
aNumber of genes in the enriched category. 
bFalse Discovery rate adjusted P-value. 
 
The functional categories shared among the genes exhibiting the “+ + -” and “- - +” profiles 
included synaptic signaling, hormone secretion and peptide transport, and neurogenesis. The 
overlap in enrichment categories between the two opposite profiles and the interaction confirm the 
overlapping processes and overlapping genes corresponding to these processes disrupted by 
amphetamine and hyperactivity. The only highly enriched cluster of categories among the genes 
exhibiting the “+ + -” profile that was not detected at a significant level among the genes exhibiting 
the opposite profile “- - +” was GO BP memory/learning and cognition. Genes in this cluster 
include Nrgn, Vip, Bdnf, Neurod2, Adora1, amphiphysin (Amph), two members of the family of 
p21 proteins (Pak1 and Pak7), two members of the solute carrier family (Slc17a7 and Slc8a2), 
cannabinoid receptor 1 (Cnr1). Our finding is consistent with the effect of low amphetamine doses 
such as that used in the present study in enhancing focus and concentration and being used as a 
treatment to ameliorate behavioral disruptions in individuals with ADHD and in rodent models of 
ADHD. 
In addition to the functional analysis of the most common profiles across the three 
orthogonal contrasts, functional analysis of each orthogonal contrast separately enabled to uncover 
specific disruption of processes and functions. Most of the functional categories detected by the 
DAVID analysis of individual orthogonal contrasts confirm the categories enriched in the most 
frequent profiles across the three contrasts. These categories included: behavior, learning or 
memory, regulation of neurotransmitter levels, response to chemical stimulus, and ion 
homeostasis. The substantial consistency of enriched molecular mechanisms among the three 
orthogonal contrasts that characterize the interaction indicates that amphetamine treatment and 





the individual gene expression profiles within each disrupted process. The two categories enriched 
in a single contrast (neuropeptide hormone system in CA-CS and ion homeostasis in HS-CS) 
appear to be an artifact of the number of differentially expressed genes analyzed within contrast 
because these categories were also detected in the functional analysis of the profile across the three 
contrast. Several enriched categories detected among the genes differentially express within 
individual orthogonal contrasts that were not directly detected in the functional analysis of profiles 
involving three orthogonal contrast were nevertheless indirectly correlated with the categories 
detected in the analysis of profiles. For example, the category GO MF GO:0008201 heparin 
binding is related to regulation of blood pressure and GO BP GO:0007631 feeding behavior is 
related to hormone and neuropeptide activity. Additional insights from the GSEA analysis of the 
standardized log2(fold change) of all genes within contrast include the enrichment of ribosomal 
pathway terms. The GO and KEGG ribosomal categories were enriched among the genes negative 
for CA-CS and positive for HA-HS and HS-CS. The ribosome term enrichment pattern detected 
is in agreement with the potentiation of amphetamine-induced locomotion by ribosome 
inactivating protein (Saporin) treatment (Jeltsch et al., 2004). 
Two unexpected discoveries were drawn from the comparison of enriched categories 
between the two most common and opposite profiles (“+ + -” and “- - +”) among the genes 
exhibiting amphetamine treatment–by-hyperactivity line interaction effects. Our first discovery is 
that genes are associated with the same or similar processes. Table 3 highlights the overlap in 
enriched categories (e.g., GO BPs synaptic signaling, forebrain development, hormone secretion) 
between “+ + -” and “- - +”. A similar overlap of enriched processes was observed between the 
profiles “-+-” and “+-+” at lower significance levels. These opposite or reverse profiles of genes 
annotated to the same mechanisms reflect possible feedback regulation (Table 3). Our second 
discovery is that processes associated with genes in a particular pair of opposite trajectories (e.g. 
“+ + -” or “- - +”) were not identified among the genes in a distinct trajectory (e.g. “- + -” and “+ 
- +”). For example, Table 3 includes the enriched GO BP cilium movement that was only enriched 
in the “+ - +” profile but was not enriched in profiles “- + -” and “+ - +”. These observations 
confirm the strong and clear impact of hyperactivity line and amphetamine treatment on gene 
profiles and associated processes. 
Our study of treatment-by-line interaction effects on pathways and processes helped us to 





effects. These findings support the discovery of pathways that can be targeted to address ADHD 
behaviors in a psychostimulant treatment-dependent fashion or to understand psychostimulant 
effects in consideration of ADHD indicators. 
 
Amphetamine treatment -by-hyperactivity line interaction effects on gene networks 
The results previously discussed offered insights into amphetamine treatment-by-
hyperactivity line interaction effects on individual genes and groups of genes belonging to the 
same functional terms. Network analysis complemented the previous analyses and helped us to 
elucidate the impact of the interaction on the relationship between genes. Gene networks were 
used to depict the relationship among the 75 genes exhibiting significant interaction effect (FDR-
adjusted P-value < 0.05) and log2(fold change) >|2| and P-value < 0.001 in at least one of the three 
orthogonal contrasts. Individual gene co-regulation networks were developed for the three 
orthogonal contrasts: CA-CS (Figure 4), HA-HS (Figure 5) and HS-CS (Figure 6). To facilitate 
interpretation, the contrast HA-CA (Figure 7) is also presented. Among the 75 genes considered, 
the inferred networks focus on the largest group of directly interconnected genes or core genes. 
Genes directly connected to the core genes that did not reach significant differential expression in 
at least one contrast or were not reliably quantified are also included in the network to facilitate 








Figure 4. Over- (green) and under- (red) expressed genes in the contrast between control 
amphetamine and control saline (CA-CS) groups for the network of genes exhibiting significant -
amphetamine treatment-by-hyperactivity line by interaction effect (FDR-adjusted P-value < 0.05) 
and at least one significant pairwise contrast between line-treatment groups (log2 (fold change) 
>|2| and P-value < 0.001). Color intensity is positively correlated with fold change. Gray 
connecting genes did not exhibit significant interaction effects. Genes: nerve growth factor 
receptor (Ngfr), neurogranin (Nrgn), inversin (Invs), Abelson helper integration site 1 (Ahi1), 
Fhl2, Huntingtin associated protein 1 (Hap1), necdin (Ndn), DLG associated protein 1 (Dlgap1), 
SH3 and multiple ankyrin repeat domains 1 (Shank1), activity regulated cytoskeleton-associated 
protein (Arc), Rapgef4, hemoglobin a (Hba-a1 and Hba-a2), and regulating synaptic membrane 







Figure 5. Under- (red) and over- (green) expressed genes in the contrast between hyperactive 
amphetamine and hyperactive saline (HA-HS) groups for the network of genes exhibiting 
significant amphetamine treatment-by-hyperactivity line interaction effect (FDR-adjusted P-value 
< 0.05) and at least on significant pairwise contrast between line-treatment groups (log2 (fold 
change) > |2| and P-value < 0.001). Color intensity is positively correlated with fold change. Gray 
connecting genes did not exhibit significant interaction effects.  Genes: nerve growth factor 
receptor (Ngfr), neurogranin (Nrgn), inversin (Invs), Abelson helper integration site 1 (Ahi1), 
Fhl2, Huntingtin-associated protein 1 (Hap1), necdin (Ndn), DLG associated protein 1 (Dlgap1), 
SH3 and multiple ankyrin repeat domains 1 (Shank1), activity regulated cytoskeleton-associated 
protein (Arc), Rapgef4, hemoglobin a (Hba-a1 and Hba-a2), and regulating synaptic membrane 







Figure 6. Over- (green) and under- (red) expressed genes in the contrast between hyperactive 
saline and control saline (HS-CS) groups for the network of genes exhibiting significant 
amphetamine treatment-by-hyperactivity line interaction effect  (FDR-adjusted P-value < 0.05) 
and at least one significant pairwise contrast between line-treatment groups (log2 (fold change) 
>|2| and P-value < 0.001). Color intensity is positively correlated with fold change. Gray 
connecting genes did not exhibit significant interaction effects.  Genes: nerve growth factor 
receptor (Ngfr), neurogranin (Nrgn), inversin (Invs), Abelson helper integration site 1 (Ahi1), 
Fhl2, Huntingtin-associated protein 1 (Hap1), necdin (Ndn), DLG associated protein 1 (Dlgap1), 
SH3 and multiple ankyrin repeat domains 1 (Shank1), activity regulated cytoskeleton-associated 
protein (Arc), Rapgef4, hemoglobin a (Hba-a1 and Hba-a2), and regulating synaptic membrane 







Figure 7. Over- (green) and under- (red) expressed genes in the contrast between hyperactive 
amphetamine and control amphetamine (HA-CA) groups for the network of genes exhibiting 
significant amphetamine treatment-by-hyperactivity line interaction effect  (FDR-adjusted P-value 
< 0.05) and at least one significant pairwise contrast between line-treatment groups (log2 (fold 
change) >|2| and P-value < 0.001). Color intensity is positively correlated with fold change. Gray 
connecting genes did not exhibit significant interaction effects.  Genes: nerve growth factor 
receptor (Ngfr), neurogranin (Nrgn), inversin (Invs), Abelson helper integration site 1 (Ahi1), 
Fhl2, Huntingtin-associated protein 1 (Hap1), necdin (Ndn), DLG associated protein 1 (Dlgap1), 
SH3 and multiple ankyrin repeat domains 1 (Shank1), activity regulated cytoskeleton-associated 
protein (Arc), Rapgef4, hemoglobin a (Hba-a1 and Hba-a2), and regulating synaptic membrane 






The edges in the gene networks represent known connections between genes based on 
curated databases of molecular interactions used by Bisogenet and the rectangular nodes represent 
the genes that exhibited significant interaction effects. The intensity of colors indicates the strength 
of the positive (green) and negative (red) contrast of gene expression between mouse groups. 
Within contrast, positively connected genes are identified by edges connecting nodes of the same 
color (green-to-green and red-to-red) whereas negatively connected genes are identified by edges 
connecting nodes of different color (green-to-red). 
The genes differentially expressed between line-treatment groups in the network are: nerve 
growth factor receptor (Ngfr), Nrgn, Inversin (Invs), Abelson helper integration site 1 (Ahi1), Fhl2, 
Hap1 (common gene between the four contrasts in the Venn diagram presented in Figure 3), 
necdin (Ndn), DLG associated protein 1 (Dlgap1), SH3 and multiple ankyrin repeat domains 1 
(Shank1), activity regulated cytoskeleton-associated protein (Arc), Rapgef4, hemoglobin a (Hba-
a1 and Hba-a2), and regulating synaptic membrane exocytosis 1 (Rims1). Ngfr is a neurotrophin 
receptor that plays a role in axonal growth. The genes depicted in the networks have been 
associated with angiogenesis, cell adhesion, apoptosis, and neuronal development processes. 
Consistent with our findings, these processes were also enriched in a study of the effects of 
amphetamine on the striatum of spontaneously hypertensive rat, an ADHD model (dela Peña et 
al., 2015).  
Consideration of the GO BP categories associated with the genes in each network aids in 
understanding both their connection and the nature of this connection. The integration of gene 
interaction and differential expression depicted in the network enabled the visualization of co-
regulation profiles. Nrgn and Rims1 positively correlated expression because both genes have the 
same pattern of differential expression (nodes with equal color) across all four networks. 
Moreover, the direction of the differential expression within contrast is consistent with the known 
role of these genes. Nrgn and Rims1 are over-expressed in the A relative to the S treatment groups 
across lines and under-expressed in the H relative to the C line across treatment. Both genes Nrgn 
and Rims1 play a role in calcium availability and transport. Nrgn is a neuropeptide positively 
associated with neural plasticity and negatively associated with cognitive deficit that binds to 
calmodulin decreasing the availability of calcium (Hoffma et al., 2014). Rims1 plays a role in 
synaptic potentiation and inhibition of postsynaptic potential through controls the neuronal 





neuronal signaling and was associated with substance abuse and emotional behaviors (Martínez-
Rivera et al., 2017). The trend of these synaptic signaling genes observed in the gene networks 
could serve to explain the therapeutic effect of amphetamine in ADHD symptoms. 
The inferred network depicts the relationship between 4 genes associated with 
neurogenesis: Ndn, Ahi1, Ngfr, and Hap1. In addition, Ndn has also been associated with sensory 
perception of pain and Ahi1 plays a role in the regulation of behavior. Ndn and Hap1 are directly 
associated in our network, and our findings support the positively correlated role of these genes 
because both genes have the same pattern of differential expression (nodes with equal color) across 
all four networks. The direction of the differential expression of Ndn, Ahi1, Ngfr, and Hap1 within 
contrast is consistent with the known role of these genes. Ndn, Ahi1, Ngfr, and Hap1 are over-
expressed in the A relative to the S treatment groups across lines and under-expressed in the H 
relative to the C line across treatment. Our network comparison suggests that the use of 
amphetamine to treat ADHD may be linked to the opposite trend between H and A on these 
neurogenesis genes. 
Further understanding of the capability of amphetamine to alleviate ADHD symptoms was 
gained from the juxtaposition of networks across contrasts across genes participating in multiple 
processes. Disruptions in Arc and Shank1 have been linked to psychostimulants and are involved 
with drug response in the mouse striatum (Buonaguro et al., 2017). Arc has been annotated to the 
amphetamine addiction KEGG pathway and is also associated with regulation of synaptic 
potentiation (Biever et al., 2016; Tan et al., 2000). Shank1 has been correlated with social and 
vocalization behavior, memory and synapse maturation. Our networks offer insights into the 
treatment- and line- dependent relationship between these genes across lines. Within line, Arc and 
Shank1 have a consistent green pattern indicating over-expression A relative to S groups, 
consistent with known gene function. However, Arc and Shank1 have opposite patterns in the 
contrasts of lines within S treatment and are not highly differentially expressed in the contrasts of 
lines within the A treatment. These results suggest that differences in expression between lines in 
these genes observed in the S treatment are diminished by the A treatment. Our network study 
uncovered one mode of action of amphetamine that ameliorates the antagonistic disruption of Arc 
and Shank in the hyperactive line. 
The comparison of the networks across contrasts complements the understanding of the 





except one gene (Hba-a1) in the CA-CS and HA-HS networks exhibit the same differential 
expression indicating that amphetamine had similar effects on both hyperactivity lines (Figs 2 and 
3). On the other hand, more genes exhibit opposite differential expression between HS-CS and 
HA-CA (Figs 4 and 5, respectively). Our network comparison depicts the interaction between 
amphetamine treatment and hyperactivity line in the disruption of gene profiles that could disrupt 
gene connections. 
The majority of the direct connections between genes affected by the treatment-by-line 
interaction across all four networks are among genes with the same pattern (e.g., edges connecting 
red nodes or edges connecting green nodes). The notable exception is Invs and the connection of 
this gene with Nrgn, Efhd2, and Ahi1. In all contrasts except HS-CS, Invs and Ahi1 share the same 
expression pattern and Invs and Nrgn have opposite expression patterns (Figure 6). This is the 
only contrast that does not involve the A treatment and network comparison enabled us to uncover 
a critical and unique effect of amphetamine. 
The comparative network analysis identified sub-networks of genes that were disrupted by 
the amphetamine treatment. The sub-network including Shank1, Arc, Rims1, Dlgap1, Rapgef4 
and Dlgap1, Rapgef4 (the latter two genes are associated with the GO BP regulation of synaptic 
signaling) does not exhibit substantial differential expression in HA-CA (Figure 7), in comparison 
to all other contrasts. This finding suggests that treatment A decreases the differential expression 
of genes between the H and C lines by targeting whole subnetworks of connected genes, rather 
than isolated genes. The HA-CA network (Figure 7) had the highest number of unchanged genes 
expression across all four networks. This depiction suggests that for the genes in the network, the 
low amphetamine dose used in this study was able to revert profiles dysregulated in the H line 
without major dysregulation in the C line.  
Network analysis highlighted the synergistic effect of the A treatment and H line in the co-
regulation of 3 genes associated with vascular and blood systems: Invs, Hba-a1, and Hba-a2. 
Disruption of genes associated with angiogenesis processes was also reported in a study of 
amphetamine and an ADHD model using the spontaneously hypertensive rat (dela Peña et al., 
2015). Hemoglobin is expressed in neurons and is essential to neuronal respiration and vascular 
system (Stankiewicz et al., 2015). All three genes, Invs, Hba-a1, and Hba-a2 were over-expressed 
in CA relative to CS (Figure 4) and under-expressed in CA relative to HA (Figure 7). Thus, the 





the H line and A treatment. These genes support the circulation of blood carrying oxygen which 
in turn support the higher activity of mice in the H line and higher alertness, focus, intensity and 
duration of training with lower fatigue of mice receiving the A treatment.  
Five genes tend to be hub genes: Dlgap1, Hba-a1, Hba-a2, Invs, and Ahi1. In Figures 4 
and 5 that compares treatments between lines, the over-expressed (green) genes tended to be in the 
periphery (outside) the networks whereas under-expressed (red) genes tend to be hub genes in the 
middle of networks. Figure 4 has one green hub (Dlgap1) and four red hubs (Hba-a1, Hba-a2, 
Invs, and Ahi1), while Figure 5 has two green hubs (Dlgap1 and Hba-a1) and three red hubs (Hba-
a2, Invs, and Ahi1). The same is not applied to Figures 6 and 7, where the color of these hubs 
change completely. Figure 6 has two green hubs (Hba-a2 and Ahi1) and three red hubs (Dlgap1, 
Hba-a1, and Invs), while Figure 7 has only green hubs (Hba-a1, Hba-a2, Invs, and Ahi1) and 
Dlgap1 tend to be neutralized. The hubs Invs and Ahi1 share similar connected genes, and most 
of them are from two families: keratins (Krt1, Krt2, Krt5, Krt10, Krt14, Krt15, Krt42, Krt73, and 
Krt76) and heat shock proteins (Hspa5, Hspa8, Hspa9, and Hspab1). Keratins are intermediate 
filament proteins that can be found in neurons and glial cells and may play a role in the neural 
differentiation (Podgorniak et al., 2015). Intermediate filament proteins and heat shock proteins 
were associated with mouse pituitary gland under heat stress situations like elevated heart rate and 
sweating (Memon et al., 2016). The hubs Hba-a1 and Hba-a2 share genes from peptidase family 
(Ctsd, Ctsl, and Ctsb). The association of hemoglobin with peptidase might be related to 
mechanisms and controls of cerebral protein catabolism (Banay-Schwartz et al., 1985). The 
changes that occur in the hub genes might be linked to the activity of gray genes that did not exhibit 
significant interaction effects that are in some way also modified by the A treatment. 
Our study of treatment-by-line interaction effects on gene co-regulation enabled the 
detection of co-expression profiles that are simultaneously amphetamine- and line-dependent. This 
information will aid in the identification of co-regulated targets that can be used to develop 
personalized ADHD or psychostimulant exposure therapies. The ensuing step is to study 
transcriptome profiles that associated with changes in either amphetamine treatment or 








Effect of hyperactivity line on the striatum transcriptome 
Our study of genes exhibiting significant H -C line contrast uncovered transcriptome 
disruptions in the ADHD model that is independent of the amphetamine treatment. Among the 860 
significantly differentially expressed genes in the striatum, 239 genes did not exhibit significant 
(FDR-adjusted P-value < 0.05) interaction effects. Table 4 lists the most differentially expressed 
genes (FDR-adjusted P-value < 0.05 and log2 (fold change) > |1.2|) that exhibit main line effect 
without significant treatment-by-line interaction.  
 
Table 4. Top genes differentially expressed (FDR-adjusted P-value < 0.05) and log2(fold change) 
> |1.2|) between mice in control (C) and hyperactivity line (H) genotypes that do not exhibit 
significant interaction effect. 
Gene Symbol Description Log2(C/H) Raw P-value FDR adjusted 
P-valuea 
Ubash3a ubiquitin associated and SH3 domain 
containing, A 
2.38 5.0E-05 2.0E-03 
Olfr658 olfactory receptor 658  -2.70 5.0E-05 2.0E-03 
Syce2 synaptonemal complex central element 
protein 2  
1.59 2.0E-04 6.5E-03 
Ninj2 ninjurin 2  -1.32 2.0E-04 6.5E-03 
A530076I17Rik RIKEN cDNA A530076I17 gene -1.84 2.5E-04 7.6E-03 
Gm2808 predicted gene, 2808  5.32 3.0E-04 8.8E-03 
Nup62cl nucleoporin 62 C-terminal like  -1.41 3.0E-04 8.8E-03 
Ppp1r2-ps2 protein phosphatase 1, regulatory 
(inhibitor) subunit 2, pseudogene 2 
5.03 4.0E-04 1.1E-02 
Nlrp6 NLR family, pyrin domain containing 6  1.30 5.5E-04 1.4E-02 
Gbp1 guanylate binding protein 1 -2.09 7.0E-04 1.7E-02 
5031414D18Rik RIKEN cDNA 5031414D18 gene -3.81 7.0E-04 1.7E-02 
P2rx1 purinergic receptor P2X, ligand-gated ion 
channel, 1 
1.31 9.0E-04 2.1E-02 
4930519G04Rik RIKEN cDNA 4930519G04 gene  2.58 1.5E-03 3.0E-02 
Il1a interleukin 1 alpha 1.40 1.6E-03 3.1E-02 
Gm17660 predicted gene, 17660 2.17 2.6E-03 4.6E-02 
1700030C10Rik RIKEN cDNA 1700030C10 gene -1.87 2.7E-03 4.8E-02 
E230025N22Rik RIKEN cDNA E230025N22 gene  1.45 2.8E-03 4.9E-02 






Among the top differentially expressed genes between the H and C groups listed in Table 
4, several genes are associated with immune response. Guanylate binding protein 1 (Gbp1, also 
known as guanylate binding protein 2b or Gbp2) is associated with cellular response to interferon 
beta and gamma and immune response. Gbp1 is over-expressed in the H-C line contrast, and this 
profile is consistent with reports that the cytokines interferon gamma and alpha (highly 
homologous to beta) decrease the activity in mouse (Crnic and Segall, 1992). Another gene 
associated with immune response, Il1a was under-expressed in H-C. The reverse association is in 
agreement with the identification of a mutation in this gene associated with children exhibiting 
Tourette syndrome that is characterized by motor tics and high risk for ADHD (He et al., 2015). 
NLR family, pyrin domain containing 6 (Nlrp6) was under-expressed in H-C and consistent with 
our finding this gene negatively regulates innate immunity and facilitate the recovery after 
peripheral nerve injury (Anand et al., 2012). 
Some genes differentially expressed in H-C has been associated in some cases with 
locomotor, behavioral, and ADHD-related disorders through methylation epigenetic mechanisms. 
Ninjurin 2 (Ninj2) exhibits positive H-C line contrast, and this gene is involved in cell adhesion, a 
process that is enriched among the genes over-expressed in HS-CS. Our findings are consistent 
with the identification of differential methylation in Ninj2 in children exhibiting ADHD symptoms 
(Wilmot et al., 2016). Likewise, 5031414D18Rik codes for a RUN and cysteine-rich domain 
containing beclin 1 interacting protein like (Rubcnl-like) and is over-expressed in H-C. Rubcnl is 
a known methylated promoter (Leal and Gulley 2017). Nucleoporin 62 C-terminal like (Nup62cl) 
encompasses a CG island that exhibits rapid or moderation methylation dynamics (Gendrel et al., 
2012). These findings support the hypothesis of epigenetic mechanisms playing important role in 
hyperactivity and potentially ADHD symptoms. 
Protein phosphatase 1, regulatory (inhibitor) subunit 2 (Ppp1r2) is enriched in GABAergic 
neurons (Belforte and Nakazawa, 2011) that are inhibited in ADHD models (Brennan and Arnsten 
2008). This association is consistent with the under-expression of Ppp1r2 in H-C found in our 
study. Also, Ppp1r2 treatment has been associated with memory suppressor in rats (Yang and 
Wilson, 2015) and this is in agreement with the enrichment of memory and learning processes 
among genes differentially expressed in HS-CS. Another gene associated with memory and 





Our result is in agreement with reports of over-expression of P2rx1 in mice with improved memory 
and learning (Meng et al., 2009). 
Unexpectedly, the functional analysis of genes exhibiting hyperactivity line effect alone 
helped us identified processes that were also identified in the treatment-by-line interaction study. 
DAVID analysis for functional enrichment uncovered 3 clusters reached an Enrichment Score > 
1.5 (Table 5). The lower level of significant relative to the interaction enrichment may be 
associated with the limited number of genes exhibiting hyperactivity only effect in the absence of 
significant interaction. The enriched categories were consistent with those uncovered among genes 
exhibiting interaction effect and included neurogenesis and neuron development and actin 
cytoskeleton organization. These categories have also been associated with ADHD symptoms and 
related phenotypes. Actin cytoskeleton was enriched in the GSEA analysis of genes under-
expressed in the HS-CS contrast. The link between dysregulation of actin cytoskeleton processes 
and ADHD has been recognized (Lesch et al., 2008; Shiow et al., 2009). Moreover, actin 
cytoskeleton processes are associated with neuronal development and this together with 
neurogenesis and axogenesis were enriched among the genes differentially expressed in the HS-
CS contrast (Table 2). These novel results demonstrate that the dysregulation of some genes in the 
neurogenesis and neuronal development processes in the hyperactivity line are not alleviated by 
amphetamine since the dysregulation is consistent across treatments whereas the dysregulation of 
other genes in the same processes is affected by the amphetamine treatment received. Our study 
of the main effect of hyperactivity line on individual gene and biological processes support the 














Table 5. Informative clusters (Enrichment Score ≥ 1.5) of descriptive DAVID FAT categories 
including Gene Ontology (GO) biological processes (BP) enriched among genes exhibiting 
significant (FDR adjusted P-value < 0.05) hyperactivity line effect excluding genes exhibiting 
interaction effect. 





Cluster 1 Enrichment Score: 2.01    
BP GO:0044089~positive regulation of cellular 
component biogenesis 
12 6.4E-3 5.4E-1 
Cluster 2 Enrichment Score: 1.59    
BP GO:0007010~cytoskeleton organization 19 4.2E-2 8.0E-1 
BP GO:0030036~actin cytoskeleton organization 11 6.4E-2 8.4E-1 
Cluster 3 Enrichment Score: 1.5    
BP GO:0022008~neurogenesis 32 6.9E-4 5.1E-1 
BP GO:0048666~neuron development 24 9.0E-4 5.1E-1 
BP GO:0010977~negative regulation of neuron 
projection development 
7 5.0E-3 5.0E-1 
aNumber of genes in the enriched category. 
bFalse Discovery rate adjusted P-value. 
 
Effect of amphetamine treatment on the striatum transcriptome 
The identification of genes that exhibited significant A-S treatment contrast permitted the 
identification of disruptions in the striatum associated with amphetamine exposure that is 
independent of the genetic background for hyperactivity in mouse as ADHD model. Among the 
183 genes exhibiting significant A-S treatment, two genes did not exhibit significant treatment-
by-line interaction (FDR-adjusted P-value < 0.05): potassium inwardly-rectifying channel, 
subfamily J, member 6 (Kcnj6) and RAR-related orphan receptor alpha (Rora). 
Kcnj6 exhibited positive A-S treatment contrast (log2 (fold change A/S) =0.37, FDR-
adjusted P-value < 0.038). Kcnj6 plays a role in the Oxy signaling pathway, morphine addiction 
pathway, potassium ion transport, neurotransmitter, and in the dopaminergic and GABAergic 
synapse. Mutations on one of the G-protein-gated inwardly-rectifying potassium (Girk) channel 
subunits, Girk2, are related to analgesic requirements the therapeutic effects of Girk channel 
inhibitors in the treatment of methamphetamine dependence and alcoholism have been proposed 





Rora is involved in amphetamine metabolism (Yarosh et al., 2015), plays a role in 
angiogenesis, learning, and positive regulation of circadian rhythm (Sun et al., 2015). Mutations 
in Rora are associated with impaired in motor functions and motor coordination (Lalonde and 
Strazielle, 2015). Rora was positive for the A-S contrast (log2 (fold change A/S) = 0.32, FDR-
adjusted P-value < 0.034) observed in this study confirms the effects that A elicits on Rora 
expression. 
 
Our study uncovered a large number of gene expression profiles exhibiting amphetamine 
effects on a hyperactive line-dependent manner (interaction effects) whereas substantially fewer 
genes exhibited amphetamine exposure effect on a line independent manner. These novel findings 
highlight the need to develop therapies for psychostimulant use that are dependent on the genetic 
























CHAPTER 3 - DIFFERENTIAL TRANSCRIPTOME ANALYSIS AND NETWORKS 




Inflammation has been implicated in behavioral disorders such as depression-like behavior. The 
tryptophan-degrading enzyme Indoleamine 2,3-dioxygenase (IDO1) is part of the tryptophan 
metabolic route, that is linked to infectious diseases and psychiatric disorders. The effect of IDO1 
depletion on the peripheral macrophages transcriptome after Bacille Calmette Guérin (BCG)-
infection has not been studied. Transcriptome and transcription factors (TF) network analyses were 
performed in the macrophages from IDO1-knockout (IDO1-KO) mice relative to wild-type (WT) 
mice under both BCG-infected and saline (Sal) treatment. Among the 546 differentially expressed 
genes exhibiting interaction effect (P-value < 0.05), sphingosine kinase 1 (Sphk1) plays a role in 
immune processes by activating of tumor necrosis factors (TNF)-alpha signaling and nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-kB) pathways, and serum amyloid a1 (Saa1) 
that is related to depressive-like behavior. Both genes were under-expressed in BCG-infected 
compared to Sal treated IDO1-KO mice. The comparison between IDO1-KO relative to WT 
genotype irrespective of challenge suggested that the macrophages may find a way to compensate 
the absence of IDO1 restoring the immune response. Also, 8,798 genes were significantly 
differentially expressed (FDR-adjusted P-value < 0.05) between BCG-infected relative to Sal 
treated mice. Among them, ATP binding cassette subfamily b member (Tap1) was under-
expressed in the BCG-infected relative to Sal treated mice, while histamine receptor h1 (Hrh1) 
was over-expressed. The functional analysis confirmed the participation of genes in significant 
GO terms (FDR-adjusted P-value < 0.05) associated with microbial response and host defense 
(i.e., GO BP response to virus; interaction with host), and macrophage metabolism (i.e., GO BP 
regulation of cysteine-type endopeptidase activity). Regulatory network analysis uncovered the 
enrichment of the transcription factors: signal transducer and activator of transcription 1 (Stat1), 
Rela proto-oncogene, NF-kB subunit (Rela), forkhead box g1 (Foxg1) and forkhead box l1 
(Foxl1). Our findings can be used as potential candidates to understand the mechanisms involved 







Many diseases including heart diseases, obesity, and AIDS, are characterized by chronic 
and systemic inflammations. The tryptophan (Trp) metabolic route has been linked with infectious, 
autoimmune, chronic inflammatory diseases, and psychiatric disorders (Baumgartner et al., 2017; 
Dantzer et al., 2008). The enzymes present in this pathway are regulated by cytokines, and their 
interaction may have a potential role in cardiovascular diseases (Baumgartner et al., 2017). The 
tryptophan-degrading enzyme Indoleamine 2,3-dioxygenase (IDO1) is activated during the 
inflammation process and impairs T cell proliferation (O'Connor et al., 2009). Some studies 
showed that IDO1 could suppress immune responses to infections and also inhibit local 
inflammation and autoimmunity (Put et al., 2016).  
Macrophages are immune cells that are found in all tissues in a variety of processes like 
development, homeostasis, and mainly immune responses to pathogens (Wynn et al., 2013). 
During inflammation, macrophages are involved in the phagocytosis of dead cells and the 
protection of the host through innate immunity (Martinez and Gordon, 2014). The acquisition of 
enhanced antimicrobial resistance is due to the interaction of macrophages with T and B 
lymphocytes (Martinez and Gordon, 2014). Disruptions in the blood-brain barrier may enable the 
migration of immune cells from the peripheral blood and elicit inflammation in the central nervous 
system. Macrophages exist in between two extremes with distinct functions: M1 macrophages 
defend the body in the presence of pathogens and tumor cells whereas M2 macrophages are related 
to inflammatory responses and adaptive immunity (Wang et al., 2014). 
The higher activity of IDO1 in response to the immune challenge has been associated with 
behavioral disorders. IDO1 plays a role in macrophage differentiation and because of the 
involvement in mechanisms of tumor immune tolerance, IDO1 is considered a target for 
therapeutic studies (Wang et al., 2014). Transcriptome studies showed that macrophages regulate 
T cell responses via up-regulation of IDO1 and this process is associated with behavioral disorders  
(Gonzalez-Pena et al., 2016b).  
Bacilli Calmette Guerin (BCG) is an intracellular pathogen and an attenuated strain of 
Mycobacterium bovis that is used in tuberculosis vaccines (O'Connor et al., 2009). Challenge with 
BCG triggers in mice immune response, inflammation in the brain, activation of IDO1 in the brain, 
and is associated with depression-like behavioral disorders (Dantzer et al., 2008; Rodriguez-Zas 





symptoms may remain up to one month after challenge (Gonzalez-Pena et al., 2016a).  No study 
has simultaneously profiled the expression of genes in macrophages from wild-type and IDO1-
KO mice after sickness recovery from BCG challenge. 
The first objective of this study was to identify gene differential expression of peripheral 
macrophage after sickness recovery from BCG challenge relative to saline control in IDO1-KO 
relative to WT mice. Second, to identify regulatory network and enrichments that uncover 
transcription factors. Finally, to find potential candidates to understand the relationship between 
inflammation caused by BCG-infection and depression-like behavior. 
 
Material and methods 
Animal experiments 
Male mice, with approximately 22 weeks old, from the C57BL/6J genotype (wild-type or 
WT) and from an IDO1-knockout genotype that had a C57Bl/6J background (IDO1-KO) were 
studied. Mice were housed in individual cages in a controlled environment, under a normal 12:12 
h light/dark cycle, 23°C of temperature, 45% of humidity. Water and food (Teklad 8640 chow, 
Harlan Laboratories, Indianapolis, IN, USA) were served ad libitum. Briefly, during three weeks 
prior to the challenge, mice were acclimated to the light cycle and facility before the injection with 
BCG or Sal. Mice were individually handled every day for few minutes before the challenge. 
Half of the mice from each genotype were challenged with BCG, and half received Saline 
(Sal) treatment following protocols (Dantzer et al., 2008; Gonzalez-Pena et al., 2016a; Gonzalez-
Pena et al., 2016b; Nixon et al., 2015). Before inoculation, each vial’s reconstitution was made 
according to provider protocols using preservative-free saline. Live attenuated mycobacteria TICE 
BCG (50 mg wet weight of lyophilized culture containing 1x108 colony forming units or 
CFU/vial; Organon Teknika Corp. LLC, USA Inc., USA) was used (Gonzalez-Pena et al., 2016a; 
Gonzalez-Pena et al., 2016b). Mice were injected once with either 10 mg/mouse (BCG-challenged 
group, n = 12) or sterile saline solution (Control group, n = 12) administered via intraperitoneal 
injection (Rodriguez-Zas et al., 2015). No peritoneal mycobacteria infection was detected in mice 
by day 20 after intraperitoneal infection with BCG. However, there was a dissemination of 





 Mice were euthanized seven days after BCG challenge. The endpoint was chosen based 
on prior studies that showed the recovery from sickness yet persistence of depressive-like 
symptoms seven days after challenge (Rodriguez-Zas et al., 2015). Mice were euthanized by 
trained personnel with CO2 asphyxiation; everything was made to minimize suffering (Gonzalez-
Pena et al., 2016b). Animal experimental procedures were performed under the approval of the 
Illinois Institutional Animal Care and Use Committee and were in accordance with the NIH Guide 
for the Care and Use of Laboratory Animals. 
Macrophages were extracted from the peritoneum (abdominal cavity)  using the previous 
protocols (Gonçalves and Mosser, 2015; Nixon et al., 2015). Mice had their abdomens disinfected, 
the skin retracted, and the peritoneal cavity was flushed with Hank's Balanced Salt Solution (cold 
harvest medium). The peritoneal fluid was centrifuged, and the resulting cell pellet was 
resuspended and plated. After 2 h incubation, the medium was aspired to remove non-adherent 
cells. The surviving adherent cells constituted the non-thioglycollate elicited peritoneal 
macrophages and cells from individual mice were frozen in Trizol at -80°C for RNA extraction 
(Gelsthorpe et al., 1997).  
Flow cytometry validation of macrophages isolation encompassed cell staining with 
primary fluorescent antibodies for two primary markers for macrophages: CD11b (Integrin 
Subunit Alpha M) and CD45 (protein tyrosine phosphatase, receptor type, C antibody) (Gonzalez-
Pena et al., 2016a; Gonzalez-Pena et al., 2016b). Fc receptors were blocked by incubation with 
anti-CD16/CD32 antibody before incubation with eBioscience anti-CD11b and anti-CD45 
antibodies (eBioscience Inc., San Diego, CA). Surface receptor expression was identified using a 
Biosciences LSR II Flow Cytometry Analyzer with BD FACSDiva software (BD Biosciences, San 
Jose, CA). Antibody gating was determined using isotype-stained controls. 
RNA extraction from macrophages followed the Trypsin procedure using a total RNA Kit 
(Omega Bio-Tek, Norcross, GA) and a DNase step to remove DNA contamination (Gelsthorpe et 
al., 1997). The RNA Integrity Numbers were accessed by using the Agilent 2100 Bioanalyzer with 
RNA Pico chip (Agilent Technologies, Palo Alto, CA). 
Differential expression analysis 
RNA libraries from individual mouse were sequenced using an Illumina HiSeq 2500 





2016a). FastQC (Babraham Institute, 2013) was used for reading quality control (Andrews, 2010). 
Quality control analysis indicated Phred nucleotide quality score above 30 and sequences were not 
trimmed or filtered (Gonzalez-Pena et al., 2016a). 
Reads were mapped to the Genome Reference Consortium GRCm38 mouse assembly 
using software Kallisto (Bray et al., 2016) with the Illumina iGenomes package (mm10; 
http://support.illumina.com/sequencing/sequencing_software/igenome.html) (Pruitt et al., 2006; 
Trapnell et al., 2009). After the quantification of transcript isoforms' abundance into counts, an R 
package tximport was used to combine counts with mapping information to quantify gene 
expression (Soneson et al., 2015). The edgeR package was used to describe the gene counts using 
a linear model including the main factors of treatment (BCG vs. Sal) and mice genotype (IDO1-
KO vs. WT) and the interaction between treatment and genotype (Robinson et al., 2010). The 
Benjamini-Hochberg false discovery rate (FDR) was used to adjust the differential expression P-
value for multiple testing (Reiner et al., 2003).  
 
Functional and Transcription Factor analyses  
Functional analysis was explored to find enriched categories among genes exhibiting 
interaction effect and main effects of treatment and genotype. The functional analysis used the 
Database for Annotation, Visualization and Integrated Discovery (DAVID; Version 6.8). 
Functional categories used in the analysis were Gene Ontology (GO) biological processes (BP), 
molecular functions (MF), and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. 
Functional Annotation Tool (FAT) classes were used in DAVID to facilitate interpretation 
(Caetano-Anollés et al., 2016). Expression Analysis Systematic Explorer (EASE) scores were used 
to measure the category enrichment, computed using a one-tailed jackknifed Fisher 
hypergeometric exact test. The statistical significance for each cluster of functional categories was 
evaluated using an Enrichment Score (ES) computed as the geometric mean (-log10 geometric 
mean of the cluster members EASE scores) (Gonzalez-Pena et al., 2016a). The Mus musculus 
genome was used as background for testing, and FDR was used to adjust the enrichment P-values 
for multiple testing (Pruitt et al., 2006; Trapnell et al., 2009). 
Transcription factors (TF) enriched among genes exhibiting significant differential 
expression (FDR adjusted P-value < 0.05) were identified using iRegulon (Shannon et al., 2003; 





gene expression regulators (regulons) and gene targets using a motif prediction parameters for 
enrichment score threshold (Shannon et al., 2003; Verfaillie et al., 2014). The information from 
many databases including GeneSigDB, Ganesh clusters, and MSigDB is integrated to identify 
transcription factors and target genes (Culhane et al., 2011; Liberzon et al., 2015). The Area Under 
the cumulative Recovery Curve obtained from the database search is used to compute the 
normalized enrichment score (NES) for each transcription factor (Shannon et al., 2003; Verfaillie 
et al., 2014). 
 
Results and Discussion 
The level of the RNA integrity indicator (RIN) was highly comparable across the four 
groups of samples. The average RIN for the samples corresponding to the groups WT-Sal, WT-
BCG, KO-Sal, and KO-BCG were: 9.7, 9.5, 9.4, and 9.6, respectively. Similarly, the average 
number of reads was similar across the four groups of samples. The average number of individual 
reads per sample corresponding to the groups Sal-WT, BCG-WT, Sal-KO, and BCG-KO were: 
55,243410.3, 59,182973.4, 62,929589.2, and 62,315095.8, respectively. The number of genes per 
sample detected from the mapping of reads to the genome was similar across groups. The average 
number of detected genes per sample corresponding to the groups Sal-WT, BCG-WT, Sal-KO, 
and BCG-KO were: 22508, 22463, 22762, and 22701. The relative difference between the groups 
with highest and lowest number of genes was 1%.  
Treatment-by-genotype interaction effects on the macrophage transcriptome 
Immune treatment-by-IDO1 genotype interaction effects were identified on 65 genes (P-
value < 0.005). Table 6 highlights the genes with most significant interaction effect (P-value < 
5x10-4). Among these are genes related to inflammatory response and immune response including: 
interleukin 10 (Il10), sphingosine kinase 1 (Sphk1), serum amyloid A1 (Saa1), C-C motif 
chemokine ligand 7 (Ccl7), C-X-C motif chemokine ligand 1 (Cxcl1), trophoblast glycoprotein 
(Tpbg), heparin binding epidermal growth factor (Egf) like growth factor (Hbegf), and 






Table 6. Most significant (P-value < 5x10-4) genes exhibiting treatment-by-genotype interaction 
effect between combinations of treatment (BCG=infected, Sal=saline) and genotype (KO=IDO1-
KO, WT=wild type) groups.  

















Il10 2.61E-05 3.70E-01 -1.55 -5.2 1.44 -2.23 -3.78 2.99 
Creb3l1 1.27E-04 6.10E-01 -1.08 -2.41 0.63 -0.7 -1.8 1.72 
Hbegf 1.41E-04 6.10E-01 -1.2 -3.54 1.46 -0.89 -2.12 2.66 
Cth 2.37E-04 6.10E-01 -1.58 -3.46 0.38 -1.51 -3.1 1.96 
Cxcl1 2.54E-04 6.10E-01 -1.39 -3.82 0.98 -1.47 -2.87 2.38 
Sphk1 2.93E-04 6.10E-01 -1.27 -3.32 1.32 -0.73 -2.02 2.6 
Ccl7 3.24E-04 6.10E-01 -0.4 -2.61 1.69 -0.53 -0.95 2.09 
Tpbg 3.68E-04 6.10E-01 -1.1 -3.24 0.86 -1.29 -2.39 1.97 
Saa1 3.82E-04 6.10E-01 -0.45 -3.46 1.36 NAc -2.12 1.81 
aLog2(fold change) between different pairs of treatment-genotype groups 
bFalse Discovery rate adjusted P-value for the overall treatment-by-genotype interaction. 
cNot available 
 
Many studies have associated inflammatory response to depression (Wiener et al., 2017). 
Peripheral levels of inflammatory cytokines might be associated with depression symptoms 
(Capuron and Miller, 2011). People with bipolar disorder had peripheral levels of Il10 positively 
correlated with functional impairment of the disorder (Wiener et al., 2017). Il10 is an 
immunosuppressive cytokine produced by almost all cells of the innate and adaptive arms of the 
immune system and can be anti- and pro-inflammatory. Il10 is engaged in the activation of the 
JAK-STAT signaling pathway and is involved with NF-kappa-B (NF-kB) activity (Ma et al., 
2015). Il10 was under-expressed in WT relative to IDO1-KO mice in macrophages in a previous 
study with the same mice genotype (Gonzalez-Pena et al., 2016b). 
Sphk1 plays an important role in inflammatory, anti-apoptotic, and immune processes by 
activating of tumor necrosis factors (TNF)-alpha signaling and the NF-kB pathways (Alvarez et 
al., 2010). Sphk1 is an isoenzyme that generates sphingosine-1-phosphate (S1P) in the central 





in hippocampus might be associated with neurological problems (Alvarez et al., 2010; Zhang et 
al., 2013). Reduced levels of SP1 and abnormal sphingolipid metabolism were reported in the brain 
with Alzheimer’s disease (Zhang et al., 2013).  Consistent with this, the present results showed 
over-expression of Sphk1 in the Sal-WT and Sal-KO, compared with BCG-WT and BCG-KO, 
which might be associated with a less protective activity of Sphk1 occurring during inflammation.  
Serum amyloid A (Saa) is an apolipoprotein used as a biomarker of infection and 
inflammation (Ma et al., 2015). A study characterized Saa as a novel mechanism for regulation of 
inflammation and immunity by an acute-phase protein by activating IL-23/IL-17 pathway (Ma et 
al., 2015). Saa1 is highly expressed in the inflammation response pathway and tissue injury (Jang 
et al., 2017). The presence of Saa1 was associated with depressive-like behavior (Jang et al., 2017). 
Consistent with this result, another study found a gene from the same family (Saa3) in mice brain 
under BCG-immune challenge (Gonzalez-Pena et al., 2016a).  
Chemokines are chemotactic cytokines coordinators of the immune system (Leighton et 
al., 2017). Ccl7 and Cxcl1 are from C-C subfamily of chemokines, and CXC subfamily of 
chemokines, respectively. Chemokines of these both subfamilies have a relationship with cognitive 
and neuromodulatory functions (Leighton et al., 2017). Ccl7 recruits pro-inflammatory cells and 
drive the response to an inflammatory activated state that contributes to depression through many 
mechanisms including enhancement of neurotoxicity, disruption of neurotransmitter systems, and 
aberrant tryptophan metabolism (Dantzer et al., 2008; Stuart et al., 2015). The up-regulation of 
Cxcl1 in CNS or peripherally occurs in response to stressor factors as peripheral 
lipopolysaccharide (LPS) injection (Girotti et al., 2011; Stuart et al., 2015). Ccl7 and Cxcl1 were 
both over-expressed in Sal-(KO) relative to Sal-(WT).   
A tropic factor that is induced by inflammatory stimuli is known as Hbegf, which is highly 
induced in astrocytes during multiple sclerosis lesion formation (Schenk et al., 2013). In the brain, 
neurotrophins are essential for neurons survival, this gene is considerate important for neural 
development, and promoting survival of dopaminergic neurons (Oyagi et al., 2009). Hbegf 
knockout in mice’s brain exhibited molecular biological characteristics of abnormal behavior 
similar to psychiatric disorders as depression and schizophrenia (Oyagi et al., 2009).  
Cth produces the enzyme cystathionine gamma-lyase (Cse) that transforms cystathionine 
into cysteine. Cse is involved in the hydrogen sulfide pathway (H2S) biosynthesis, and H2S could 





2015; Liu et al., 2017a). This gene was up-regulated in macrophages of mice under LPS challenge, 
Cse/H2S biosynthesis ameliorated the inflammatory response (Liu et al., 2017a). The Cse/H2S 
system had a protective function against the LPS-induced inflammation in another study in mice’s 
vascular cells under immune challenge (Bourque et al., 2017). This study showed over-expression 
of Cth in the Sal-WT and Sal-KO, compared with BCG-WT and BCG-KO, more studies should 
be done to understand why the activity of Cth is low during inflammation.  
 Creb3l1 and Tpbg exhibited a significant treatment-by-genotype interaction. Creb3l1 may 
have a role blocking the proliferation of virus-infected cells and inhibiting virus activity (Denard 
et al., 2011). Tpbg is a member of glycoprotein containing leucine-rich repeats that are used as a 
target antibody-mediated immune responses (Harrop et al., 2006). Creb3l1 and Tpbg were under-
expressed in BCG relative to Sal treated mice in both genotypes. In this study, some genes that 
have a protective function have decreased expression during inflammation.  
 
Functional categories enriched among genes exhibiting treatment-by-genotype interaction 
effects 
Enriched functional categories using 546 genes exhibiting an interaction effect (P-value 
<0.05) were investigated by DAVID. Table 7 summarizes informative clusters that had 
Enrichment Score > 3. Enriched functional categories confirm the treatment-by-genotype 
interaction effect on genes involved in the regulation of the GO terms immune system, 
inflammatory response, generation of neurons, cardiovascular system development, regulation of 
cellular component movement, and response to lipopolysaccharide identified among genes with a 
significant interaction effect. 
In addition to Cxc1, ccl7, and Il10 discussed before; six more genes in the chemokine 
subfamily were part of the enriched GO term positive regulation of immune system process 
category. Other important genes present in this enriched GO term are: Poliovirus Receptor (Pvr), 
Toll-Like Receptor 1 (Tlr1), Cd14 Molecule (Cd14), and Leucine-Rich Repeat Containing G 
Protein-Coupled Receptor 4 (Lgr4). This enrichment is in accordance with another study of BCG-
challenged and control mice in microglia and macrophages (Gonzalez-Pena et al., 2016a). 
Some genes that were enriched in many GO terms are essential to understanding regulation 





receptor for poliovirus replication mediates natural killer (NK) cell adhesion and leads to 
immunological synapse between the target cell and NK cell (Fuchs et al., 2004). Tlr1 is from the 
Toll-like receptor (TLR) family, important to develop effective immunity and acts with Cd14 in 
response to triacylated lipopeptides (Oliveira-Nascimento et al., 2012). The Cd14 mediates 
inflammatory response, innate immune response to bacterial lipopolysaccharide and is expressed 
in monocytes/macrophages. Proinflammatory cytokine secretion leads to NF-kB activation 
(Arroyo-Espliguero et al., 2004). Lgr4 act as negative regulator of innate immunity and is 
important for autoimmune diseases (Du et al., 2013).  
From the enrichment of the category generation of neurons, some genes presented in this 
GO term were discussed in association with behavior disorders, like SH3 and multiple ankyrin 
repeat domains 3 (Shank3), Wnt family member 2 (Wnt2), and solute carrier family 6 member 4 
(Slc6a4). The Shank3 is an intracellular scaffolding protein associated with neurotransmitter 
receptors, synapse formation, schizophrenia, and autism (Südhof, 2008). Wnt2 is a secreted growth 
factor important for developmental processes and multiple biological functions like cellular 
differentiation, and regulation of neuronal migration was associated with autism (Won et al., 
2013). Slc6a4 is a member of neurotransmitter transports’ family associated with transport of 
serotonin, is a target of psychomotor stimulants, and has been related to depression (Margoob and 
Mushtaq, 2011). 
The GO term cardiovascular system development included two genes identified for 
interaction effect, Hbegf, and Cth, among others important for this system like ryanodine receptor 
2 (Ryr2) and adam metallopeptidase domain 19 (Adam19). Ryr2 is found in the cardiac muscle 
sarcoplasmic reticulum and is a component of calcium channel, important for the cardiac muscle 
contraction (Lanner et al., 2010). Adam19 has main roles in heart development, neurogenesis, 
angiogenesis, and release of proteins like EGF receptor ligands (Zhou et al., 2004). 
From the genes annotated to the GO term response to lipopolysaccharide, Cxcl1, Il10, and 
Admt are also involved in other pathways like GO terms regulation of cell proliferation and 
positive regulation of the metabolic process. Other genes that are participating in the GO term 
response to lipopolysaccharide is platelet factor 4 (Pf4). The Pf4 is a regulator of vascular and 
immune biology has a direct role in B-cell differentiation in bone marrow, has antimicrobial 





GO terms that are involved in categories such as regulation of leukocyte chemotaxis, 
response to peptide, leukocyte activation, regulation of transmembrane receptor protein 
serine/threonine kinase signaling pathway, and peptidyl-tyrosine phosphorylation were enriched 
in this study in response to immune challenge. The treatment-by-genotype interaction effects on 
pathways and processes helped to identify mechanisms and specific genes that can be targeted to 
address depression-like behaviors after inflammation or to understand effects of IDO1 knockout 
in the whole process. 
Table 7. Informative clusters (Enrichment Score > 3) of descriptive DAVID FAT categories 
including Gene Ontology (GO) biological processes (BP) and KEGG pathway enriched among 
546 genes exhibiting significant treatment-by-genotype interaction effects. 





Cluster 1 Enrichment Score: 16.44    
BP FAT GO:0051272~positive regulation of cellular 
component movement 
46 2.21E-15 4.30E-12 
 Cluster 3 Enrichment Score: 8.87 
   
BP FAT GO:0002684~positive regulation of immune 
system process 
48 6.00E-09 1.16E-05 
 Cluster 4 Enrichment Score: 8.64 
   
BP FAT GO:0006954~inflammatory response 43 9.10E-10 1.76E-06 
 Cluster 12 Enrichment Score: 5.25 
   
BP FAT GO:0042981~regulation of apoptotic process 69 1.26E-07 2.43E-04 
 Cluster 14 Enrichment Score: 4.75 
   
BP FAT GO:0048699~generation of neurons 66 3.28E-06 6.34E-03 
 Cluster 15 Enrichment Score: 4.64 
   
BP FAT GO:0072358~cardiovascular system 
development 
56 5.03E-08 9.73E-05 
 Cluster 16 Enrichment Score: 4.38 
   
BP FAT GO:0032496~response to lipopolysaccharide 26 1.27E-05 2.47E-02 
 Cluster 20 Enrichment Score: 4.08 
   
BP FAT GO:0018108~peptidyl-tyrosine phosphorylation 21 9.83E-06 1.90E-02 
 Cluster 25 Enrichment Score: 3.89 
   
BP FAT GO:0090092~regulation of transmembrane 
receptor protein serine/threonine kinase 
signaling pathway 
18 1.26E-05 2.43E-02 
 Cluster 26 Enrichment Score: 3.82 
   
BP FAT GO:0002688~regulation of leukocyte 
chemotaxis 






Table 7 (cont.)     
Category Term Counta Raw P-value FDR-
adjusted P-
valueb 
 Cluster 36 Enrichment Score: 3.19 
   
KEGG 
PATHWAY 
mmu04390:Hippo signaling pathway 16 2.40E-05 3.06E-02 
aNumber of genes in the enriched category. 
bFalse Discovery rate adjusted P-value. 
 
Transcription factor network analysis of genes exhibiting treatment-by-genotype 
interaction effects 
The study of TFs is important to detect regulators of the genes associated with treatment-
by-genotype interaction effects. Among the 65 genes identified (P-value < 0.005) by interaction 
effects, 20 genes with P-value < 0.002 were present in the network analysis. Figure 8 shows the 
regulatory networks for TF exhibiting a normalized enrichment score (NES) > 3.0, the top enriched 
TFs with higher NES were selected. Table 8 lists the enriched TFs exhibiting a normalized 
enrichment score > 2.0 among the 65 genes identified (P-value < 0.005) by interaction effects. 
 
Table 8. Transcription factors (TF) enriched (normalized enrichment score NES > 3.0) among 
differentially expressed (number N of target genes = 65) genes exhibiting significant treatment-
by-genotype interaction effects at P-value <0.005. 
Transcription factor NESa Target Gene Nb 
Pparg 5.186 29 
Ugp2 4.726 9 
E2f1 4.479 27 
Jazf1 4.346 11 
Klf13 4.217 15 
Spib 4.189 10 
Hnrnph3 4.170 23 
Pura 4.151 28 
Mafa 3.877 14 
Pou2f1 3.589 8 
Sod1 3.509 5 
Hand2 3.482 30 






Table 8 (cont.)   
Transcription factor NESa Target Gene Nb 
Hey1 3.422 23 
Ing4 3.41 7 
Kdm5a 3.366 17 
Mtf1 3.215 12 
Gata2 3.207 10 
Jdp2 3.169 17 
Socs4 3.139 13 
Zcchc14 3.114 20 
Hand2 3.111 11 
Purg 3.033 13 
Tfap4 3.024 35 
Nr4a2 2.996 11 
Mylk 2.978 41 
Smad4 2.956 15 
Tead3 2.910 25 
Mettl14 2.880 9 
Nxph3 2.870 9 
Ahr 2.836 12 
aNormalized enrichment score 
bNumber N of target genes 
 
Among genes identified by iRegulon network analysis (Figure 8), the Creb3l1, Hbegf, 
Sphk1, and Tpbg were already discussed in the treatment-by-genotype interaction effects on the 
macrophage transcriptome section. The most enriched TF peroxisome proliferator-activated 
receptor gamma (Pparg) is involves in antidepressant-like activity and is a regulator of 
adipogenesis, being an important parameter in the obesity, which is associated with inflammation 
(Donma and Donma, 2016). Pparg is regulating both Hbegf and Sphk1. Both TFs UDP-Glucose 
Pyrophosphorylase 2 (Ugp2) and JAZF Zinc Finger 1 (Jazf1) are regulating the gene Creb3l1. The 
gene E2F transcription factor 1 (E2fr) promote expression of pro-apoptotic factors and is 






Figure 8. Regulatory network of transcription factors (normalized enrichment score > 3.0) and the 
target genes exhibiting significant treatment-by-genotype interaction effects at P-value <0.005. 
Green octagons denote TFs. The pink ovals are targets. 
The identification of TFs with regulatory networks confirmed the findings discussed in the 
treatment-by-genotype interaction effects on the macrophage transcriptome section and both 
regulons and regulators could be potential candidates to understand the mechanisms involved in 
the interaction effects. 
 
Effect of IDO1 genotype on the macrophage transcriptome 
The processes and pathways of immune systems activating macrophages are very complex. 
Having a gene knockout in macrophages may be important to understand molecular mechanisms 
affecting the regulation and dysregulation of specific genes. This study aims to understand the 
regulation of gene expression in the macrophages in the presence and absence of IDO1, a gene 
that is highly regulated by cytokines (Baumgartner et al., 2017). Table 9 lists four significant 
(FDR-adjusted P-value < 0.05) differentially expressed genes between mice with IDO1-KO and 





The genes differentially expressed might be related to other mechanisms of control 
occurring in the macrophage to compensate for the absence of IDO1 in the cell. Macrophages are 
not the only immune cells that produce cytokines, other cells, like NK cells, have the same function 
(Martinez and Gordon, 2014). IDO1 deficiency in dendritic cells leads to decrease of regulatory T 
cells (Tregs) and Il10 in serum. However, controversial results for IDO1 deletion in the 
inflammatory response were also existed (Baumgartner et al., 2017). 
In this study, a gene from transmembrane protein’s (Tmem) family, Tmem181, was under-
expressed in the IDO1-KO relative to the WT genotype group. Tmem181 is a receptor for 
cytolethal distending toxins (CDTs), which are potent toxins secreted by bacteria or virus. Mutant 
Tmem181 may have a role in the rate-limiting intoxication, where the CDT can bind the protein 
of Tmem181’s cell surface (Carette et al., 2009). This gene might be essential to understanding 
pathogenesis and mechanisms of pathogen intoxication in the macrophages. The Tmem181 
activity may be affected by the lack of IDO1 in the inflammation response in the IDO1-KO 
genotype group. 
Another differentially expressed gene that might be involved in the suppression of IDO1 
is the dynein light chain tctex-type 1 (Dynlt1). Dynein chains interact with viral proteins and are 
involved in the cellular cytoplasmic transportation mechanism that transport organelles along the 
microtubules, permitting the virus to travel and reach their replication sites (Merino-Gracia et al., 
2011). Dynein motor is essential for the successful viral infection. The over-expression of dynein 
light chains could increase the infection of papillomavirus, while the Dynlt1 depletion can inhibit 
the infection of this virus (Schneider et al., 2011). Dynlt1was under-expressed in the IDO1-KO 
relative to WT genotype group, giving a higher anti-viral response in the macrophages of IDO1-
KO group. 
The differentially expressed gene Relt like 1 (Rell1) is homolog/paralog of Relt, from the 
TNF-receptor superfamily. TNF is important for regulating the immune response, inflammation, 
and for participating in many processes in the cell (Cusick et al., 2010). Rell1 has been reported 
as a stimulator of T-cell proliferation and responsible for activating an apoptotic pathway in 
epithelial cells (Cusick et al., 2010). IDO1 over-expression can also induce cellular death, by 
producing kynurenine (Kyn), which has pro-apoptotic properties (Asghar et al., 2017). On the 





T cells (Asghar et al., 2017). Although the mechanisms involving T cells and IDO1 are still 
ambiguous, Rell1 and IDO1 might play a common role in apoptosis.  
Midline1 (Mid1) was associated with the airway hyper-responsiveness (AHR), a chronic 
airway inflammation (Foster et al., 2017). The inhibition of the activity of Mid1 can decrease the 
expression and production of some interleukins, and also decrease AHR (Foster et al., 2017). This 
gene can indirectly promote type 2 helper t cells (Th2) responses, which are essential for the 
immune system (Foster et al., 2017). Mid1 was over-expressed in the IDO-KO relative to the WT 
group, which might be related to a mechanism that suppresses the absence of IDO1. 
The number of genes differentially expressed prevented the identification of enriched 
categories using DAVID. The results of differentially expressed genes showed that few genes are 
involved in the differences between IDO1 phenotype and WT, suggesting that the macrophages 
may find a way to compensate the absence of IDO1 restoring the cell function. The mechanisms 
involved with this possible suppression can be the activation of inflammatory cells and induction 
of immune tolerance by divergent pathways. 
 
Table 9. Differentially expressed genes (FDR-adjusted P-value < 0.05) between mice in wild-type 
(WT) and IDO1 knocked out (KO) genotypes.  







Tmem181b-ps Transmembrane protein 181B, pseudogene -0.91 1.60E-42 2.30E-38 
Dynlt1b Dynein light chain Tctex-type 1 -1 2.00E-21 1.40E-17 
Rell1 RELT-like protein 1 precursor 0.4 1.50E-07 7.30E-04 
Mid1 PREDICTED: E3 ubiquitin-protein ligase 
Midline-1 
0.78 4.20E-06 1.50E-02 
G530011O06Rik RIKEN cDNA G530011O06 gene 1.03 7.4E-05 2.1E-01 
Rps4l Ribosomal protein S4-like 0.36 9.4E-05 2.2E-01 
Srpx Sushi-repeat-containing protein SRPX 
precursor 
1.20 3.0E-04 5.3E-01 
Pde8a High affinity cAMP-specific and IBMX-
insensitive 3\',5\'-cyclic phosphodiesterase 8A 
-0.22 3.2E-04 5.3E-01 
Gm33272 Predicted gene, 33272 -0.72 3.3E-04 5.3E-01 







Effect of BCG infection on the macrophage transcriptome 
The transcriptome of macrophages BCG-infected compared to the Sal unchallenged mice, 
allowed to find many possible pathways involved in the recovery process post-infection. Among 
the 8,798 significant differentially expressed genes (FDR-adjusted P-value < 0.05), 4,530 genes 
were under-expressed in the BCG relative to Sal treatment and 4,268 genes were over-expressed 
in the BCG relative to Sal treatment. Most significant genes that were under-expressed and over-
expressed in BCG relative to Sal treatment are listed in Tables 10, and 11, respectively.  
Table 10. Top 20 differentially expressed genes (FDR-adjusted P-value < 0.05) under-expressed 
in the BCG relative to Sal treatment.  




Ly6i PREDICTED: lymphocyte antigen 6I -9.20 1.0E-66 1.5E-62 
Ly6c2 PREDICTED: lymphocyte antigen 6C2 -8.09 6.9E-66 5.0E-62 
Zbp1 Z-DNA-binding protein 1 -4.43 2.2E-60 1.1E-56 
Fcgr1 high affinity immunoglobulin gamma Fc receptor I precursor -5.62 1.2E-59 3.5E-56 
Pira6 paired-Ig-like receptor A6 -4.68 1.2E-59 3.5E-56 
AW112010 expressed sequence AW112010 -4.79 9.5E-59 2.3E-55 
Spon1 spondin-1 precursor -6.99 3.2E-57 5.8E-54 
Smpdl3b acid sphingomyelinase-like phosphodiesterase 3b precursor -4.30 3.3E-57 5.8E-54 
Lair1 leukocyte-associated immunoglobulin-like receptor 1 -4.23 3.7E-57 5.8E-54 
Gpr141 PREDICTED: probable G-protein coupled receptor 141 -6.33 1.8E-56 2.6E-53 
Gbp2 guanylate-binding protein 1 -4.38 1.7E-55 2.2E-52 
Tap1 antigen peptide transporter 1 -2.87 1.0E-54 1.2E-51 
Ms4a6b membrane-spanning 4-domains subfamily A member 6B -3.68 1.4E-54 1.5E-51 
Fcgr4 low-affinity immunoglobulin gamma Fc region receptor III-A precursor -4.08 1.8E-54 1.8E-51 
I830127L07Rik PREDICTED: lymphocyte antigen 6A-2/6E-1 -8.85 6.9E-54 6.6E-51 
Aif1 PREDICTED: allograft inflammatory factor 1 -4.45 7.7E-54 6.9E-51 
Hrh2 PREDICTED: histamine H2 receptor -4.16 1.8E-53 1.5E-50 
Il18bp PREDICTED: interleukin-18-binding protein -3.48 2.4E-53 1.9E-50 
Bst1 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 precursor -2.34 4.6E-53 3.5E-50 
Lst1 leukocyte-specific transcript 1 protein -4.69 7.6E-53 5.5E-50 





Many under-expressed genes in the BCG relative to Sal treatment (Table 10), are 
associated with microbial response and host defense, macrophage structure, function, or 
metabolism. The genes Z-DNA binding protein 1 (Zbp1), leukocyte-associated immunoglobulin-
like receptor 1 (Lair1), high affinity immunoglobulin gamma Fc receptor I (Fcgr1), low affinity 
immunoglobulin gamma Fc region receptor III-a precursor (Fcgr4), allograft inflammatory factor 
1 (Aif1), and guanylate binding protein 2 (Gbp2) have the host defense function in common. The 
genes spondin 1 (Spon1), sphingomyelin phosphodiesterase acid like 3b (Smpdl3b), transporter 1, 
ATP binding cassette subfamily b member (Tap1), share the macrophage component function.  
 The Zbp1 is a Z-DNA binding protein that interacts with RIP homotypic interaction motif 
(Rhim), a domain that is present in the protein encoded by Zbp1 and may lead to the activation of 
NF-kB, caspase 8-dependent apoptosis, and interferon production (Upton and Kaiser, 2017). Zbp1 
plays a role in the innate immunity and limit some virus infection (Upton and Kaiser, 2017). The 
absence of this gene can cause damage in parasite degradation by the system, augmenting the 
parasite number, and parasite survival (Pittman et al., 2016). The under-expression of this gene in 
the BCG relative to Sal treatment is different from studies that found Zbp1 more expressed during 
the infection, nevertheless, this decrease of expression might be related to a lack of activation that 
is induced by IFN-y, favoring the parasite growth (Pittman et al., 2016). 
Lair1 belongs to an immunoglobulin superfamily and produces a signal that downregulates 
NK cells, T cells, and B cells (Poggi and Zocchi, 2014). Lair1 is present in leukocytes, and the 
decrease or absence of this gene can cause autoimmune or neoplastic diseases, like B cell chronic 
leukemia (Poggi and Zocchi, 2014). Lair1 was recently classified as an antibody, which are 
proteins of the immune system that respond to the presence of bacteria, virus, and parasites (Hsieh 
and Higgins, 2017).  
Fcgr1 is a receptor that has a high affinity for antibodies, binding to immunoglobulin-G 
(IgG) in neutrophils and is related to the immune system (Minett et al., 2016). As a leukocyte 
surface antigen, Fcgr1a plays a role in the innate and adaptive responses (Farias et al., 2014). The 
expression of this gene in microglia was associated with neurodegenerative pathologies like 
dementia, and bad cognition (Minett et al., 2016). The expression of Fcgr1a can be induced by 
inflammatory cytokines in the presence of bacteria and is over-expressed during infection on the 
surface of neutrophils (Farias et al., 2014). This gene may have a potential therapeutic role and 





responses (Farias et al., 2014). Fcgr1a was under-expressed in the BCG relative to Sal treatment. 
This profile is opposite to that previously reported suggesting that the expression of this gene can 
also be negatively affected by the presence of high level of inflammation. Another gene from the 
CD molecules family was under-expressed in the BCG relative to the Sal treatment Fcgr4is part 
of NK cells and have a cytotoxic function (Suzuki et al., 2017). A study showed that low levels of 
CD56+CD16- are associated with depression, sleep disturbance, and vulnerability to viral infection 
(Suzuki et al., 2017). 
The gene Aif1 induces macrophages activation and might be related to bipolar disorder and 
sleep disorder (Cai et al., 2017; Kittel-Schneider et al., 2017; Wadhwa et al., 2017). In this findings, 
Aif1 is under-expressed in the in the BCG relative to Sal treatment. In a study of depression-related 
symptoms, Aif1, that is also a glial cell marker in the brain, had elevated expression in a group 
under LPS challenge. In the same study, IDO was up-regulated in the brain of animals that suffered 
LPS treatment, suggesting that the peripheral immune challenge can cause neuroinflammation and 
kynurenine production (Parrott et al., 2016).  
Gbp2 is essential for antibacterial defenses, inhibiting bacterial replication, and providing 
host protection against different types of pathogens (Li et al., 2017b). Mutation in this gene was 
associated with a migraine, and the absence of Gbp2 expression was associated with no migraine 
(Jiang et al., 2015). In macrophages, genes from Gbp family can also promote caspase-11 
activation when infected with bacteria, regulating inflammation and cell death, mice deficient of 
Gbp have higher mortality in LPS infection than compared with the WT mice (Finethy et al., 2017). 
In these results, Gbp2 is under-expressed in the BCG relative to the Sal treatment.  
Some differentially expressed genes were also related to macrophage component function. 
Spon1 encodes the protein F-spondin that is induced by neuronal injury and damage the binding 
of cells to the extracellular matrix protein (ECM) (Jahanshad et al., 2013). Spon1 interacts with 
receptors’ family of alipoliprotein E (Apoe), which might be a strong genetic risk factor for 
Alzheimer’s disease (Jahanshad et al., 2013). The over-expression of Spon1 is related to cognitive 
improvements (Jahanshad et al., 2013). The under-expression of Spon1 in the BCG relative to the 
Sal treatment might be associated with a difficulty to recover the normal functions caused by the 
infection. 
The Smpdl3b is involved in the innate immunity signaling, and TLR-induced signaling 





present a hyper-responsiveness to TLR (Heinz et al., 2015). Smpdl3b is also a high 
phosphodiesterase active in macrophages surface, and a reduction in the expression of this gene 
causes reduction of the macrophage order (Heinz et al., 2015). Cells with Smpdl3b depletion 
present hyper-inflammatory response in the presence of lipid supplementation (Heinz et al., 2015). 
The under-expression of this gene in the BCG-infected group might be related to the damage 
caused by inflammation, compared to the Sal treated group that presents normal levels of 
expression of Smpdl3b. 
Tap1 is from the ATP-binding cassette (ABC) transporters family, and has a role in the 
transportation of peptides across the ER membrane, the depletion of this gene is related to the 
impairment of assembly and transport of MHC class I (Nelson et al., 2013). Loss of MHC class I 
shows a deficit of memory, being important in synaptic plasticity and cognition, and might be 
related to depression (Nelson et al., 2013). These results are in agreement with findings of this 
study where Tap1 was under-expressed in the BCG relative to Sal treatment, suggesting a presence 
of depression-like behavior. 
The results of under-expressed genes showed that many genes are involved in the 
differences between mice infected with BCG and with Sal. Some of the top genes presented in 
Table 10 were discussed and showed direct mechanisms of action in the host defense that might 
be damaged, by destroying the action against the microbial infection or preventing protective 
mechanisms to improve the impaired functions caused by the infection. Some genes were related 
to neurodegenerative disorders or depression, confirming the hypothesis that the BCG infection 
might have a role in the cause of depression-like behaviors. Also, another suggestion for this results 
is that the mechanisms involved in the inflammation process can be influencing other organs in a 
similar way.  
Table 11 lists the top 20 genes over-expressed in the BCG compared with Sal treatment. 
Genes over-expressed in the BCG relative to the Sal treatment, similarly to those under-expressed 
have roles related to the microbial response and host defense, and macrophage structure. The genes 
lysozyme 1 (Lyz1) and aquaporin 9 (Aqp9) have the microbial response function. The genes 
mitochondrial calcium uniporter (Mcu) and histamine receptor h1 (Hrh1) are associated with 
macrophage structure. 
 Lyz1 encodes lysozymes, that are antimicrobial agents, and related to immune system, 





which regulates inflammation, apoptosis, and cytokine production (Vance, 2010). Digestive 
enzymes activate immune sensors inside the cell, and the resistance of bacteria to lysozyme avoid 
the recognition of their presence by Nlrp3 inflammasome (Shimada et al., 2010; Vance, 2010). 
Lysozyme resistance facilitates the bacteria to evade the inflammasome (Vance, 2010). Also, 
lysozyme is important for innate response and upregulated against infection by pathogens (Gao et 
al., 2017). Lyz1 is over-expressed in the BCG relative to the Sal treatment. Aqp9 is from 
aquaporin’s (Aqp) family, and the high expression of Aqp9 was associated with infectious disease 
and systemic inflammatory response syndrome compared with healthy controls (Holm et al., 
2016). In agreement with this study, Aqp9 is over-expressed in the BCG relative to the Sal 
treatment. The over-expression of both Lyz1 and Aqp9 in the BCG relative to the Sal treatment 
might be confirming the presence of inflammation and immune system reaction. 
Mcu is a mediator of ER calcium uptake by mitochondria, regulates metabolism, cell 
viability, and ROS production (Gu et al., 2017). Mcu silencing can correct calcium defect 
associated with an increase of excessive mitochondrial calcium (Wang et al., 2017). This defect is 
caused by the clearance of apoptotic cells by phagocytes (Wang et al., 2017). Mice that were Mcu 
deficient in macrophages were protected from pulmonary fibrosis (Gu et al., 2017). Mcu is over-
expressed in the BCG relative to the Sal treatment suggesting damage in the immune response. 
Hrh1 encodes a histamine G-coupled receptor (H1R) and is part of the histaminergic 
system (Wright et al., 2017). Some genes of this system play a role in the neuroinflammation, 
cognition, sleep, and attention (Wright et al., 2017). Hrh1 was associated with NF-kb signaling, 
and cytokine production (Virakul et al., 2016). The Hrh1 was over-expressed in in the BCG relative 
to the Sal treatment. Genes (FDR-adjusted P-value < 0.05) over-expressed in the BCG relative to 
the Sal treatment showed the potential relationship between inflammation and behavioral 










Table 11. Top 20 differentially expressed genes (FDR-adjusted P-value < 0.05) over-expressed in 
the BCG relative to Sal treatment. 




Lyz1 lysozyme C-1 precursor 1.29 8.8E-27 3.7E-25 
Mcu PREDICTED: calcium uniporter protein, mitochondrial 0.81 7.1E-26 2.8E-24 
Neurl1a E3 ubiquitin-protein ligase NEURL1 1.76 8.4E-26 3.2E-24 
Fam198b PREDICTED: protein FAM198B 2.07 1.1E-24 3.7E-23 
Hrh1 histamine H1 receptor 1.65 2.3E-24 7.5E-23 
Aqp9 aquaporin-9 1.41 2.3E-24 7.7E-23 
Dcstamp PREDICTED: dendritic cell-specific transmembrane protein 2.27 7.0E-24 2.2E-22 
Ear2 eosinophil cationic protein 2 precursor 2.30 8.0E-24 2.5E-22 
LOC108168644 PREDICTED: proline-rich protein 36-like 2.24 9.2E-24 2.9E-22 
Cdkn1c PREDICTED: cyclin-dependent kinase inhibitor 1C 1.79 2.5E-23 7.6E-22 
Cd200r3 PREDICTED: cell surface glycoprotein CD200 receptor 3 2.10 2.8E-23 8.4E-22 
Tspyl2 PREDICTED: testis-specific Y-encoded-like protein 2 0.88 2.9E-23 8.6E-22 
Epas1 endothelial PAS domain-containing protein 1 2.03 1.9E-22 5.1E-21 
Cpeb1 PREDICTED: cytoplasmic polyadenylation element-binding protein 1 2.16 2.8E-22 7.5E-21 
Atp6v0a1 V-type proton ATPase 116 kDa subunit a 1.10 4.6E-22 1.2E-20 
Hpn serine protease hepsin 2.03 8.7E-22 2.2E-20 
Gbe1 1,4-alpha-glucan-branching enzyme 1.28 1.2E-21 2.8E-20 
Lrrc32 PREDICTED: leucine-rich repeat-containing protein 32 2.39 2.3E-21 5.5E-20 
F13a1 coagulation factor XIII A chain precursor 1.81 6.5E-21 1.5E-19 
Nav2 PREDICTED: neuron navigator 2 1.70 7.5E-21 1.7E-19 
aFalse Discovery Rate adjusted P-value. 
 
Functional analysis of genes exhibiting BCG treatment effect 
The functional analysis of genes exhibiting significant BCG infection effects can 
complement our findings in the differential expression analysis. However, different from the 
pattern assumed for the differentially expressed analysis of BCG-infected effects, the direction of 
regulation in over-expression or under-expression was not separated to find informative categories 
related to BCG-challenged. Functional analysis of 2,255 differentially expressed genes (FDR-
adjusted P-value < 0.05) with log2 (fold change) >|1| was implemented using DAVID. Most 





Ontology (GO) biological processes (BP), molecular functions (MF), and KEGG pathways 
enriched among genes exhibiting significant effects are described in Table 12. 
Enriched functional categories confirm the patterns previously discussed including GO BP 
terms related to microbial response and host defense, and macrophage structure or metabolism. 
For microbial response and host defense the following categories were enriched: response to virus, 
negative regulation of inflammatory response, response to lipid, positive regulation of cytokine 
production involved in immune response, antigen processing and presentation of peptide antigen 
via MHC class I, positive regulation of T cell mediated cytotoxicity, positive regulation of cell 
death, myeloid cell activation involved in immune response, negative regulation of viral life cycle, 
interaction with host, positive regulation of response to wounding, antigen processing, and 
presentation of endogenous peptide antigen (Table 12). 
Myocyte enhancer factor 2c (Mef2c), toll-like receptor 3 (Tlr3), and S100 calcium binding 
protein a8 (S100a8) are part of many functional categories. Mef2c was associated with cognition, 
behavior, and memory  (Mitchell et al., 2017). The expression of genes of TLR family is associated 
with the major depressive disorder in the presence of inflammation (Hung et al., 2017). The 
presence of gene S100a8 in inflammation is in accordance with a study that had S100a8 over-
expressed in response to BCG challenge in microglia cells (Gonzalez-Pena et al., 2016a). Another 
gene from the same family of S100a8, S100a9, was also associated with inflammation and 
depression (Ha et al., 2010). 
For functional categories related to macrophage structure, cellular function, and 
metabolism, the following  GO BP and MF terms were enriched: regulation of GTPase activity, 
cellular response to peptide hormone stimulus, nucleoside-triphosphatase regulator activity, 
regulation of peptidyl-tyrosine phosphorylation, cellular calcium ion homeostasis, 
phosphatidylinositol-mediated signaling, regulation of cysteine-type endopeptidase activity, and 
regulation of peptidase activity (Table 12). 
In agreement with this study, genes related to metabolism of regulatory peptides, 
inflammatory response, and immune system were associated with major depressive disorder (Song 
et al., 2013). Alanyl aminopeptidase, membrane (Anpep) and matrix metallopeptidase 8 (Mmp8) 
are associated with both inflammatory response and depression (Song et al., 2013). In this study, 





morphogenesis. Pathways related to inflammatory responses, energy metabolism, including 
hormonal signals were also associated with depression in humans (Carboni et al., 2016).  
Seven KEGG pathways were enriched in this analysis: graft-versus-host disease; antigen 
processing, and presentation; type I diabetes mellitus; axon guidance; chemokine signaling 
pathway; ECM-receptor interaction; focal adhesion. These results are highlighting the host defense 
mechanism that is acting in the presence of infection. The KEGG pathways together suggest that 
the animals might have behavior-like symptoms. First, because genes related to neuronal function, 
axon guidance, and synaptic vesicle cycle were associated with symptoms of depression (Brites 
and Fernandes, 2015; Carboni et al., 2016). Second, because focal adhesion and chemokine 
signaling pathway were also described as significantly enriched for major depressive disorder 
(Carboni et al., 2016). Finally, Type I diabetes mellitus was significantly enriched in the KEGG 
pathway, which is consistent with the findings that glucose metabolism, gluconeogenesis, and 
glycolysis are associated with the disorder. Also, the risk for type 2 diabetes mellitus may be 
increased in patients with depression (Carboni et al., 2016).   
The enrichment of categories among genes exhibiting significant BCG effects relative to 
Sal treatment using GSEA confirmed and complemented the results of GO terms related to 
immune system. These findings allowed a better understanding of the processes that might be 
happening in the macrophage during the inflammation response affecting the whole immune 
system and consequently developing depression-like behaviors. 
 
Table 12. Most informative clusters (Enrichment Score > 2) of descriptive DAVID FAT categories 
including Gene Ontology (GO) biological processes (BP), molecular functions (MF), and KEGG 
pathways enriched among genes exhibiting significant (FDR-adjusted P-value < 0.05) and with 
log2(fold change) >|1| between mice infected with BCG relative to Sal treatment. 




  Cluster 11 Enrichment Score: 15.49 
   
 BP_FAT GO:0009615~response to virus 86 1.04E-12 2.11E-09 
  Cluster 14 Enrichment Score: 11.10 
   
 BP_FAT GO:0043087~regulation of GTPase activity 55 1.3E-05 2.64E-02 
  Cluster 15 Enrichment Score: 10.80 
   
 BP_FAT GO:0050728~negative regulation of inflammatory 
response 






Table 12 (cont.)     




  Cluster 17 Enrichment Score: 8.62 
   
 BP_FAT GO:0001916~positive regulation of T cell mediated 
cytotoxicity 
11 1.98E-05 4.01E-02 
  Cluster 20 Enrichment Score: 8.18 
   
 BP_FAT GO:0010942~positive regulation of cell death 115 1.9E-09 3.85E-06 
  Cluster 22 Enrichment Score: 7.42 
   
 BP_FAT GO:0071375~cellular response to peptide hormone 
stimulus 
50 1.12E-05 2.26E-02 
  Cluster 27 Enrichment Score: 6.70 
   
 MF_FAT GO:0060589~nucleoside-triphosphatase regulator 
activity 
58 8.46E-07 1.45E-03 
  Cluster 29 Enrichment Score: 6.52 
   
 BP_FAT GO:0050730~regulation of peptidyl-tyrosine 
phosphorylation 
52 1.14E-07 2.30E-04 
  Cluster 31 Enrichment Score: 6.37 
   
 BP_FAT GO:0033993~response to lipid 162 1.1E-08 2.22E-05 
  Cluster 34 Enrichment Score: 6.25 
   
 BP_FAT GO:0002720~positive regulation of cytokine 
production involved in immune response 
15 3.67E-06 7.43E-03 
  Cluster 36 Enrichment Score: 6.10 
   
 BP_FAT GO:0006874~cellular calcium ion homeostasis 73 1.4E-05 2.83E-02 
  Cluster 37 Enrichment Score: 5.94 
   
 BP_FAT GO:0002474~antigen processing and presentation 
of peptide antigen via MHC class I 
26 3.63E-08 7.36E-05 
KEGG_PATHWAY mmu05332:Graft-versus-host disease 21 7.43E-07 9.82E-04 
KEGG_PATHWAY mmu04612:Antigen processing and presentation 25 1.62E-05 2.15E-02 
KEGG_PATHWAY mmu04940:Type I diabetes mellitus 21 1.7E-05 2.24E-02 
  Cluster 40 Enrichment Score: 5.58 
   
KEGG_PATHWAY mmu04360:Axon guidance 43 3.17E-10 4.19E-07 
  Cluster 41 Enrichment Score: 5.562 
   
 BP_FAT GO:0002275~myeloid cell activation involved in 
immune response 
24 1.57E-06 3.17E-03 
  Cluster 43 Enrichment Score: 5.43 
   
 BP_FAT GO:1903901~negative regulation of viral life cycle 24 4.22E-06 8.55E-03 
  Cluster 45 Enrichment Score: 5.31 
   
 BP_FAT GO:0048015~phosphatidylinositol-mediated 
signaling 
31 2.39E-05 4.84E-02 
  Cluster 47 Enrichment Score: 5.14 
   
KEGG_PATHWAY mmu04062:Chemokine signaling pathway 49 4.9E-07 6.48E-04 
  Cluster 53 Enrichment Score: 4.75 
   
KEGG_PATHWAY mmu04512:ECM-receptor interaction 28 1.78E-06 2.35E-03 
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  Cluster 62 Enrichment Score: 4.24 
   
 BP_FAT GO:2000116~regulation of cysteine-type 
endopeptidase activity 
45 2.25E-05 4.55E-02 
  Cluster 79 Enrichment Score: 3.24 
   
 BP_FAT GO:0052547~regulation of peptidase activity 67 3.02E-06 6.12E-03 
  Cluster 84 Enrichment Score: 3.09 
   
 BP_FAT GO:0051701~interaction with host 24 1.61E-05 3.26E-02 
  Cluster 96 Enrichment Score: 2.87 
   
 BP_FAT GO:1903036~positive regulation of response to 
wounding 
20 1.26E-05 2.55E-02 
  Cluster 122 Enrichment Score: 2.47 
   
 BP_FAT GO:0002483~antigen processing and presentation 
of endogenous peptide antigen 
11 7.4E-07 1.50E-03 
aNumber of genes in the enriched category. 
bFalse Discovery rate adjusted P-value. 
 
Transcription factor network analysis of genes exhibiting BCG treatment effect 
The understanding of TFs that affect the macrophage transcriptome is important to find 
sets co-dysregulated genes associated with BCG infection effects. The top significant genes 
(4,455) that were differentially expressed (FDR adjusted P-value < 2.0E-6) for BCG infection 
effects were used for transcription factor discoveries, without separating by the direction of 
expression (Table 13). The top enriched TF (NES > 3.0) in this analysis was the interferon 
regulatory factor 4 (Irf4), important in to mediate inflammation (Al Mamun et al., 2018). The 
second enriched TF, Irf9, is also from the IRF family of transcription factors, and both Tables 13 
and 14 showed this gene between the top enriched TFs. 
All the 4,530 genes under-expressed (FDR-adjusted P-value < 0.05) in the BCG relative to 
the Sal treatment, and all the 4,268 genes over-expressed (FDR-adjusted P-value < 0.05) in the 
BCG relative to the Sal treatment were used for co-regulation analysis. The results of the TFs 
identified for both under- and over-expressed are in Table 14. Among these enriched TFs (NES > 
3.0), the ETS transcription factor (Elk1) is the top enriched TF for the under-expressed genes. The 
Elk1 is a nuclear effector of the ERK cascade, which plays a role in synaptic plasticity and memory 
(Thiels et al., 2002). Network analysis in another study that leads inflammation to major depressive 





top enriched TF for over-expressed genes, MYC proto-oncogenes, BHLH transcription factor 
(Myc), are interacting through the Jun proto-oncogene, AP-1 transcription factor subunit (Jun), 
important in inflammatory responses and depression-like behavior (Malki et al., 2016). In the same 
study of network analysis, Elk1 also interacts with Jun (Malki et al., 2016). 
 
Table 13. Transcription factors (TF) enriched (normalized enrichment score NES > 2.0) among 
differentially expressed genes (FDR adjusted P-value < 2.0E-6; number N of target genes = 4,455) 
genes in BCG-infected relative to Saline treated mice. 
Transcription factor NESa Target Gene Nb 
Irf4 5.232 2186 
Irf9 5.230 1058 
Sirt6 3.656 664 
Ikzf1 3.383 965 
Snapc4 3.333 461 
Zfp503 3.317 184 
Nf1 3.238 457 
Gata2 3.238 1719 
Pura 2.932 1093 
Rrn3 2.888 1578 
Ywhaz 2.882 260 
Srf 2.824 237 
Klf4 2.698 2584 
Gm4204 2.677 950 
Bcl3 2.646 338 
Stat6 2.602 1131 
Elk1 2.560 806 
Cebpe 2.559 300 
Ets1 2.557 605 
Hes5 2.543 1334 
Ubp1 2.514 1624 
Bach2 2.504 1107 
Stat1 2.503 599 
Ar 2.494 245 
Foxo1 2.444 48 
Atf5 2.443 553 
Runx1 2.437 1582 
aNormalized enrichment score 





Table 14. Transcription factors (TF) enriched (normalized enrichment score NES > 3.0) among 
under-expressed (number N of target genes = 4,530) and over-expressed (number N of target genes 
= 4,268) genes in BCG-infected relative to Saline treated mice. 
Under-expressed genes  Over-expressed genes 
TFa NESb Target 
Gene Nc 
 TF NES Target 
Gene N 
Elk1 5.530 3031  Myc 3.502 1048 
Zfp143 4.308 1513  Smad1 3.416 94 
Yy1 4.118 1371  Tef 3.314 1147 
Sp3 3.766 2394     
Irf9 3.657 1152     
Rfx2 3.631 1789     
Mlx 3.019 238     
aTranscription Factor 
bNormalized enrichment score 
cNumber N of target genes 
 
Network analysis were performed on more stringent number of differentially expressed 
genes to identify the transcription factors that are influencing the BCG infection effects. Among 
the 4,530 genes under-expressed (FDR-adjusted P-value < 0.05) in the BCG relative to the Sal 
treatment, 150 genes with log2 (fold change) < -3 were selected for co-regulation analysis. Among 
the 4,268 genes over-expressed in the BCG relative to the Sal treatment, 105 genes with log2 (fold 
change) > 2.5 were selected for co-regulation analysis. Figures 9 and 10 show the regulatory 
networks for TF exhibiting a normalized enrichment score > 3.0, the top enriched TFs (> 30 
targets) with higher number of targets were selected, however, to facilitate visualization, they were 
filtered to 30 targets for each TF in the network. Table 15 lists the enriched TFs exhibiting a 
normalized enrichment score > 3.0 among genes under-expressed and over-expressed (FDR-







Figure 9. Regulatory network of transcription factors (normalized enrichment score > 3.0 and > 
30 targets) and the 30 target genes under-expressed in BCG relative to Saline-treated mice. Red 
octagons denote TFs. The blue ovals are TFs that are targeting each other. The purple ovals are 
targets. 
 
The co-regulatory network results are in agreement and complement the results discussed 
in the other sections. The regulatory network for under-expressed target genes (Figure 9) includes 
signal transducer and activator of transcription 1 (Stat1; normalized enrichment score = 5.9), Rela 
proto-oncogene, NF-kB Subunit (Rela; normalized enrichment score = 4.9), core-binding factor 
beta subunit (Cbfb; normalized enrichment score =3.7), and interferon regulatory factor 6 (Irf6; 





Stat1 is from STAT protein family and can be activated by interferons (IFNs) and 
cytokines. Specifically, IFN-a, which is associated with depression symptoms, can lead to the 
phosphorylation of Stat1 and Stat2 (Borsini et al., 2017). Both IFN-alpha and Stat1-mediated 
production of cytokine is involved in cell apoptosis process in the brain and neurogenesis (Borsini 
et al., 2017). The presence of high levels of Stat1 was associated with severe major depressive 
disorder and dysregulation of neurotransmitter systems (Hoyo-Becerra et al., 2015). Stat1 was a 
hub gene connected with Janus kinase 2 (Jak2), signal transducer, an activator of transcription 3 
(Stat3), and nuclear factor erythroid derived2 (Nfe2) in network analysis, being over-expressed in 
the BCG-infected compared to Sal treatment group within macrophages and microglia (Gonzalez-
Pena et al., 2016a). Stat1 is regulating a gene that serves as a neurotransmitter, brain-derived 
neurotrophic factor (Bdnf), which is considerate a marker for depression treatment (Martocchia et 
al., 2014). Stat1 is being regulated by the predicted regulons Irf6 and is also both regulating and 
being regulated by Rela. 
The gene Rela is a subunit of the canonical pathway NF-kB, which is essential for B cell 
maturation and activation (Milanovic et al., 2017). Rela is an abundant form in NF-kB, important 
to play a role in the innate and adaptive immune system, inflammation and cancer (Martincuks et 
al., 2017). Rela and Stat1 regulate five genes in common: B-cell CLL/lymphoma 3 (Bcl3), growth 
arrest and DNA damage-inducible beta (Gadd45b), C-C motif chemokine ligand 2 (Ccl2), 
intercellular adhesion molecule 1 (Icam1), and cyclin-dependent kinase inhibitor 1a (Cdkn1a). 
Cdkn1a is regulated by the four predicted regulons or TFs. 
As the Irf4 and Irf 9 found as enriched TFs in Tables 13 and 14, the Irf6 is also from the 
interferon transcription factor (IRF) family, which primarily regulate immune system maturation, 
playing a role in the expression of pro- and anti-inflammatory cytokines (Li et al., 2017a). Irf6 
plays a role in the macrophage activation, and is related to metabolic disorders and indirectly 
mediate TLR signaling (Li et al., 2017a). In the network, Irf6 is regulating many genes related to 
immune system like Il6 (Figure 9). 
The TF Cbfb regulates genes involved in hematopoiesis and osteogenesis and is constituted 
of genes from RUNX family (Morita et al., 2017). The inhibition of RUNX has anti-tumor 
potential, implicating in cell death pathway (Morita et al., 2017). Cbfb regulates the target 
suppressor of cytokine signaling 1 (Socs1), that is a negative regulator of Tlr4 signaling, and a 





enriched among under-expressed genes between mice infected with BCG relative to Sal treatments 
implicated in the finding of candidate regulons that can be potentially used as biomarkers to 
understand the molecular mechanisms involving inflammation and depression-like behavior. 
Four enriched TFs were selected and had > 30 target genes among the genes over-expressed 
in the BCG-infected relative to the Sal treatment group (Figure 10): forkhead box g1 (Foxg1; 
normalized enrichment score = 3.8), forkhead box l1 (Foxl1; normalized enrichment score = 3.7), 
upstream transcription factor 1 (Usf1; normalized enrichment score = 3.6), and TEA domain 
transcription factor 1 (Tead1; normalized enrichment score = 3.1) (Table 15). 
 
Figure 10. Regulatory network of transcription factors (normalized enrichment score > 3.0 and > 
30 targets) and the 30 target genes over-expressed in BCG-infected relative to Saline treated mice. 






Foxg1 plays a role in the brain development and may lead to human neurological disorders 
(Kumamoto and Hanashima, 2017). This TF is a candidate gene for two neurological disorders, 
West and Rett syndromes, and in epilepsy, suggesting the participation of Foxg1 in the interneuron 
development (Yang et al., 2017). Also, Foxg1 regulates SMAD/transforming growth factor beta 
(TGF-B) pathway that leads to antidepressants mechanisms of action (Kinsler et al., 2010). 
Deficiency of Foxg1 may reflect in differences in behavior, such as hyperactivity, and can lead to 
impairment of antidepressant response (Kinsler et al., 2010). In agreement with these findings, 
Foxg1 is connected to the SMAD family member 3 (Smad3) suggesting a possible neurological 
effect during inflammation in the BCG-infected relative to Sal treatment group (Figure 10). 
Although Foxl1 also belongs to the FOX family, this gene plays a different role in the 
immune system (Zhong et al., 2017). An over-expression of Foxl1 is related to inhibition of cell 
proliferation and migration, downregulation of Wnt/B-catenin signaling pathway and can also 
promote TNF-related apoptosis-inducing ligand (TRAIL) (Li et al., 2016; Zhong et al., 2017). In 
Figure 10, both Foxg1 and Foxl1 are regulating fos proto-oncogene, ap-1 transcription factor 
subunit (Fos or c-fos), which is related to antidepressant treatment, high neuronal activity and 
behavioral disorders (Fan et al., 2017; Zhu et al., 2017). Foxg1 and Foxl1 regulate fos and more 
fifteen genes in common, and from these, one is regulated by all four regulons (Cdkn1a), and one 
is regulated by three regulons (Cbp/P300 interacting transactivator with Glu/Asp-rich carboxy-
terminal domain 2 (Cited2)). Cdkn1a is a cell cycle regulator, related to clock genes (Sato et al., 
2017). Cited2 is a repressor of macrophage pro-inflammatory activation (Kim et al., 2017). 
Usf1 also is a TF that binds the gene Bdnf promoter IV in the brain of rats (Cortes-Mendoza 
et al., 2013; Ren et al., 2016; Spohrer et al., 2017). Usf1 is regulating the gene Cad, mutations in 
this gene were involved with epileptic encephalopathy (Koch et al., 2017). Tead1 belongs to TEAD 
transcription factor family and plays an important role in development and Hippo signaling 
pathway, which regulates cell growth, proliferation, and homeostasis (Lin et al., 2017). In Figure 
10, Tead1 is regulating Saa1, a gene that was discussed in the interaction section and is related to 
depressive-like behavior in brain (Jang et al., 2017). The study of regulons with regulatory 
networks confirmed the findings discussed in other sections and implicated in the identification of 
transcription factors that can be potential candidates to understand the mechanisms involved in the 





Table 15. Transcription factors (TF) enriched (normalized enrichment score NES > 3.0) among 
under-expressed (number N of target genes = 150) and over-expressed (number N of target genes 
= 105) genes in BCG-infected relative to Saline treated mice. 
Under-expressed genes  Over-expressed genes 
TFa NESb Target 
Gene Nc 
 TF NES Target 
Gene N 
Stat1 5.982 94  Zbtb18 4.111 29 
Rela 4.936 46  Foxg1 3.795 30 
Cbfb 4.344 39  Foxl1 3.728 42 
Ywhae 4.146 25  Foxn4 3.613 40 
Ikzf1 3.999 18  Pou3f4 3.596 25 
Tppp 3.817 15  Usf1 3.562 35 
Bcl6 3.676 14  Sox10 3.426 17 
Irf6 3.573 56  Ing4 3.348 14 
Gata5 3.443 16  Kdm4d 3.331 17 
Jun 3.341 31  Tead1 3.135 49 
Mettl3 3.307 15  Stat1 3.123 30 
Ets1 3.033 12  Jun 3.064 19 
Trp53 3.004 8  Smad4 3.026 17 
aTranscription Factor 
bNormalized enrichment score 
cNumber N of target genes 
 
According to Table 15, the gene Jun proto-oncogene, AP-1 transcription factor subunit 
(Jun) was also among the top enriched TF for under-expressed genes in BCG-infected relative to 
Saline-treated mice and had > 30 targets. Jun, as discussed at the beginning of this section, was 
associated with major depressive disorder, neuroplasticity and neurogenesis in a rat model of 
depression in the prefrontal cortex (Malki et al., 2015). Among the top TF enriched over-expressed 
genes, the forkhead box N4 (Foxn4) and Stat1 also had > 30 targets. Foxn4 positively regulates 
the orphan nuclear receptor subfamily 4 group A member 2 (Nr4a2), which is essential for the 
ventral midbrain dopaminergic neurons and is related to Parkinson’s disease (Jiang and Xiang, 
2009). Despite zinc finger and BTB domain containing 18 (Zbtb18) was not in the top enriched 
TFs, this gene had 29 targets and had the highest score for NES among the TFs for over-expressed 
genes in BCG-infected relative to Saline-treated mice. Zbtb18 is associated with microdeletion 





might be important TFs in this study for being enriched for under-expressed and over-expressed 
genes in BCG-infected relative to Saline-treated mice. 
 
Comparison between results of two different pipelines 
The analysis of the contrast BCG(WT)-Sal(WT) was performed using both Tuxedo 
pipeline (TopHat, Cufflinks, Cuffdiff) and Kallisto, tximport and edgeR to better identify how 
different these two methodologies are. The number of significant differentially expressed genes 
(FDR adjusted P-value <0.05) identified with Cuffdiff was 4,137, while edgeR identified 6,843. 
The edgeR method had 2,681 genes that were not present in Cuffdiff analysis, and Cuffdiff had 
995 genes not present in edgeR analysis. The values of P-value, FDR-adjusted P-values, and fold 
changes from Cuffdiff were compared with edgeR using 11,029 genes that were common between 
both analyses. Both initial files were filtered by non-annotated genes, low or no expressed genes. 
Then, data from both analyses were combined by gene Id. P-value, FDR-adjusted P-values, and 
fold changes were logged 10 transformed to normalize data. However, the data were still not 
normally distributed, and Spearman method was used to calculate correlation in the SAS software 
(Saxton and Institute 2004).  
The Spearman method results showed 87% of correlation (P-value < 0.0001) between 
adjusted P-values, 98% of correlation (P-value < 0.0001) between log10 (fold changes), and also 
87% of correlation (P-value < 0.0001) between P-values for both analyses. The results showed that 
both pipelines, having Cuffdiff and edgeR for differential expression analysis, share a high number 
of significant genes, with a similar level of P-value, FDR-adjusted P-values, and fold changes. 
Despite a lower number of differentially expressed genes in Cuffdiff, both methods showed a 
strong correlation in the results. 
 
In summary, our study of individual gene expression patterns, functional analysis, and TF 
confirmed that genes associated with immune pathways remain dysregulated seven days after BCG 
treatment. The association between macrophage transcriptome and depression-like symptoms may 
support reports that immune cells from the peripheral blood can surpass the blood-brain barrier 
and elicit central nervous system inflammation. The detection of genes that exhibited interaction 





between IDO1-KO and WT mice. Several genes and pathways associated with depression and 
neurological disorders that exhibit depression symptoms further aid in understanding the 














































CHAPTER 4 - GENE CO-EXPRESSION NETWORK ANALYSIS TO FIND MODULAR 




Systems biology approaches are used to elucidate mechanisms that orchestrate cellular 
functions and regulate complex traits. Gene co-expression networks are useful for interpretation 
of large datasets. Networks modules can reveal functional processes and pathways that are shared 
between genes. Differential co-expression analysis compares the structure of two co-expression 
networks between conditions, in this case, providing insight into alterations in the regulatory 
systems between genotype lines and between drug treatments. Weighted gene co-expression 
network analysis identified modules related to the selected line (H) for hyperactivity and drug 
treatment of amphetamine (A). Co-expressed genes in module grey were significantly correlated 
with genotype, and functional analysis enriched the GO BP terms regulation of cell death and Wnt 
signaling pathway. Among the members of module grey, the genes frizzled class receptor 9 (Fzd9), 
insulin-like growth factor (Igf1), and tachykinin receptor 1 (Tacr1) are related to behavior, 
learning, and memory, and genes peptidylprolyl isomerase F (cyclophilin F) (Ppif) and cytochrome 
c oxidase subunit IV isoform 2 (Cox4i2) is associated with neurodegenerative disorders. Genes in 
modules tan, cyan, and salmon were significantly correlated with treatment. The tan module had 
GO BP terms related to nervous system development, while cyan module had regulation of 
nitrogen compound metabolic process and salmon module had regulation of multicellular 
organismal process as significant. Among genes in the salmon module, the gene Jun proto-
oncogene (Jun) is specifically related with an amphetamine addiction, and the genes neurogenic 
differentiation 1 (Neurod1), purine-nucleoside phosphorylase (Pnp), and xanthine dehydrogenase 
(Xdh) are related with response to the drug, drug binding, and drug metabolism, respectively. In 
the cyan module, the gene cAMP responsive element binding protein 3-like 1 (Creb3l1) is related 
to the dopaminergic synapse, Huntington's disease, and amphetamine addiction. From the tan 
module, the gene oxytocin (Oxt) plays a role in response to amphetamine and behavior, while the 
gene kallikrein related-peptidase 8 (Klk8) is important in the nervous system development, 
behavior, learning or memory. Four co-expressed genes found in the significant modules, Creb3l1, 
Neurod1, Ppif and Oxt also exhibited significant (FDR adjusted P-value < 0.05) treatment-by-line 





(Ephb3), important for the nervous system, as negatively differentially connected to mice receiving 
the A relative to the S treatment. The gene Ppif was positively differentially connected to mice 
from C relative to the H line and is possibly one of the most important genes of this analysis for 




Gene expression analysis helped to understand the molecular basis of the simultaneous 
effects of genotype, using mice from the line (H) selected for hyperactivity, a model of attention 
deficit hyperactivity disorder (ADHD), and of amphetamine treatment (A). Systems biology is 
used in this study to understand better the mechanisms underlying the hyperactivity line-
amphetamine treatment.  
The systems biology methods of correlation network analysis and identification of hub 
genes that contribute to gene patterns across the samples have been widely applied to diseases like 
heart disease, and diabetes (Sengupta et al., 2009; Tang et al., 2018). The networks can be 
constructed based on the data from gene expression analysis. Gene co-expression networks have 
been used to detect modules that are biologically meaningful and to find the relationship between 
modules. These modules are composed of highly interconnected genes organized according to 
functional processes and pathways. Weighted Gene Co-expression Network Analysis (WGCNA) 
is a software package in the R environment that uses gene co-expression information to uncover 
networks (Langfelder and Horvath, 2007). WGCNA routines were used to identify gene modules 
related correlated to the hyperactivity line or amphetamine treatment. 
Another approach known as differential co-expression analysis compares the structure of 
two co-expression networks and connectivity between conditions, providing insight into 
alterations in the regulatory systems (de la Fuente, 2010). This method has been successfully used 
to identify differential co-expression in cancer and to identify transcription factors and microRNAs 
related with phenotypes (Choi et al., 2005). 
 The objective of this study was to identify modules and genes associated with the selected 
line (H) for hyperactivity and drug treatment of amphetamine (A) using WGCNA and differential 





of differential gene expression found in Chapter 2 and complement our insights, as these are 
powerful alternatives to find more answers about complex systems. 
 
Materials and Methods 
Data collection and sequencing 
Mice from a hyperactivity line (H) selected for increased home cage activity and from a 
contemporary control line (C) were studied (Majdak et al., 2014; Majdak et al., 2016; Zombeck et 
al., 2011). Home cage activity was individually measured, and male H mice exhibited significantly 
higher activity and motor impulsivity compared to C mice. Room conditions of temperature, light, 
diet, and management followed previous protocols (Majdak et al., 2016). At approximately five 
months of age, one intraperitoneal injection of either 0.25 mg/kg of d-amphetamine (treatment A) 
or equal amount of saline (treatment S) was given to each mouse in the home cage over three days 
(Majdak et al., 2016). Two hours after injection, mice were decapitated, and brains were removed 
immediately. In total, 20 mice were analyzed across the 2 activity lines and the two amphetamine 
treatments. All animal procedures were approved by the Illinois Institutional Animal Care and Use 
Committee and were in accordance with the National Institutes of Health Guide for the Care and 
Use of Laboratory Animals. 
Striatum was extracted and dissected and stored in a centrifuge tube at -80oC following 
published protocols (Caetano-Anollés et al., 2016; Saul et al., 2017). RNA was extracted, isolated, 
and purified. Total RNA yield measured using Qubit1 2.0 (Life Technologies, Carlsbad, CA, USA) 
was > 14 ug per sample. The RNA Integrity Number (RIN) measured using Fragment Analyzer 
(Advanced Analytical Technologies Inc., Ankeny, IA, USA) was > 8 for all samples. The libraries 
were prepared and sequenced using Illumina HiSeq 2500. FASTQ files containing paired-end 
reads of length 100nt were generated and demultiplexed with the software Casava 1.8.2 (Illumina, 
San Diego, CA, USA).  
The software program FastQC was used to assess Phred quality score of the reads 
(Andrews, 2010). The nucleotide quality score was > 30 across all read positions and was not 
trimmed (Nixon et al., 2015). The software program TopHat2 v2.1.1 was used to map the reads to 
the mouse genome assembly Genome Reference Consortium GRCm38 (Pruitt et al., 2006; 





program Cufflinks2 (Trapnell et al., 2012) with default specifications, generating fragment per 
kilobase per million mapped reads (FPKM) for each sample.  
 
Weighted Gene Co-expression Network Analysis  
The WGCNA package in R was used for the analysis of co-expression networks (Zhang 
and Horvath, 2005). The input data was the table of FPKM values generated by Cufflinks2 per 
annotated gene and sample. The expression on 44,796 genes and “CUFFs” (short transcripts 
assembled by Cufflinks or transfrags in GTF format, normally not annotated) across 20 samples 
genes were available. This information was filtered to remove genes with low expression level or 
variation across samples as per recommendations in the software manual. Genes that had mean 
expression < 0.1 and standard deviation < 0.3 across samples were excluded as well all “CUFFs”. 
This filtering reduced the number of genes available for network analysis to 2,193 genes. The 
purpose was to eliminate low-expressed or non-varying genes that are considerate noise in 
WGCNA analysis (Zhang and Horvath, 2005).   
After filtering, the FPKM values were log transformed (log2 (FPKM +1)). Although 
normalization does not make a lot of difference for WGCNA analysis, the log-transformed FPKM 
values were also normalized by mean and standard deviation across all samples (van Dam et al., 
2017). The genes that remained on the list were evaluated according to their connectivity. The 
Pearson correlation coefficient was used as a measure for co-expression, and a threshold was given 
to this correlation to find networks that influence the trait. Genes that had significant pairwise 
expression profiles associated with samples/phenotype were considered connected (Zhang and 
Horvath, 2005).  
In a network, nodes are considerate biomolecular species as metabolites, proteins, and 
genes, while the edges represent the interaction between nodes (de la Fuente, 2010). The 
probability that a node is connected with another “k” node decays following the power law, 
indicating that large networks are organized into scale-free networks (Zhang and Horvath, 2005). 
The power-law distribution is also called scale-free topology and can be explained using a network 
growth model. In other words, the free-scale topology depends on the growth of the network; new 





nodes are called hubs, and scale-free networks are dominated by heterogeneous topology detecting 
few hubs that are more essential in the system (Zhang and Horvath, 2005).  
Next step was choosing a set of soft-thresholding power by calling the network topology 
analysis function (Zhang and Horvath, 2005). A soft threshold determines that the network will be 
weighted by assigning a connection weight to each gene pairs (Zhang and Horvath, 2005). 
Constructing a weighted gene network entails the choice of the soft thresholding power β to which 
co-expression similarity is raised to calculate adjacency. A measure of similarity between the gene 
expression profiles was defined (Zhang and Horvath, 2005). In this study, the absolute value of 
the Pearson correlation sij = |cor(i, j)| was used. Each co-expression network corresponds to an 
adjacency matrix that encodes the connection strength between each pair of nodes (Zhang and 
Horvath, 2005). The resulting adjacency matrix was used to define a measure of node dissimilarity 
(distance). The node dissimilarity measure was used as input of a clustering method to define 
network modules (clusters of nodes) (Zhang and Horvath, 2005). An important aim of co-
expression network analysis is to detect subsets of nodes (modules) that are tightly connected to 
each other. The use of ‘soft’ adjacency functions is to avoid the disadvantages of hard thresholding 
(Zhang and Horvath, 2005).  
Connectivity, clustering coefficient, and topological overlap were calculated for the 
networks (Zhang and Horvath, 2005). The connectivity or row sum is the sum of the correlations 
between a gene and all the other genes of the network. The adjacency matrix encodes the 
connection strengths between pairs of nodes or genes, and this matrix is generated by the Pearson 
correlation between all genes elevated to the beta parameter, which is chosen based on topology 
scale-free index (R2) (Zhang and Horvath, 2005).  
The groups of genes that have the same degree of overlap is determined by counting the 
number of neighbors (first-order interactions) that a pair of nodes shares (Zhang and Horvath, 
2005). The topological overlap matrix (TOM) is calculated from this, and a value between 0 and 
1 (connected =1, all neighbors of a node are also neighbors of the other node; unconnected=0, two 
nodes do not share any neighbors) is attributed to each pair of nodes (Zhang and Horvath, 2005). 
The TOM matrix was used as input for an average linkage hierarchical clustering step based on 
Euclidean distances method that results in a dendrogram or tree. A height cutoff value was chosen 
in the dendrogram to decide where to cut the tree branches; the cutoff choice is guided by the TOM 





modules, and small values result in small tight modules. The resulting branches correspond to gene 
modules (Zhang and Horvath, 2005).  
In WGCNA, co-expression modules are represented by eigengene networks that contain 
genes that are more representative of the gene expression profile instead of using all genes. A 
module eigengene is equivalent to a first principal component of a given module, and usually 
explains more than 50% of the variance of the module expressions (Langfelder and Horvath, 
2007).  
The association of individual genes with the traits (genotype and treatment) was made by 
Gene Significance (GS), which is the absolute value of correlation between the gene and the trait. 
The correlation of the module eigengene and the gene expression profile was also quantified, this 
measure is called module membership (MM) (Zhang and Horvath, 2005). 
In this study two traits were considered for final interpretation: the line H versus line C, 
and treatment A versus treatment S. Statistically significant modules selected and the genes present 
in these modules were studied for functional enrichment using a hypergeometric test, the web-
service Database for Annotation, Visualization and Integrated Discovery (DAVID; Version 6.8) 
(Huang et al., 2009). The functional categories Gene Ontology (GO) biological processes (BP), 
molecular functions (MF), and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways 
were assessed. The geometric mean of the enrichment P-values (Enrichment Score, ES) was used 
as evidence supporting the category clusters. The mouse genome was used as background for 
testing and FDR was used to adjust the enrichment P-values for multiple testing (Pruitt et al., 
2006). 
 
Differential co-expression analysis 
In Chapter 2, the differential expression between two traits (line and treatment) and the 
interaction between them were discussed. In differential expression analysis, genes were 
significantly different for both line (H and C) and treatment (A and S) based on the observation of 
the mean expression level of genes. A new approach called differential co-expression was applied 
in this study to find genes significantly different for both line and treatment based on the 






The difference of connectivity between two or more genes in two different conditions, 
(between H and C and between A and S) can play an important role in the phenotypes (line and 
treatment). The difference from co-expression analysis is that the networks will be constructed 
from two different subgroups of samples (two conditions) from a prior WGCNA. In total, 18 
samples and 2,193 genes were used in WGCNA analysis, and for differential co-expression 
analysis the number of samples and genes were the same (5 Control-Amphetamine (CA), 4 
Control-Saline (CS), 5 Hyperactive-Amphetamine (HA), 4 Hyperactive-Saline (HS)). The Pearson 
correlation was used to quantify the association between two gene expression levels. The 
calculation of correlation of the expression between a pair of genes was made separately for the 
fours subgroups: H, C A and S, and the connectivity were compared between lines and between 
treatments separately. 
The same step used in WGCNA was repeated for each subgroup. An adjacency matrix that 
measures the connection strengths was constructed, and the power for each subgroup was selected 
based on the free topology criterion (de la Fuente, 2010). Then, the connectivity was calculated as 
a function of the soft-thresholding power. 
After finding the connectivity of each subgroup, the connectivity estimates were 
normalized to facilitate the comparison between subgroups (range of values for normalized 
connectivity was 0-1). Normalization encompasses the dividing each gene connectivity by the 
maximum connectivity of that subgroup (Fuller et al., 2007). The measure to calculate the 
differential connectivity between subgroups is DiffK(i) = K1(i) – K2(i). The results are the 
differences in the connectivity between two subgroups, and the differences are considerate 
significant if DiffK is < |0.4| (Fuller et al., 2007). Negative values of this difference imply that line 
C or treatment S connectivity (K2) is greater than line H or treatment A (K1) connectivity. The 
differentially co-expressed genes were analyzed for functional enrichment using DAVID. 
 
Results and Discussion  
Weighted Gene Co-expression Network Analysis 
Filtering of genes. A CVS file including columns corresponding to the 20 samples from 
the four genotype-treatment groups: CA, CS, HA, HS. This file contained a total of 44,796 rows 





All entries denoted CUFFS were deleted because of unknown annotation leaving 4,530 genes. 
Another filter was applied per gene row. Genes that had no expression value in at least ten samples 
were removed leaving 3,472 genes for analysis. Further filtering for computational reasons 
encompassed removal of genes that had mean expression < 0.1 and standard deviation < 0.3 were 
removed, leaving 2,193 genes for WGCNA analysis. From these 2,193 genes, 333 exhibited 
significant interaction effect, 54 were differentially expressed in the main effect of A treatment, 
and 194 genes were differentially expressed in the main effect of H genotype at FDR adjusted P-
value < 0.05. 
Filtering and clustering of samples. Figure 11 shows the clustering of 20 samples based 
on the log-transformed FPKM of 2,193 genes after pre-processing with the objective of outlier 
detection. Two samples (CS411 and HS499) were creating a separated branch from the main one, 
and for this reason, these two samples were eliminated of the analysis as they might be 
confounding factors in the attempt to create one big simple cluster. Figure 12 presents the cluster 










Figure 11: Clustering dendrogram of 20 genotypes by treatment samples (5 Control-Amphetamine 
(CA), 5 Control-Saline (CS), 5 Hyperactive-Amphetamine (HA), and 5 Hyperactive-Saline (HS)) 
based on their Euclidean distance using 2,193 genes. Height corresponds to the cut of the tree. The 






Figure 12: Clustering dendrogram of 18 genotypes by treatment samples (5 Control-Amphetamine 
(CA), 4 Control-Saline (CS), 5 Hyperactive-Amphetamine (HA), and 4 Hyperactive-Saline (HS)) 
based on their Euclidean distance using 2,193 genes. The first color band represents line (red 
indicates line H and white indicates line C). Height corresponds to the cut of the tree. The leaves 
of the tree correspond to the samples. LogFPKM means log transformed FPKMs.  
 
The clustering in Figure 12 includes three grey boxes showing that HS samples tend to 
cluster close to the CA samples (samples HS197 with CA409 and CA407; samples HS886, HS483 
and CA454). Also, the HA samples tend to cluster close to CS samples (samples HA487, HA872, 
HA905, and CS477). These trends could suggest that the amphetamine treatment used in this study 
affects the transcripts of control mice similar to the hyperactivity genotype (CA ~ HS). Also, the 
amphetamine treatment used in this study had opposite associations with the transcript level 
between both mice genotypes. The amphetamine treatment on the hyperactive line was associated 
with transcript levels similar to saline treatment on control mice (HA ~ CS). These results are 






Gene network analysis in WGCNA focuses on the clustering of genes based on their gene 
expression, rather than the clustering of samples. An approach similar was used to compare the 
gene expression pattern using a cluster of samples to prove that samples that clustered together 
had transcriptional patterns (Svahn et al., 2016).  
The information in Figure 13 was used to select a set of soft-thresholding power by calling 
the network topology analysis function. The selected power was 6, the lowest power for which the 
scale-free topology fit index curve flattens out upon reaching a high value (in this case, roughly 
0.85). 
 
Figure 13: Analysis of network topology for various soft-thresholding powers. The left panel 
shows the scale-free fit index (y-axis) as a function of the soft-thresholding power (x-axis). The 
right panel displays the mean connectivity (degree, y-axis) as a function of the soft-thresholding 
power (x-axis). 
The selection of the soft-thresholding power enabled the identification of gene modules. 
These modules encompass genes that exhibit highly correlated expression profiles across the 
samples or high topological overlap. Both Figures 14 and 15 show a hierarchical clustering 





network application and provides a simple visual comparison of module assignments (branch 
cuttings) based on the dynamic hybrid branch cutting method. Figure 15 is more used in the case 
that one wants to merge such modules since their genes are highly co-expressed.  
 
Figure 14: Clustering dendrogram of genes and gene modules identified using different colors. 
Height corresponds to the cut of the tree. Dynamic tree cut results from hierarchical linkage 
clustering. The color-band below the dendrogram denotes the modules, which are defined as 






Figure 15. Clustering dendrogram of genes, with dissimilarity based on the topological overlap, 
with the original module colors.  Height corresponds to the cut of the tree. ME before the name of 
colors means module eigengenes. 
 
Table 16 lists the number of genes in each of 19 modules depicted in Figure 15. The list 
of the correlation estimates and P-values between the 19 module eigenvalues and the genotype and 
treatment indicators is presented in Figure 16. The C and H genotypes were coded 0 and 1, 
respectively and the S and A treatments were coded 0 and 1, respectively, to compute correlation. 
Thus, a -0.5 correlation between transcript eigenvalue for the cyan module and treatment indicates 
that higher levels of gene expression in this module are associated with the S relative to the A 
treatment. One correlation between module eigenvalues and genotypes (grey module) had a P-
value < 0.1 and the estimate were -0.62 indicating that higher gene expression levels were observed 
in the C relative to the H genotype. Three modules (tan, cyan, and salmon) exhibited a significant 
(P-value < 0.1) correlation between the eigenvalue transcripts. The tan and cyan modules had 
negative correlations whereas salmon had a positive correlation. The grey, tan, cyan and salmon 


















































Figure 16.  The matrix of module-trait correlations (first cell entry) and P-values (second cell entry 
in parenthesis) between traits (columns) and module eigenvalues (rows). The color scale on the 
right indicates the sign and strength of the correlation estimate from –1 (green) to 1 (red). In the 
figure, the significant modules are highlighted (P-value < 0.1). “Line” means genotype and “trt” 






The plots in Figure 17 depict the gene significance (GS) versus module membership (MM) 
for the modules that exhibited a significant (P-value < 0.1) association between the eigengene and 
genotype (grey, Figure 17A) or treatment (tan, cyan and salmon, Figure 17B, C, and D, 
respectively). The GS and MM measures allow identifying genes that correlate with the traits as 
well as high module membership in interesting modules. Here, the grey module was the only 
significant module and presented moderate correlation with genotype. Despite significant, the 
modules salmon, cyan, and tan presented weak correlation with treatment.  
A)                                                                   B) 
 
Figure 17. Gene significance (GS) versus module membership (MM) for four modules exhibiting 
significant (P-value < 0.1) association between the eigenvalue expression and genotype or 
treatment.  A) Grey module presented moderate correlation with genotype. B) Salmon module 
salmon presented weak correlation with treatment. C) Cyan module presented weak correlation 
with treatment. D) Tan module presented weak correlation with treatment. “Cor” means 













Figure 17 (cont.) 
C)                                                                      D) 
 
Figure 17 (continued). Gene significance (GS) versus module membership (MM) for four 
modules exhibiting significant (P-value < 0.1) association between the eigenvalue expression and 
genotype or treatment.  A) Grey module presented moderate correlation with genotype. B) Salmon 
module salmon presented weak correlation with treatment. C) Cyan module presented weak 
correlation with treatment. D) Tan module presented weak correlation with treatment. “Cor” 
means correlation and “p” means P-value. 
 
Genes and enriched function with module associated with genotype or treatment 
Table 17 summarizes the most significant clusters of enriched GO BP terms within the 
grey module that had eigenvalue expression significantly correlated with genotype, like regulation 
of cell death and Wnt signaling pathway. Table 18 summarizes the most significant clusters of 
enriched GO BP terms within the tan, cyan and salmon modules that had eigenvalue expression 
significantly correlated with treatment. The tan module had GO BP terms related to nervous system 
development, while cyan module had regulation of nitrogen compound metabolic process and 










Table 17. Enriched clusters (FDR adjusted P-value <0.05) of Gene Ontology (GO) biological 
processes (BP) among the 247 genes in the grey module that had eigenvalue expression 
significantly associated with genotype.  





Cluster 1 Enrichment Score: 4.13 
   
BP GO:0010941~regulation of cell death 34 2.64E-05 0.049 
Cluster 3 Enrichment Score: 3.18 
   
BP GO:0030278~regulation of ossification 12 8.21E-06 0.015 
Cluster 6 Enrichment Score: 2.49 
   
BP GO:0016055~Wnt signaling pathway 15 2.50E-05 0.046 
BP GO:0198738~cell-cell signaling by wnt 15 2.57E-05 0.048 
aNumber of genes in the enriched category. 
bFalse Discovery rate adjusted P-value. 
 
Table 18. Clusters of Gene Ontology (GO) biological processes (BP) among the 95 genes in the 
salmon module, among the 90 genes in the cyan module, and among the 99 genes in the tan module 
that had eigenvalue expression significantly associated with treatment. 
Category Term Counta Raw P-
value 
FDR-
adjusted   
P-valueb 
Salmon 
    
Cluster 1 Enrichment Score: 2.13 
   
BP GO:2000026~regulation of multicellular organismal 
development 
16 0.0013 2.29 
BP GO:0051241~negative regulation of multicellular 
organismal process 
12 0.0016 2.79 
Cyan 
    
Cluster 1 Enrichment Score: 1.137 
   
BP GO:0051171~regulation of nitrogen compound 
metabolic process 
24 0.025 34.99 
Tan 
    
Cluster 1 Enrichment Score: 1.92 
   
BP GO:0051960~regulation of nervous system 
development 
16 4.43E-06 0.01 
BP GO:0008285~negative regulation of cell proliferation 12 6.81E-05 0.12 
BP GO:0007399~nervous system development 23 7.76E-05 0.14 
aNumber of genes in the enriched category. 






The top genes of each module were selected based on their function that may be important 
for the trait, and are presented in Table 19. Four of these genes also exhibited significant (FDR 
adjusted P-value < 0.05) treatment-by-line interaction effect. One of these genes (Oxt) was already 
discussed in Chapter 2. 
 
Table 19. Top important genes found in the four significant modules of the analysis and P-values 
and FDR adjusted P-values according to the comparison with treatment-by-line interaction effect 
and the main effect of genotype (grey module) and treatment (salmon, cyan, and tan modules) in 
the differential expression analysis of Chapter 2.  
Gene Symbol Gene Name P-value FDR adjusted P-
valuea 
Grey Module    
Fzd9 Frizzled class receptor 9 0.333 0.868 
Igf1 Insulin-like growth factor 0.902 0.999 
Tacr1 Tachykinin receptor 1 0.556 0.989 
Atf4 Activating transcription factor 4 0.771 0.999 
Bche Butyrylcholinesterase 0.366 0.896 
Cat Catalase 0.668 0.999 
Ppif Peptidylprolyl isomerase F (cyclophilin F) 2.7E-06 1.4E-04 
Cox4i2 Cytochrome c oxidase subunit IV isoform 2 0.917 0.999 
Salmon Module    
Jun Jun proto-oncogene 0.546 0.999 
Neurod1 Neurogenic differentiation 1 6.6E-09 1.0E-06 
Pnp Purine-nucleoside phosphorylase 0.432 0.999 
Xdh Xanthine dehydrogenase 0.542 0.999 
Cyan Module    
Creb3l1 cAMP responsive element binding protein 3-
like 1 
2.2E-03 2.9E-02 
Emx2 Empty spiracles homeobox 2 0.775 0.999 
Ppia Peptidylprolyl Isomerase A 0.440 0.999 
Gm3244 Predicted pseudogene 3244 0.546 0.999 
Tgm2 Transglutaminase 2, C polypeptide 0.353 0.999 
Tan Module    
Oxt Oxytocin 7.8E-13 7.0E-10 
Klk8 Kallikrein related-peptidase 8 0.559 0.999 
Cxcr4 Chemokine (C-X-C motif) receptor 4 0.336 0.999 
aFalse Discovery rate adjusted P-value. 
 
The identification of gene modules by WGCNA gives more information about the gene 
expression dataset that may be ignored just by doing differentially expression analysis. These 
results prove this concept by revealing important genes for the main effects of genotype and 
treatment, mostly not discussed before. Within the grey module, that was significantly correlated 





(Igf1), and tachykinin receptor 1 (Tacr1) were selected for being related to behavior, learning, and 
memory according to DAVID Functional Annotation Table. In agreement with this study, Fzd9 (-
/-) mutant mice in hippocampus presented severe deficits on tests of visuospatial learning/memory, 
and increased apoptosis in developing dentate gyrus (Zhao et al., 2005). Igf1 is involved in synaptic 
plasticity and acts on Igf1-receptor, which deletion causes impaired memory formation and 
learning (Liu et al., 2017b). Tacr1 is also known as a neurokinin-1 receptor (Nk1r) in the brain. 
Nk1r activation in the hippocampus plays a role in neuropeptides that have excitatory effects, and 
in the striatum, Tacr1 mediates learning and memory (Liu et al., 2017b). The gene activating 
transcription factor 4 (Atf4) is related to dopaminergic synapse and amphetamine addiction, and 
the gene butyrylcholinesterase (Bche) and catalase (Cat), with response to drug cocaine, and 
alcohol, respectively (e Silva et al., 2018; Mattes et al., 1997; Pavlovsky et al., 2013; Valera et al., 
2013). Atf4 is induced by amphetamine and stress in rat striatum, and the overexpression of this 
genes is involved with addiction-like and emotional behavior (Green et al., 2008; Pavlovsky et al., 
2013). Peptidylprolyl isomerase F (cyclophilin F) (Ppif) encodes cyclophilin D, which deficiency 
in improves learning, memory and synaptic function in Alzheimer’s disease (Du et al., 2008). 
Cytochrome c oxidase subunit IV isoform 2 (Cox4i2) is up-regulated in astrocytes in hypoxic and 
toxic conditions and is involved with increased necrosis rates in a mice model of Huntington’s 
disease (Misiak et al., 2010). The fact that all these genes are correlated with C line relative to H 
line might suggest an alteration in the activity of these genes in the H line. 
Genes found in these modules can be acting similarly or together with differentially 
expressed genes. For example, both neuropeptide vasopressin (Avp) and Tacr1 are important in 
the social interaction (Nelson et al., 2017). Avp, already discussed in Chapter 2, exhibiting 
significant treatment-by-line interaction effect, can also influence social, affective and addictive 
behaviors (Nelson et al., 2017). The increase in the expression of Avp and Tacr1 are associated 
with a decrease in social interaction (Nelson et al., 2017). This study identifies genes inside 
modules that are important for the complex system, which makes analysis of co-expression 
essential to complement the results already found. 
Among genes in the salmon module that was significantly correlated with mice receiving 
A relative to S treatment, the gene Jun proto-oncogene, AP-1 transcription factor subunit (Jun) is 
related to an amphetamine addiction, exposition to amphetamine increases brain expression of Jun, 





nucleoside phosphorylase (Pnp) deficiency causes apoptosis of activated T-cells, which 
consequently turns Pnp in the chemotherapeutic target for T-cell proliferative disorders (Gebre et 
al., 2017). Xanthine dehydrogenase (Xdh) is related to oxidative metabolism of purines and the 
increase in the expression of this gene is involved with oxidative stress in the brain of mice model 
for diabetes (Aliciguzel et al., 2003). The activity of neurogenic differentiation 1 (Neurod1) 
decreases after drug (morphine) administration, impairing contextual memory, regulating the 
opioid tolerance’s development (Li et al., 2014). These genes are correlated with A relative to S 
treatment which might suggest a drug addiction behavior and an alteration in the purine 
metabolism and due to the A treatment. Just Neurod1 exhibited significant treatment-by-line 
interaction effect; the other genes were not differentially expressed in a previous analysis of the 
main effect of in mice receiving the A relative to the S treatment. 
The cyan module that was significantly correlated with mice receiving S relative to A 
treatment also presented important genes that complement results found in Chapter 2, like the gene 
cAMP responsive element binding protein 3-like 1 (Creb3l1), that is a putative transcription factor 
of gene Avp (involved with addiction behavior before) in rat hypothalamus, and also called 
old astrocyte specifically induced substance (Oasis) when expressed in astrocytes, and may be 
important for protection against neuronal damage (Chihara et al., 2009; Greenwood et al., 2015). 
Mutations in the gene empty spiracles homeobox 2 (Emx2) may cause central nervous system 
malformation called schizencephaly and can include a motor or cognitive impairment and epilepsy  
(Dies et al., 2013). Peptidylprolyl isomerase A (Ppia) is also called cyclophilin A, and the presence 
extracellular Ppia mediates neuroinflammation in both patients and mouse model of sclerosis 
(Pasetto et al., 2017). The up-regulation of transglutaminase 2, C polypeptide (Tgm2) in different 
brain regions, is implicated with several neurodegenerative disorders, like Huntington’s, 
Alzheimer’s and Parkinson’s diseases (Lai et al., 2008). The presence of these genes correlated 
with mice receiving S relative to A treatment suggests protection or damage of neuronal functions. 
Finally, from the tan module that was also significantly correlated with mice receiving S 
relative to A treatment, oxytocin (Oxt) was selected for playing a role in response to amphetamine 
and behavior as discussed before. Kallikrein related-peptidase 8 (Klk8) that is related to nervous 
system development, behavior, learning or memory according to DAVID Functional Annotation 
Table. Klk8-knockout mice in hippocampus present impaired spatial working memory and 





motif) receptor 4 (Cxcr4) that modulates brain inflammation and neurotransmitter release, is down-
regulated in the presence of drug anti-depressant administration in the hippocampus and the frontal 
cortex of adult rats in an animal model of depression (Trojan et al., 2017). 
From the genes selected in the significant modules, four of them, one present in the grey 
module (Ppif), one in the salmon module (Neurod1), one in the cyan module (Creb3l1), and one 
in the tan module (Oxt), were differentially expressed in Chapter 2 and co-expressed in this 
analysis. Although Ppif, Neurod1, Creb3l1, and Oxt exhibited significant treatment-by-line 
interaction effect, just Oxt was discussed due to a large number of significant genes. 
 
Differential Co-expression Analysis 
Both WGCNA and differential co-expression analysis is useful for finding genes related to 
the traits of this study. The WGCNA showed genes in modules that are significantly and correlated 
with genotype and treatment. In WGCNA, all samples, irrespective of the trait (genotype or 
treatment) are used for the module construction (Fuller et al., 2007). In differential co-expression 
analysis what changes is that now we have subgroups to compare. Our aim in this analysis was to 
identify differentially connected genes between genotypes and between treatments. The genes that 
have differential connectivity may have a rewiring in response to environmental changes (Fuller 
et al., 2007). 
Differential co-expression analysis revealed that 1,968 genes showed differences in the 
connectivity between the A and S treatments. Table 20 is showing the top 10 of 87 genes that were 
meaningful (DiffK > |0.4|) and positively differentially connected, meaning that 87 genes had 
greater connectivity in A treatment than in S treatment. Table 21 is showing the top 10 of 188 
genes that were meaningful (DiffK > |0.4|) and negatively differentially connected, meaning that 









Table 20. Top 10 genes that were meaningful (DiffK > |0.4|) and positively differentially 
connected in mice receiving the A relative to the S treatment. 
Gene Symbol Connectivity in A 
treatment 
Connectivity in S 
treatment 
Norm.a in A 
treatment 
Norm. in S 
treatment 
DiffKb 
Slc35c1 55.236 4.902 0.989 0.072 0.917 
Zfpm2 55.842 5.737 1 0.085 0.915 
Ccdc3 55.842 7.656 1 0.113 0.887 
Atoh8 55.842 8.244 1 0.122 0.878 
Efna1 55.842 9.530 1 0.141 0.859 
Nrtn 51.593 4.489 0.924 0.066 0.857 
9330133O14Rik 55.842 12.126 1 0.179 0.821 
Foxk1 55.842 12.339 1 0.182 0.818 
Zfp316 55.842 12.755 1 0.188 0.812 
Copz2 55.842 12.806 1 0.189 0.811 
a Normalization dividing connectivities by the maximum value 
b Differential co-expression 
 
Table 21. Top 10 genes that were meaningful (DiffK > |0.4|) and negatively differentially 
connected in mice receiving the A relative to the S treatment. 
Gene Symbol Connectivity in A 
treatment 
Connectivity in S 
treatment 
Norm.a in A 
treatment 
Norm. in S 
treatment 
DiffKb 
Phax 6.655 67.694 0.119 1 -0.881 
Anxa2 6.244 67.167 0.112 0.992 -0.880 
Rai2 6.694 67.694 0.119 1 -0.880 
Zfp39 6.895 67.167 0.123 0.992 -0.869 
Bmp2 7.608 67.694 0.136 1 -0.864 
Gna15 7.910 67.167 0.142 0.992 -0.850 
Ephb3 8.596 67.694 0.154 1 -0.846 
C1qtnf6 8.637 67.694 0.155 1 -0.845 
Lysmd1 8.744 67.694 0.157 1 -0.843 
Gpn3 8.879 67.694 0.159 1 -0.841 
a Normalization dividing connectivities by the maximum value 
b Differential co-expression 
 
This analysis also revealed that 2,128 genes showed differences in the connectivity 
between the H and C lines. Table 22 is showing the top 10 of that 109 genes that were meaningful 
(DiffK > |0.4|) and positively differentially connected, meaning that 109 genes had greater 





meaningful (DiffK > |0.4|) and negatively differentially connected, meaning that 50 genes had 
greater connectivity in H line than in C line. 
 
Table 22. Top 10 genes that were meaningful (DiffK > |0.4|) and positively differentially 
connected in mice from C relative to the H line. 









Mterf 75.542 37.040 0.834 0.333 0.501 
Tmco1 87.790 51.887 0.969 0.467 0.503 
Zfp748 73.043 33.689 0.807 0.303 0.504 
Ccdc80 75.542 36.678 0.834 0.329 0.505 
Slc19a2 75.542 36.619 0.834 0.329 0.505 
Ppif 66.891 25.925 0.739 0.233 0.506 
Trim62 73.043 33.478 0.807 0.301 0.506 
Ddc 73.043 33.196 0.807 0.298 0.508 
Haus4 73.043 32.944 0.807 0.296 0.511 
2310008H04Rik 87.790 50.954 0.970 0.459 0.512 
a Normalization dividing connectivities by the maximum value 
b Differential co-expression 
 
Table 23. Top 10 genes that were meaningful (DiffK > |0.4|) and negatively differentially 
connected in mice from C relative to the H line. 









Hspe1 23.311 111.164 0.257 1 -0.742 
A330050F15Rik 26.913 111.164 0.297 1 -0.703 
Chchd8 27.003 111.164 0.298 1 -0.702 
Sbk1 27.076 111.164 0.299 1 -0.701 
Pcdh20 27.456 111.164 0.303 1 -0.697 
Dolk 27.476 111.164 0.303 1 -0.696 
Mki67ip 27.917 111.164 0.308 1 -0.692 
Snora65 27.930 111.164 0.308 1 -0.691 
Hhip 28.757 111.164 0.318 1 -0.682 
Cotl1 29.037 111.164 0.321 1 -0.679 
a Normalization dividing connectivities by the maximum value 






From the most meaningful (DiffK > |0.4|) and positively differentially connected to mice 
receiving the A relative to the S treatment, the gene atonal bhlh transcription factor 8 (Atoh8) may 
be important for the implication in specification and differentiation of neuronal cell lineages in the 
brain (Yao et al., 2010). For the negatively differentially connected to mice receiving the A relative 
to the S treatment, EPH receptor B3 (Ephb3) is an ephrin receptor and mediate numerous 
developmental processes, particularly in the nervous system, playing a deleterious role in synaptic 
stability and plasticity after brain injury (Perez et al., 2016). 
From the most meaningful (DiffK > |0.4|) and positively differentially connected to H-C 
line, the gene Ppif is a member of the peptidyl-prolyl cis-trans isomerase (PPIase) family. Among 
the related pathways of Ppif are calcium signaling pathway and respiratory electron transport 
according to DAVID Functional Annotation Table. This gene is probably one of the most 
important for this analysis because Ppif was differentially expressed in Chapter 2, significantly co-
expressed in the module grey, and differentially co-expressed. For the most meaningful (DiffK > 
|0.4|) and negatively differentially connected to mice from C relative to the H line, SH3 domain 
binding kinase 1 (Sbk1) is related to signal-transduction pathways and control of brain 
development according to DAVID Functional Annotation Table. The number of genes positively 
and negatively differentially connected to mice receiving the A relative to the S treatment and mice 
from C relative to the H line prevented the identification of enriched categories using DAVID. 
However, DAVID Functional Annotation Table was used to identify what function is related to 
each gene. 
 
Comparisons between analyses 
Weighted Gene Co-expression Network Analysis vs. Differential Expression Analysis 
Among the 2,193 genes analyzed in WGCNA, 54 were differentially expressed using 
Cuffdiff software (Chapter 2) for the main effect of A treatment, and 194 genes were differentially 
expressed in the main effect of H genotype, and 333 genes exhibited significant treatment-by-line 
interaction effect at FDR adjusted P-value < 0.05. Among the 194 genes differentially expressed 
across genotypes, the significant grey module included five genes: sarcospan (Sspn), lymphocyte 
cytosolic protein 1 (Lcp1), angiotensin II receptor-associated protein (Agtrap), insulin-like growth 





be highlighted as being required for synapse integrity and synaptic plasticity (Hirai et al., 2005). 
Among the genes in module grey, 41 presented significant interaction effect, as the Ppif, already 
discussed, neuronal differentiation 6 (Neurod6), that might be involved in the development and 
differentiation of the nervous system, and synuclein gamma (Sncg) that is a paralog of synuclein 
alpha (Sncg), involved in the pathogenesis of neurodegenerative diseases like Parkinson’s disease 
(Khan et al., 2017; Siddiqui et al., 2016).  
Among the modules including genes correlated with treatment, the salmon module did not 
encompass differentially expressed genes. The tan module presented 12 genes significant for 
interaction effects, including insulin receptor substrate 4 (Irs4), and Oxt. The cyan module 
presented 13 genes that were significant for interaction effects, including Creb3l1 and family with 
sequence similarity 19 member A1, C-C motif chemokine-like (Fam19a1)). The gene Fam19a1 
encodes TAFA proteins, which are neurokines that act as regulators of immune and nervous cells  
(Tang et al., 2004). In general, the WGCNA analysis gives complementary information about the 
gene expression dataset and helps to focus on genes that might be important. 
 
Weighted Gene Co-expression Network Analysis vs. Differential Co-expression Analysis 
Differential co-expression analysis identified 87 genes that were meaningful and positively 
differentially connected, while 188 genes were meaningful and negatively differentially connected 
between mice receiving the A relative to the S treatment. From the positively differentially 
connected, seven were present in the tan module, and three were present in the cyan module. From 
the negatively differentially connected, ten genes were also present in the salmon module, one in 
the tan module, and two in the cyan module. 
This analysis also revealed that 109 genes were meaningful and positively differentially 
connected, while 50 genes that were meaningful and negatively differentially connected between 
mice from C relative to the H line. From the positively differentially connected, just three genes 
were also present in the grey module, including the gene Ppif. No gene was both co-expressed in 
the grey module and negatively differentially connected between mice from C relative to the H 






The study of weighted gene co-expression network and differential co-expression analysis 
offered insights that complemented the findings from the differential expression, functional and 
network analyses in Chapter 2. The study of correlations between genes and treatments or lines, 
and correlations between genes identified genes that exhibited similar patterns of expression 
irrespectively of the individual level of differential expression. Differences in gene expression 
correlation across treatments and lines help to understand changes in connectivity associated with 
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